JP7499174B2 - 第viii因子(fviii)遺伝子治療法 - Google Patents
第viii因子(fviii)遺伝子治療法 Download PDFInfo
- Publication number
- JP7499174B2 JP7499174B2 JP2020505478A JP2020505478A JP7499174B2 JP 7499174 B2 JP7499174 B2 JP 7499174B2 JP 2020505478 A JP2020505478 A JP 2020505478A JP 2020505478 A JP2020505478 A JP 2020505478A JP 7499174 B2 JP7499174 B2 JP 7499174B2
- Authority
- JP
- Japan
- Prior art keywords
- fviii
- composition
- aav
- human
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000001690 Factor VIII Human genes 0.000 title claims description 404
- 108010054218 Factor VIII Proteins 0.000 title claims description 404
- 229960000301 factor viii Drugs 0.000 title claims description 379
- 238000001415 gene therapy Methods 0.000 title description 5
- 150000007523 nucleic acids Chemical class 0.000 claims description 240
- 102000039446 nucleic acids Human genes 0.000 claims description 223
- 108020004707 nucleic acids Proteins 0.000 claims description 223
- 239000013608 rAAV vector Substances 0.000 claims description 192
- 239000013598 vector Substances 0.000 claims description 149
- 230000014509 gene expression Effects 0.000 claims description 126
- 239000000203 mixture Substances 0.000 claims description 84
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 claims description 83
- 210000000234 capsid Anatomy 0.000 claims description 80
- 230000000694 effects Effects 0.000 claims description 77
- 230000002829 reductive effect Effects 0.000 claims description 68
- 102000040430 polynucleotide Human genes 0.000 claims description 48
- 108091033319 polynucleotide Proteins 0.000 claims description 48
- 239000002157 polynucleotide Substances 0.000 claims description 48
- 230000001225 therapeutic effect Effects 0.000 claims description 41
- 210000004185 liver Anatomy 0.000 claims description 34
- 241001164825 Adeno-associated virus - 8 Species 0.000 claims description 28
- 208000009292 Hemophilia A Diseases 0.000 claims description 28
- 230000015271 coagulation Effects 0.000 claims description 28
- 238000005345 coagulation Methods 0.000 claims description 28
- 241000702423 Adeno-associated virus - 2 Species 0.000 claims description 25
- 102100026735 Coagulation factor VIII Human genes 0.000 claims description 24
- 201000003542 Factor VIII deficiency Diseases 0.000 claims description 24
- 238000012217 deletion Methods 0.000 claims description 24
- 230000037430 deletion Effects 0.000 claims description 24
- 241001634120 Adeno-associated virus - 5 Species 0.000 claims description 23
- 208000032843 Hemorrhage Diseases 0.000 claims description 22
- 208000034158 bleeding Diseases 0.000 claims description 22
- 230000000740 bleeding effect Effects 0.000 claims description 22
- 239000003018 immunosuppressive agent Substances 0.000 claims description 21
- 239000008194 pharmaceutical composition Substances 0.000 claims description 21
- 241001655883 Adeno-associated virus - 1 Species 0.000 claims description 20
- 229960003444 immunosuppressant agent Drugs 0.000 claims description 20
- 241000202702 Adeno-associated virus - 3 Species 0.000 claims description 19
- 241000580270 Adeno-associated virus - 4 Species 0.000 claims description 18
- 241000972680 Adeno-associated virus - 6 Species 0.000 claims description 18
- 241001164823 Adeno-associated virus - 7 Species 0.000 claims description 18
- 241000649045 Adeno-associated virus 10 Species 0.000 claims description 18
- 241000649046 Adeno-associated virus 11 Species 0.000 claims description 18
- 241000124008 Mammalia Species 0.000 claims description 16
- 230000001861 immunosuppressant effect Effects 0.000 claims description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 15
- 241000702421 Dependoparvovirus Species 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 238000012417 linear regression Methods 0.000 claims description 13
- 239000000945 filler Substances 0.000 claims description 12
- 230000028993 immune response Effects 0.000 claims description 12
- 108091092195 Intron Proteins 0.000 claims description 7
- 208000007536 Thrombosis Diseases 0.000 claims description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- 230000024932 T cell mediated immunity Effects 0.000 claims description 4
- 238000011321 prophylaxis Methods 0.000 claims description 3
- 230000028996 humoral immune response Effects 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- 230000002269 spontaneous effect Effects 0.000 claims description 2
- 206010027514 Metrorrhagia Diseases 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 description 122
- 238000000034 method Methods 0.000 description 88
- 102000004169 proteins and genes Human genes 0.000 description 71
- 235000018102 proteins Nutrition 0.000 description 66
- 102000057593 human F8 Human genes 0.000 description 59
- 210000004027 cell Anatomy 0.000 description 55
- 238000011282 treatment Methods 0.000 description 53
- 239000013607 AAV vector Substances 0.000 description 51
- 241000282412 Homo Species 0.000 description 48
- 108090000765 processed proteins & peptides Proteins 0.000 description 41
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 38
- 241001465754 Metazoa Species 0.000 description 33
- 201000010099 disease Diseases 0.000 description 32
- 102000004196 processed proteins & peptides Human genes 0.000 description 31
- 230000003612 virological effect Effects 0.000 description 29
- 239000013612 plasmid Substances 0.000 description 26
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 25
- 238000001802 infusion Methods 0.000 description 24
- 108020004414 DNA Proteins 0.000 description 23
- 102000053602 DNA Human genes 0.000 description 23
- 241000700605 Viruses Species 0.000 description 22
- 239000003814 drug Substances 0.000 description 22
- 238000012384 transportation and delivery Methods 0.000 description 21
- 108010071690 Prealbumin Proteins 0.000 description 20
- 102000009190 Transthyretin Human genes 0.000 description 20
- 231100000319 bleeding Toxicity 0.000 description 20
- 239000003795 chemical substances by application Substances 0.000 description 20
- 239000002245 particle Substances 0.000 description 20
- 102100022641 Coagulation factor IX Human genes 0.000 description 19
- 235000001014 amino acid Nutrition 0.000 description 18
- 230000004044 response Effects 0.000 description 18
- 239000000427 antigen Substances 0.000 description 17
- 108091007433 antigens Proteins 0.000 description 17
- 102000036639 antigens Human genes 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 17
- 239000000047 product Substances 0.000 description 16
- 239000000523 sample Substances 0.000 description 16
- 229940024606 amino acid Drugs 0.000 description 15
- 150000001413 amino acids Chemical class 0.000 description 15
- 229940079593 drug Drugs 0.000 description 15
- 238000001727 in vivo Methods 0.000 description 15
- 229920001184 polypeptide Polymers 0.000 description 15
- 229920002477 rna polymer Polymers 0.000 description 15
- 238000012546 transfer Methods 0.000 description 15
- 241000282567 Macaca fascicularis Species 0.000 description 14
- 230000000295 complement effect Effects 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 14
- -1 cyclosporine A) Chemical compound 0.000 description 14
- 239000002773 nucleotide Substances 0.000 description 14
- 125000003729 nucleotide group Chemical group 0.000 description 14
- 239000003154 D dimer Substances 0.000 description 13
- 102100037850 Interferon gamma Human genes 0.000 description 13
- 108010074328 Interferon-gamma Proteins 0.000 description 13
- 108700019146 Transgenes Proteins 0.000 description 13
- 108010052295 fibrin fragment D Proteins 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 239000013615 primer Substances 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- 241000649047 Adeno-associated virus 12 Species 0.000 description 12
- 108091034117 Oligonucleotide Proteins 0.000 description 12
- 239000002299 complementary DNA Substances 0.000 description 12
- 229960003130 interferon gamma Drugs 0.000 description 12
- 230000004048 modification Effects 0.000 description 12
- 238000012986 modification Methods 0.000 description 12
- 238000011510 Elispot assay Methods 0.000 description 11
- 108010076282 Factor IX Proteins 0.000 description 11
- 230000008901 benefit Effects 0.000 description 11
- 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 11
- 229960004222 factor ix Drugs 0.000 description 11
- 230000023597 hemostasis Effects 0.000 description 11
- 230000001965 increasing effect Effects 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 230000001105 regulatory effect Effects 0.000 description 11
- 150000003431 steroids Chemical class 0.000 description 11
- 206010053567 Coagulopathies Diseases 0.000 description 10
- 230000002159 abnormal effect Effects 0.000 description 10
- 125000003275 alpha amino acid group Chemical group 0.000 description 10
- 210000003494 hepatocyte Anatomy 0.000 description 10
- 238000004806 packaging method and process Methods 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 241000282553 Macaca Species 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 239000003623 enhancer Substances 0.000 description 9
- 238000002560 therapeutic procedure Methods 0.000 description 9
- 230000026683 transduction Effects 0.000 description 9
- 238000010361 transduction Methods 0.000 description 9
- 238000011269 treatment regimen Methods 0.000 description 9
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 8
- 108010082126 Alanine transaminase Proteins 0.000 description 8
- 239000003114 blood coagulation factor Substances 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 7
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 7
- 108091026890 Coding region Proteins 0.000 description 7
- 230000002411 adverse Effects 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 230000023555 blood coagulation Effects 0.000 description 7
- 230000002950 deficient Effects 0.000 description 7
- 231100000673 dose–response relationship Toxicity 0.000 description 7
- 208000009429 hemophilia B Diseases 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 230000000069 prophylactic effect Effects 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 238000001990 intravenous administration Methods 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 230000003472 neutralizing effect Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000010076 replication Effects 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000003981 vehicle Substances 0.000 description 6
- 239000013603 viral vector Substances 0.000 description 6
- 108090000565 Capsid Proteins Proteins 0.000 description 5
- 102100023321 Ceruloplasmin Human genes 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 230000000405 serological effect Effects 0.000 description 5
- 230000002459 sustained effect Effects 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 4
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 4
- 108010036949 Cyclosporine Proteins 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- 208000031220 Hemophilia Diseases 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 230000035602 clotting Effects 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000007170 pathology Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical class CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000125945 Protoparvovirus Species 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229960000074 biopharmaceutical Drugs 0.000 description 3
- 208000015294 blood coagulation disease Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000005022 packaging material Substances 0.000 description 3
- 230000036470 plasma concentration Effects 0.000 description 3
- 230000008488 polyadenylation Effects 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 229930105110 Cyclosporin A Natural products 0.000 description 2
- 241000701022 Cytomegalovirus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000005176 Hepatitis C Diseases 0.000 description 2
- 101000823116 Homo sapiens Alpha-1-antitrypsin Proteins 0.000 description 2
- 241001135569 Human adenovirus 5 Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010062016 Immunosuppression Diseases 0.000 description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
- 241000713666 Lentivirus Species 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 102000003792 Metallothionein Human genes 0.000 description 2
- 108090000157 Metallothionein Proteins 0.000 description 2
- 108700011259 MicroRNAs Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 241000714474 Rous sarcoma virus Species 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 208000027276 Von Willebrand disease Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 2
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000007975 buffered saline Substances 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229960001265 ciclosporin Drugs 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 230000009852 coagulant defect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- 229930182912 cyclosporin Natural products 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000002716 delivery method Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 208000009190 disseminated intravascular coagulation Diseases 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000007459 endoscopic retrograde cholangiopancreatography Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 208000031169 hemorrhagic disease Diseases 0.000 description 2
- 231100000234 hepatic damage Toxicity 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 230000005745 host immune response Effects 0.000 description 2
- 102000051631 human SERPINA1 Human genes 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000008818 liver damage Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 2
- 239000002679 microRNA Substances 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 229940014456 mycophenolate Drugs 0.000 description 2
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 108010079892 phosphoglycerol kinase Proteins 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 238000009256 replacement therapy Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 229960004641 rituximab Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010043554 thrombocytopenia Diseases 0.000 description 2
- 230000005100 tissue tropism Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000002463 transducing effect Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical class OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 101150037123 APOE gene Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000031873 Animal Disease Models Diseases 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 102100029470 Apolipoprotein E Human genes 0.000 description 1
- 101710095339 Apolipoprotein E Proteins 0.000 description 1
- 208000001593 Bernard-Soulier syndrome Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101150044789 Cap gene Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 208000028702 Congenital thrombocyte disease Diseases 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 101100216294 Danio rerio apoeb gene Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical class OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010014172 Factor V Proteins 0.000 description 1
- 108010023321 Factor VII Proteins 0.000 description 1
- 229940124135 Factor VIII inhibitor Drugs 0.000 description 1
- 108010074105 Factor Va Proteins 0.000 description 1
- 108010014173 Factor X Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010058861 Fibrin Fibrinogen Degradation Products Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 231100001273 GLP toxicology study Toxicity 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000013607 Glanzmann thrombasthenia Diseases 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241001272567 Hominoidea Species 0.000 description 1
- 101000823435 Homo sapiens Coagulation factor IX Proteins 0.000 description 1
- 241000701109 Human adenovirus 2 Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 241000282596 Hylobatidae Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000028221 Mild hemophilia A Diseases 0.000 description 1
- 208000033375 Moderate hemophilia A Diseases 0.000 description 1
- 241000713333 Mouse mammary tumor virus Species 0.000 description 1
- 101000772176 Mus musculus Transthyretin Proteins 0.000 description 1
- 101100172173 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) hcr-1 gene Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000282579 Pan Species 0.000 description 1
- 208000013544 Platelet disease Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000282405 Pongo abelii Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000026552 Severe hemophilia A Diseases 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Chemical class OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Chemical class [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 108010022394 Threonine synthase Proteins 0.000 description 1
- 208000000392 Thrombasthenia Diseases 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 101710195626 Transcriptional activator protein Proteins 0.000 description 1
- 108091034131 VA RNA Proteins 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 102000004210 Vitamin K Epoxide Reductases Human genes 0.000 description 1
- 108090000779 Vitamin K Epoxide Reductases Proteins 0.000 description 1
- 101000756604 Xenopus laevis Actin, cytoplasmic 1 Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 101150087698 alpha gene Proteins 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Chemical class OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 238000011558 animal model by disease Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical class O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000011111 cardboard Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000005101 cell tropism Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940105774 coagulation factor ix Drugs 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 102000004419 dihydrofolate reductase Human genes 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000001667 episodic effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 229940012413 factor vii Drugs 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000208 fibrin degradation product Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000010448 genetic screening Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 210000002767 hepatic artery Anatomy 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229940052349 human coagulation factor ix Drugs 0.000 description 1
- 229960000027 human factor ix Drugs 0.000 description 1
- 229960000900 human factor viii Drugs 0.000 description 1
- 230000008348 humoral response Effects 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006058 immune tolerance Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Chemical class 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229940127215 low-molecular weight heparin Drugs 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000001630 malic acid Chemical class 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000013411 master cell bank Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000028174 moderately severe hemophilia A Diseases 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000011087 paperboard Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 208000004521 platelet storage pool deficiency Diseases 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000036515 potency Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002947 procoagulating effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000009163 protein therapy Methods 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000010837 receptor-mediated endocytosis Effects 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 101150066583 rep gene Proteins 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000003340 retarding agent Substances 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 210000003752 saphenous vein Anatomy 0.000 description 1
- 239000013644 scAAV2 vector Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000003875 slow muscle fiber Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 238000012385 systemic delivery Methods 0.000 description 1
- 239000011975 tartaric acid Chemical class 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 102000014898 transaminase activity proteins Human genes 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000031998 transcytosis Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 description 1
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 1
- 229960005080 warfarin Drugs 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5184—Virus capsids or envelopes enclosing drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14145—Special targeting system for viral vectors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
[0001]この特許出願は、2017年8月1日に出願された米国特許仮出願第62/540,053号;2017年11月9日に出願された米国特許仮出願第62/583,890号;2017年12月8日に出願された米国特許仮出願第62/596,535号;及び2017年12月8日に出願された米国特許仮出願第62/596,670号の利益を主張する。上記出願の内容全体は、全てのテキスト、表及び図面を含めて、参照により本明細書に組み込まれる。
[0002]本発明は、組換え凝固因子の製造及び異常な止血と関連する医学的障害の治療の分野に関する。より詳細には、本発明は、第VIII因子(FVIII)タンパク質をコードする核酸を投与する方法、及び血友病Aの治療方法を提供する。
[0003]いくつかの刊行物及び特許文献が、本発明が関連する技術の状態を記載するために本明細書の全体を通じて引用される。これらの引用のそれぞれは、参照により、完全に記載されたかのように本明細書に組み込まれる。
[0006]本発明によれば、血友病Aを有する又は第VIII因子(FVIII)を必要とするヒトを治療する方法が提供される。一実施形態では、方法は、組換えアデノ随伴ウイルス(rAAV)ベクターを投与するステップを含み、ベクターゲノムは、Bドメイン欠失を有する第VIII因子(FVIII)(hFVIII-BDD)をコードする核酸変種を含み、核酸変種は、配列番号7に対して95%又はそれより高い同一性を有する。別の実施形態では、方法は、組換えアデノ随伴ウイルス(rAAV)ベクターを投与するステップを含み、ベクターゲノムは、Bドメイン欠失を有する第VIII因子(FVIII)(hFVIII-BDD)をコードする核酸変種を含み、核酸変種は、2つより多くのシトシン-グアニンジヌクレオチド(CpG)を有しない。
[0149]血友病Aを有する又は第VIII因子(FVIII)を必要とするヒトを治療する方法が本明細書に開示され、提供される。そのような方法は、細胞及び/又はヒトにおいて発現されることができ、次いでin vivoで増加したFVIII又はhFVIII-BDDタンパク質レベルをもたらすことができるFVIII又はhFVIII-BDDをコードする核酸又は核酸変種を含むゲノム(geneome)を有するrAAVベクターを使用して達成することができる。FVIII又はhFVIII-BDDをコードする例示的な核酸変種は、参照野生型哺乳動物(例えば、ヒト)FVIII若しくはhFVIII-BDDと比較して低減したCpG及び/又は参照野生型哺乳動物(例えば、ヒト)FVIII若しくはhFVIII-BDDと100%未満の配列同一性を有することができる。そのような方法はまた、1キログラム当たり6x1012vrAAVベクターゲノム(vg/kg)未満の量のrAAVベクター用量を投与することにより達成することができる。1キログラム当たり6x1012vrAAVベクターゲノム(vg/kg)未満の量の用量で投与されるrAAVベクターは、FVIII又はhFVIII-BDDをコードする核酸又は核酸変種を含むベクターゲノムを含むことができる。
CpGが低減した第VIII因子DNA配列並びに細胞株を製造するある特定のベクター構築物、プラスミド構築物及びAAVベクター
[0298]FVIIIをコードする18の異なるCpGが低減した核酸変種(配列番号1~18)を製造し、発現アッセイにおいて評価した。変異体トランスサイレチン(TTRmut)プロモーター(配列番号22)を用いてCpGが低減したヒトFVIII cDNA構築物を生成した。
AAV2 ITR
トランスサイレチン(TTR)プロモーター:野生型プロモーターと比較して遺伝子発現を増加させる4つの点変異を有する肝臓特異的なトランスサイレチン(TTR)プロモーター(Costa et al. 1991)
合成イントロン:ヒト伸長因子EF-1アルファ遺伝子に由来する
FVIIIコーディング配列:Bドメインが欠失した、コドン最適化ヒトFVIIIコーディング配列
ウサギベータグロビンポリAシグナル配列(Levitt et al. 1989)
AAV2 ITR
遺伝子カセット(hFVIIIコーディング配列及び関連する調節エレメント)をプラスミドにクローニングしてベクタープラスミドpAAV-TTRmut-hFVIII-X07を得る。
ウイルスITRを欠いたAAVウイルスゲノム(rep及びcap)をプラスミドにクローニングしてAAVパッケージングプラスミドpLK03を得て、AAVベクターパッケージング用のトランスの必要とされるAAV2 rep及びAAV-LK03 cap遺伝子を得る。非相同組換えによる複製コンピテントAAVの形成を防止するためにrep遺伝子用のウイルスプロモーター(p5)をプラスミド中に再配置した。
アデノウイルス-2からの3つの遺伝子を第3のプラスミド(pCCVC-AD2HP)にクローニングして、ベクター製造のための必要なヘルパーウイルス遺伝子を得る。プラスミドpCCVC-AD2HPv2は11,832bpのプラスミド構築物であり、3つのアデノウイルス遺伝子であるE2A、E4及びVA RNAを有して、AAVベクターの複製及びキャプシド形成のために必要な「ヘルパー」機能を提供する。プラスミドpCCVC-AD2HPv2はpCCVC-AD2HPの誘導体であり、AmpR遺伝子及びpUC ori配列の部分を含有するDrdI-DrdI 1882bp制限断片が除去され、KanR遺伝子全体及びpUC ori配列の部分を含有するプラスミドpAAV2-hRPE65v2からのDrdI-DrdI断片で置換されている。
非ヒト霊長動物(NHP)におけるAAV-SPK-8005及びAAV-SPK-8011(LK03キャプシド、FVIII-X07(配列番号7))ベクターの評価
[0304]アデノ随伴ウイルス(AAV)ベクターにパッケージングされたFVIII導入遺伝子構築物を非ヒト霊長動物(NHP)に送達した。パイロット試験及びGLP試験の両方を行った。
非ヒト霊長動物(NHP)におけるAAV-LK03キャプシドの体内分布
[0322]非ヒト霊長動物におけるAAV-LK03キャプシドの体内分布を非GLP試験において評価した。ヒト凝固第IX因子をコードするAAV-LK03-キャプシド形成ベクター(AAV-LK03-hFIX)の静脈内投与は、2つの主な標的組織は肝臓及び脾臓であることを示した(図9)。脾臓指向性はAAV-LK03の特有の特徴ではない。例えば、高い安全性の記録と共にいくつもの肝臓指向性遺伝子療法試験(例えば、NCT02396342、NCT02082860、NCT02576795)において使用されているAAV5キャプシドは、非ヒト霊長動物の肝臓を標的化するよりも高い有効性ではないとしても肝臓と共に脾臓を標的化する(Paneda et al. 2013)。SPK-8011発現カセットでは、肝臓特異的であると考えられるマウストランスサイレチン又はTTRプロモーターが使用される(Costa、1991)。プロモーターの肝臓特異的な性質をさらにサポートするために、SPK-8011と同じ発現カセット(すなわち、AAV-SPK-8005)をパッケージングする異なるAAVベクターの投与後にマウスの肝臓及び脾臓におけるベクター由来のFVIII発現をPCRベースの発現解析により測定した。図10に示すように、脾臓におけるヒトFVIII発現は、肝細胞に由来するヒトFVIII発現と比較して数桁低い。
in vitroの設定で分析されたAAV-LK03キャプシドの形質導入効率
[0324]カニクイザル及びヒト起源の初代肝細胞に細胞1個当たり500~62,500ベクターゲノムの範囲内の4つの異なる感染多重度(MOI)でルシフェラーゼを発現するAAV-LK03ベクターを形質導入した。形質導入の72時間後にルシフェラーゼ発現を分析した。
ヒト臨床試験用量の算出
[0326]非ヒト霊長動物(NHP)において観察されたhFVIIIレベルに基づいて、ヒトにおいて提案される5x1011vg/kgの開始用量における予測されるFVIIIレベルの推定値を決定した。異なるベクターのロットはわずかに異なる肝臓形質導入有効性を有することがあるので、パイロット及びGLPの両方の毒物学NHP試験からのデータを使用して、5x1011vg/kgの投与後のFVIII濃度の範囲を補間した。この分析について、線形回帰モデル(図12)を使用し、すなわち、AAV用量と結果として得られるhFVIII発現レベルとの関係は、線形性から有意に逸脱しなかった(表2)。
ヒト臨床試験の設計
[0330]適格性
試験のために適格の年齢:18歳以上(成人、高齢者)
試験のために適格の性別:男性
健常ボランティアの受入れ:なし
18歳以上の男性
正常の≦2%の血漿FVIII活性レベルを有する病歴により立証される血友病Aの確定診断
>150の曝露日数(ED)のFVIII濃縮物又はクリオプレシピテートを受けている
オンデマンド療法を受けている及び正常の1~2%のFVIIIベースラインレベルを有する場合に限り先行する12カ月にわたり>10の出血事象を経験している
いかなるFVIII生成物に対してもアレルギー性反応の前歴を有しない
中央検査室による評価で第VIII因子阻害剤に対する測定可能な阻害剤を有さず、及びFVIIIタンパク質への阻害剤の前歴を有しない
信頼できるバリアー避妊法の使用への同意
活動性B型又はC型肝炎の証拠
B型又はC型肝炎に対する抗ウイルス療法を現在受けている
重大な基礎肝疾患を有する
CD4数≦200/mm3と共にHIV-1又はHIV-2の血清学的証拠*を有する(*HIV+であり、並びにCD4数>200/mm3及び検出不可能なウイルス負荷を有して安定な参加者は登録のために適格である)
AAV-Spark200キャプシドと反応性の検出可能な抗体を有する
直前の52週以内に遺伝子移入試験に又は直前の12週以内に治験製品を用いた臨床試験に参加した
異なる用量のAAV-SPK-8011(LK03キャプシド)-hFVIIIにおいて予測されるFVIIIレベル
[0333]臨床試験NCT03003533(「血友病Aに対する遺伝子移入試験」)は、LK03(配列番号27)として公知のAAVキャプシドのファースト・イン・ヒューマンの使用である。非ヒト霊長動物での試験により、増加用量のAAV-SPK-8011(LK03キャプシド)-hFVIIIは、少なくとも一部の用量範囲について、線形性から有意に逸脱しないようである用量依存的な方式で循環性ヒトFVIIIのレベルの増加を結果としてもたらすことが示される。第1のコホートにおける平均定常状態FVIIIレベル(±平均値の標準誤差)は、正常の約11.7±2.3%であった。この用量コホートにおける2人の参加者というnを考慮すると、観察されるFVIIIレベルにおける比較的低いばらつきが、より多くの参加者が試験に組み入れられる時に維持されるかどうかを予測することは難しい。
ヒト臨床試験の結果
[0335]重篤(N=11)又は中等度に重篤(N=1)な血友病Aを有する12人の男性において用量漸増試験を行った。対象は18~52歳の範囲内であった。遺伝子療法の前に、12人のうち8人の対象を予防により、及び12人のうち4人の対象をエピソード治療で処置した。対象を3つの投与コホートのうちの1つに登録し、5×1011vg/kg(N=2、対象1及び2)、1×1012vg/kg(N=3、対象3、4及び6)、又は2×1012vg/kg(N=7、対象5及び7~12)の用量でSPK-8011(AAV-hFVIII、LK03キャプシド)を注入した。
TTRプロモーター
[0347]トランスサイレチン(TTR)プロモーターの特徴付けは元々、Costa and Grayson 1991, Nucleic Acids Research 19(15):4139-4145に記載された。TTRプロモーター配列は、TATTTGTGTAGからTATTGACTTAGに改変された配列であった。
4つのヌクレオチド変異(TTRmut)を有するTTRプロモーター、配列番号22
GTCTGTCTGCACATTTCGTAGAGCGAGTGTTCCGATACTCTAATCTCCCTAGGCAAGGTTCATATTGACTTAGGTTACTTATTCTCCTTTTGTTGACTAAGTCAATAATCAGAATCAGCAGGTTTGGAGTCAGCTTGGCAGGGATCAGCAGCCTGGGTTGGAAGGAGGGGGTATAAAAGCCCCTTCACCAGGAGAAGCCGTCACACAGATCCACAAGCTCCT
CpGが低減したFVIIIをコードする導入遺伝子構築物及び例示的なAAVキャプシド
FVIIIをコードするCpGが低減した核酸変種X01(配列番号1)
atgcagattg agctgtctac ctgcttcttc ctgtgcctgctgaggttctg cttctctgct
accaggaggt actacctggg ggctgtggag ctgagctgggattacatgca gtctgacctg
ggggagctgc ctgtggatgc caggtttccc cccagggtgcccaagagctt ccccttcaat
acctctgtgg tgtataagaa gaccctgttt gtggagttcactgatcatct gttcaacatt
gctaaaccca ggcccccctg gatggggctg ctgggccctaccatccaggc tgaggtgtat
gacactgtgg tgatcactct gaagaacatg gctagccatcctgtgtctct gcatgctgtg
ggggtgagct actggaaggc ttctgagggg gctgagtatgatgatcagac tagccagagg
gagaaggagg atgacaaggt gttccctggg ggctctcacacctatgtctg gcaggtgctg
aaggagaatg gccccatggc ctctgatcct ctgtgtctgacctatagcta cctgagccat
gtggacctgg tgaaggacct gaactctggc ctgattggggccctgctggt gtgtagggag
gggagcctgg ccaaggagaa gacccagacc ctgcacaagttcattctgct gtttgctgtg
tttgatgagg gcaagagctg gcattctgaa accaagaacagcctgatgca ggacagggat
gctgcctctg ctagggcctg gcccaagatg cacactgtgaatgggtatgt caataggtct
ctgcctggcc tgattggctg ccacaggaag tctgtgtactggcatgtgat tgggatgggc
accacccctg aggtgcacag catctttctg gagggccacaccttcctggt gaggaatcac
agacaggcca gcctggagat cagccccatc accttcctgactgcccagac cctgctgatg
gacctgggcc agtttctgct gttctgccac atctctagccaccagcatga tggcatggag
gcctatgtga aggtggactc ctgccctgag gagccccagctgaggatgaa gaataatgag
gaggctgagg actatgatga tgacctgact gactctgagatggatgtggt gagatttgat
gatgacaatt ctcccagctt cattcagatc aggtctgtggccaagaagca tcccaagacc
tgggtgcact acattgctgc tgaggaggag gactgggactatgcccccct ggtgctggcc
cctgatgaca ggagctataa gagccagtac ctgaataatggcccccagag gattgggagg
aagtataaga aggtgaggtt catggcctat actgatgaaaccttcaagac cagagaggcc
atccagcatg agtctgggat cctggggccc ctgctgtatggggaggtggg ggacaccctg
ctgatcatct tcaagaacca ggccagcagg ccctacaacatctaccctca tggcatcact
gatgtgaggc ctctgtacag cagaaggctg cccaagggggtgaagcatct gaaggacttc
cccattctgc ctggggagat tttcaagtac aagtggactgtgactgtgga ggatggccca
accaagtctg accctaggtg cctgactagg tactacagcagctttgtgaa tatggagagg
gacctggcct ctggcctgat tggccccctg ctgatctgctacaaggagtc tgtggatcag
aggggcaacc agatcatgtc tgacaagagg aatgtgatcctgttctctgt gtttgatgag
aacaggagct ggtacctgac tgagaacatt cagaggtttctgcccaaccc tgctggggtg
cagctggagg accctgaatt ccaggcctct aacatcatgcacagcattaa tggctatgtg
tttgacagcc tgcagctgtc tgtgtgcctg catgaggtggcctactggta cattctgagc
attggggccc agactgactt cctgtctgtg ttcttctctggctacacctt taagcacaag
atggtgtatg aggataccct gaccctgttt cctttctctggggagactgt gttcatgagc
atggagaacc ctggcctgtg gatcctgggc tgccacaactctgacttcag gaacaggggg
atgactgctc tgctgaaggt gagcagctgt gataagaacactggggacta ctatgaggac
agctatgagg acatctctgc ctatctgctg agcaagaataatgctattga gcccaggagc
ttctctcaga acccccctgt gctgaagagg caccagagggagatcaccag aactactctg
cagtctgacc aggaggagat tgactatgat gacaccatctctgtggagat gaagaaggag
gattttgata tttatgatga ggatgaaaac cagagccccaggagctttca gaagaagact
aggcactatt tcattgctgc tgtggagagg ctgtgggactatggcatgtc ttctagcccc
catgtgctga ggaacagggc ccagtctggc tctgtgccccagttcaagaa ggtggtgttc
caggagttca ctgatggcag cttcactcag cccctgtacaggggggagct gaatgagcac
ctggggctgc tgggccctta tatcagggct gaggtggaggataacatcat ggtgaccttc
aggaaccagg ccagcaggcc ctacagcttc tactctagcctgatcagcta tgaggaggac
cagaggcagg gggctgagcc caggaagaac tttgtgaagcccaatgagac caagacttat
ttctggaagg tgcagcacca tatggccccc accaaggatgagtttgattg caaagcctgg
gcctacttct ctgatgtgga cctggagaag gatgtgcactctgggctgat tggccccctg
ctggtgtgcc acaccaacac tctgaaccct gcccatggcaggcaggtgac tgtgcaggag
tttgccctgt tcttcaccat ctttgatgag actaagagctggtacttcac tgagaacatg
gagaggaact gcagggcccc ctgcaatatc cagatggaggaccccacctt taaggaaaat
tataggtttc atgccattaa tggctacatc atggacaccctgcctggcct ggtgatggcc
caggaccaga ggatcaggtg gtacctgctg agcatgggcagcaatgagaa cattcacagc
atccacttct ctggccatgt gttcactgtg aggaagaaggaggagtacaa gatggccctg
tataatctgt accctggggt gtttgagact gtggagatgctgcccagcaa ggctggcatc
tggagggtgg agtgcctgat tggggagcac ctgcatgctggcatgagcac cctgttcctg
gtgtattcta acaagtgtca gacccccctg ggcatggcctctggccatat cagggacttc
cagatcactg cctctggcca gtatgggcag tgggcccccaagctggccag gctgcattac
tctggcagca tcaatgcctg gagcaccaag gagccattcagctggattaa ggtggacctg
ctggctccaa tgattatcca tggcatcaag acccagggggccaggcagaa gtttagcagc
ctgtacatct ctcagtttat catcatgtac tctctggatggcaaaaagtg gcagacctac
aggggcaatt ctactggcac tctgatggtg ttctttggcaatgtggacag ctctgggatc
aagcacaaca tctttaaccc ccctatcatt gccaggtacattaggctgca ccccacccat
tacagcatca ggagcaccct gaggatggag ctgatgggctgtgatctgaa cagctgcagc
atgcccctgg gcatggagag caaggctatc tctgatgcccagattactgc cagcagctac
ttcaccaata tgtttgccac ctggagcccc agcaaggccaggctgcacct gcagggcagg
tctaatgcct ggaggcccca ggtgaacaac cccaaggagtggctgcaggt ggacttccag
aagaccatga aggtgactgg ggtgaccacc cagggggtgaagagcctgct gactagcatg
tatgtgaagg agttcctgat cagcagcagc caggatggccatcagtggac cctgttcttc
cagaatggca aggtgaaggt gttccagggc aatcaggacagcttcacccc tgtggtgaac
agcctggacc cccccctgct gaccagatac ctgaggatccacccccagag ctgggtgcat
cagattgccc tgaggatgga ggtgctgggg tgtgaggcccaggacctgta ctga
FVIIIをコードするCpGが低減した核酸変種X02(配列番号2)
atgcagattg agctgtctac ctgctttttc ctgtgtctgctgaggttctg cttctctgcc
actaggaggt actacctggg ggctgtggag ctgtcttgggattacatgca gtctgatctg
ggggagctgc ctgtggatgc caggtttcct cccagggtgcccaagtcttt ccccttcaat
acctctgtgg tgtataagaa gaccctgttt gtggagtttactgatcacct gttcaacatt
gccaagccca ggcccccttg gatgggcctg ctggggcccaccatccaggc tgaggtgtat
gacactgtgg tgatcaccct gaagaacatg gcctctcaccctgtgagcct gcatgctgtg
ggggtgagct actggaaggc ctctgagggg gctgagtatgatgaccagac cagccagagg
gagaaggagg atgataaggt gttccctggg gggagccacacttatgtgtg gcaggtgctg
aaggagaatg gcccaatggc ctctgatccc ctgtgcctgacctattctta cctgagccat
gtggacctgg tgaaggacct gaactctggc ctgattggggccctgctggt gtgcagggag
ggctctctgg ctaaggagaa gacccagacc ctgcacaagttcatcctgct gtttgctgtg
tttgatgagg ggaagagctg gcactctgag accaagaacagcctgatgca ggacagggat
gctgcctctg ccagggcctg gcccaaaatg cacactgtgaatggctatgt gaataggagc
ctgcctggcc tgattggctg ccacaggaag tctgtgtattggcatgtgat tggcatgggc
accacccctg aggtgcactc tatcttcctg gagggccatactttcctggt gaggaatcat
aggcaggcca gcctggagat tagccccatt acctttctgactgcccagac cctgctgatg
gacctgggcc agttcctgct gttttgccac atcagctctcaccagcatga tggcatggag
gcctatgtga aggtggatag ctgccctgag gagccccagctgaggatgaa gaacaatgag
gaggctgagg attatgatga tgatctgact gattctgaaatggatgtggt gaggtttgat
gatgacaata gcccctcttt catccagatc aggtctgtggccaagaagca tcctaagacc
tgggtgcact acattgctgc tgaggaggag gactgggactatgctcccct ggtgctggcc
cctgatgaca ggtcttacaa gagccagtac ctgaacaatggcccccagag aattgggagg
aagtataaga aggtgagatt catggcttac actgatgagaccttcaagac tagggaggcc
atccagcatg agtctggcat tctgggcccc ctgctgtatggggaggtggg ggacaccctg
ctgatcatct tcaagaacca ggcctctagg ccctacaatatttaccccca tgggatcact
gatgtgaggc ccctgtacag caggaggctg cctaagggggtgaagcatct gaaggacttc
cccatcctgc ctggggagat cttcaagtat aagtggactgtgactgtgga agatggcccc
accaagtctg accctaggtg cctgaccagg tactactcttcttttgtgaa catggagagg
gacctggcct ctggcctgat tggccccctg ctgatctgctacaaggagtc tgtggaccag
agggggaacc agattatgtc tgacaagagg aatgtgattctgttctctgt gtttgatgag
aacaggagct ggtatctgac tgagaacatc cagaggttcctgcccaatcc tgctggggtg
cagctggagg accctgagtt ccaggccagc aacatcatgcacagcatcaa tgggtatgtg
tttgattctc tgcagctgtc tgtgtgcctg catgaggtggcctactggta catcctgagc
attggggctc agactgattt cctgtctgtg ttcttttctggctacacctt taagcataag
atggtgtatg aggacactct gaccctgttt cccttctctggggagactgt gtttatgagc
atggagaacc ctggcctgtg gatcctgggc tgccacaactctgatttcag gaacaggggc
atgactgctc tgctgaaggt gtcttcttgt gacaagaacactggggacta ttatgaggac
agctatgagg acatctctgc ctacctgctg agcaagaacaatgctattga gcccagatct
ttcagccaga acccccctgt gctgaagagg caccagagggagatcactag gaccaccctg
cagtctgacc aggaggagat tgactatgat gacactatctctgtggagat gaagaaggag
gactttgata tctatgatga ggatgagaac cagtctcccaggagcttcca gaaaaagacc
aggcactact tcattgctgc tgtggagagg ctgtgggactatggcatgtc ttctagcccc
catgtgctga ggaacagggc ccagtctggg tctgtgccccagttcaagaa ggtggtgttc
caggagttca ctgatgggag cttcacccag cctctgtacaggggggagct gaatgagcac
ctggggctgc tgggccctta tattagggct gaggtggaggacaacatcat ggtgactttc
aggaatcagg cctctaggcc ctatagcttc tacagctctctgatcagcta tgaggaggat
cagaggcagg gggctgagcc caggaagaac tttgtgaagcccaatgagac caagacctac
ttctggaagg tgcagcacca catggctcct accaaggatgagtttgactg caaggcctgg
gcctactttt ctgatgtgga cctggagaag gatgtgcactctggcctgat tggccccctg
ctggtgtgtc ataccaacac cctgaaccct gcccatggcaggcaggtgac tgtgcaggag
tttgccctgt tcttcaccat ctttgatgag accaagagctggtactttac tgagaacatg
gagaggaatt gcagagcccc ttgcaacatc cagatggaggacccaacctt caaagagaac
tacaggttcc atgccatcaa tgggtacatc atggacaccctgcctggcct ggtgatggct
caggaccaga ggatcaggtg gtatctgctg agcatgggcagcaatgagaa tatccatagc
attcacttct ctggccatgt gttcactgtg aggaagaaggaggagtacaa gatggccctg
tataacctgt accctggggt gtttgagact gtggagatgctgccaagcaa ggctgggatt
tggagggtgg agtgcctgat tggggagcac ctgcatgctggcatgtctac cctgttcctg
gtgtactcca ataagtgcca gacccccctg ggcatggcctctggccacat cagggacttc
cagatcactg cctctggcca gtatgggcag tgggccccaaagctggccag gctgcactat
tctgggagca tcaatgcttg gagcaccaag gagcctttcagctggattaa ggtggatctg
ctggccccca tgatcattca tggcatcaaa acccagggggctagacagaa gttttctagc
ctgtacatca gccagttcat catcatgtac agcctggatggcaagaagtg gcagacttac
aggggcaata gcactggcac cctgatggtg ttttttggcaatgtggacag ctctggcatc
aagcacaaca tctttaaccc ccccattatt gccaggtatatcaggctgca tcccacccac
tattctatta ggtctactct gagaatggag ctgatgggctgtgacctgaa cagctgtagc
atgcccctgg ggatggagag caaggctatc tctgatgcccagatcactgc cagctcttat
ttcaccaata tgtttgccac ctggtctccc tctaaggccaggctgcacct gcagggcagg
agcaatgctt ggaggcccca ggtgaataac cccaaggagtggctgcaggt ggacttccag
aagaccatga aggtgactgg ggtgactacc cagggggtgaagtctctgct gactagcatg
tatgtgaagg agttcctgat cagcagcagc caggatgggcatcagtggac tctgttcttc
cagaatggca aggtgaaggt cttccagggg aaccaggatagcttcactcc tgtggtgaac
tctctggacc cccccctgct gactaggtat ctgaggatccacccccagag ctgggtgcac
cagattgccc tgaggatgga ggtgctgggc tgtgaggcccaggacctgta ttga
FVIIIをコードするCpGが低減した核酸変種X03(配列番号3)
atgcagattg aactgtctac ttgtttcttc ctgtgcctgctgaggttttg cttctctgct
actaggaggt actatctggg ggctgtggag ctgtcttgggactatatgca gtctgacctg
ggggagctgc ctgtggatgc taggtttccc cccagggtgcccaagagctt cccctttaac
acctctgtgg tgtataagaa gactctgttt gtggagttcactgaccatct gttcaacatt
gccaagccaa ggcccccctg gatgggcctg ctgggccccaccatccaggc tgaggtgtat
gacactgtgg tgattactct gaagaacatg gccagccatcctgtgagcct gcatgctgtg
ggggtgtctt actggaaggc ctctgagggg gctgagtatgatgaccagac ctctcagagg
gagaaggagg atgacaaggt gttccctggg ggctctcatacctatgtgtg gcaggtcctg
aaggagaatg ggcccatggc ctctgacccc ctgtgcctgacctactctta tctgtctcat
gtggacctgg tgaaggacct gaactctggc ctgattggggccctgctggt gtgcagggag
ggcagcctgg ctaaggagaa gacccagact ctgcacaagttcatcctgct gtttgctgtg
tttgatgagg gcaagagctg gcactctgag accaagaacagcctgatgca ggacagggat
gctgcctctg ctagggcctg gcccaagatg cacactgtgaatgggtatgt gaacaggagc
ctgccaggcc tgattggctg ccataggaag tctgtgtattggcatgtgat tgggatgggg
actacccctg aggtccacag cattttcctg gaggggcatacctttctggt gaggaaccac
aggcaggcct ctctggagat ctctcccatt actttcctgactgcccagac cctgctgatg
gacctgggcc agttcctgct gttctgccac atcagcagccaccagcatga tggcatggag
gcctatgtga aggtggatag ctgccctgag gagccccagctgaggatgaa aaacaatgag
gaggctgagg attatgatga tgacctgact gattctgagatggatgtggt gaggtttgat
gatgataaca gccccagctt catccagatt aggtctgtggccaagaagca tcccaagacc
tgggtgcact acattgctgc tgaggaggag gattgggactatgctcctct ggtgctggcc
cctgatgaca ggagctacaa gagccagtac ctgaataatggcccccagag gattggcagg
aagtataaga aggtgaggtt catggcctac actgatgagacctttaagac cagggaggcc
atccagcatg aatctgggat cctgggcccc ctgctgtatggggaggtggg ggacaccctg
ctgattatct ttaagaacca ggctagcagg ccctacaacatttaccccca tggcattact
gatgtgaggc ccctgtacag caggaggctg cccaagggggtgaagcacct gaaggatttc
cccattctgc ctggggagat ctttaagtac aaatggactgtgactgtgga ggatggccct
actaagtctg atcccaggtg tctgaccaga tactacagcagctttgtgaa tatggagagg
gacctggctt ctggcctgat tggccccctg ctgatctgctacaaggagtc tgtggaccag
aggggcaatc agattatgtc tgacaagagg aatgtgatcctgttctctgt gtttgatgag
aacagaagct ggtacctgac tgagaacatc cagaggttcctgcccaaccc tgctggggtg
cagctggagg accctgagtt ccaggctagc aatatcatgcacagcattaa tggctatgtg
tttgacagcc tgcagctgtc tgtgtgcctg catgaggtggcctattggta cattctgagc
attggggccc agactgattt cctgtctgtg ttcttttctggctacacctt caagcacaag
atggtgtatg aggatactct gaccctgttt cccttctctggggagactgt gttcatgagc
atggagaacc ctggcctgtg gatcctgggc tgtcacaactctgacttcag gaacaggggc
atgactgccc tgctgaaggt gagctcttgt gataagaacactggggacta ctatgaggac
tcttatgagg acatctctgc ctacctgctg agcaagaacaatgctattga gcccaggagc
ttctctcaga atccccctgt gctgaagagg catcagagggagatcactag gactaccctg
cagtctgacc aggaagagat tgactatgat gacaccatctctgtggaaat gaagaaggag
gactttgata tctatgatga ggatgaaaac cagagccccaggagcttcca gaagaagacc
aggcattact tcattgctgc tgtggagagg ctgtgggactatgggatgag ctcttctccc
catgtgctga ggaatagggc tcagtctggc tctgtcccacagttcaagaa ggtggtgttt
caggagttca ctgatggcag cttcactcag cccctgtacaggggggagct gaatgagcat
ctgggcctgc tggggcccta catcagggct gaggtggaggataacattat ggtgactttc
aggaaccagg cctctaggcc ctacagcttc tacagcagcctgatcagcta tgaggaggac
cagaggcagg gggctgagcc caggaagaac tttgtgaagcccaatgagac taagacctat
ttctggaagg tgcagcatca catggctccc actaaagatgagtttgactg caaggcctgg
gcctacttct ctgatgtgga tctggagaag gatgtgcattctgggctgat tggccctctg
ctggtctgcc atactaacac cctgaatcct gcccatggcaggcaggtgac tgtgcaggag
tttgccctgt tctttaccat ctttgatgag accaagtcttggtacttcac tgagaacatg
gagaggaact gcagggcccc ctgtaacatc cagatggaggaccccacctt taaggagaac
tacaggttcc atgccatcaa tggctacatc atggacactctgcctggcct ggtgatggcc
caggaccaga ggatcaggtg gtacctgctg tctatgggctctaatgagaa cattcattct
atccacttct ctggccatgt gtttactgtg aggaagaaggaggagtacaa gatggccctg
tacaatctgt accctggggt gtttgaaact gtggagatgctgccctctaa ggctggcatc
tggagggtgg agtgcctgat tggggaacac ctgcatgctggcatgagcac cctgttcctg
gtctatagca ataagtgcca gacccccctg gggatggcctctgggcatat cagagacttc
cagatcactg cctctggcca gtatggccag tgggcccccaagctggccag gctgcactac
tctggcagca ttaatgcctg gagcaccaag gagcccttctcttggatcaa ggtggacctg
ctggctccca tgatcatcca tgggatcaag acccagggggccaggcagaa gttcagcagc
ctgtacatct ctcagttcat catcatgtac tctctggatggcaagaagtg gcagacctac
aggggcaata gcactgggac cctgatggtg ttctttgggaatgtggacag ctctggcatc
aagcacaata tcttcaaccc ccccatcatt gccaggtacatcagactgca ccccactcat
tacagcatca ggagcactct gaggatggag ctgatgggctgtgacctgaa tagctgctct
atgcccctgg gcatggagag caaggccatt tctgatgcccagattactgc ctcttcttac
ttcactaata tgtttgccac ctggagcccc agcaaggccaggctgcatct gcaggggagg
agcaatgcct ggaggcccca ggtgaacaac cccaaggagtggctgcaggt ggacttccag
aagactatga aggtgactgg ggtgaccact cagggggtgaagagcctgct gaccagcatg
tatgtgaagg agttcctgat ctcttctagc caggatgggcaccagtggac cctgtttttc
cagaatggga aggtgaaggt gtttcagggc aatcaggacagctttactcc tgtggtgaac
agcctggacc cccccctgct gactaggtac ctgaggattcacccccagag ctgggtgcac
cagattgccc tgaggatgga ggtgctgggc tgtgaggcccaggatctgta ctga
FVIIIをコードするCpGが低減した核酸変種X04(配列番号4)
atgcagattg agctgtctac ctgcttcttt ctgtgcctgctgaggttctg tttctctgcc
actaggaggt attatctggg ggctgtggag ctgtcctgggactacatgca gtctgatctg
ggggagctgc ctgtggatgc caggttccct cccagggtgcccaagtcttt ccctttcaat
acctctgtgg tgtacaagaa gactctgttt gtggagtttactgatcacct gtttaacatt
gccaagccca ggcccccctg gatggggctg ctgggccccaccatccaggc tgaggtgtat
gacactgtgg tgattactct gaagaatatg gcttctcaccctgtgagcct gcatgctgtg
ggggtgagct actggaaggc ctctgagggg gctgagtatgatgaccagac cagccagagg
gagaaggagg atgacaaggt gttccctggg ggcagccacacttatgtgtg gcaggtgctg
aaggagaatg gcccaatggc ctctgacccc ctgtgcctgacctacagcta tctgagccat
gtggatctgg tgaaggatct gaactctggc ctgattggggccctgctggt gtgcagggag
ggctctctgg ccaaggagaa gactcagact ctgcacaagttcatcctgct gtttgctgtg
tttgatgagg gcaagagctg gcactctgag accaagaactctctgatgca ggatagggat
gctgcttctg ccagggcctg gcccaagatg cacactgtgaatgggtatgt gaataggagc
ctgcctgggc tgattgggtg tcacaggaag tctgtgtactggcatgtgat tggcatgggc
accactcctg aggtgcacag catctttctg gagggccacacttttctggt gaggaatcac
aggcaggcca gcctggagat cagccccatc accttcctgactgcccagac cctgctgatg
gatctgggcc agttcctgct gttttgccat atcagcagccatcagcatga tgggatggag
gcttatgtga aggtggactc ttgccctgag gagcctcagctgaggatgaa gaataatgaa
gaggctgagg actatgatga tgatctgact gactctgagatggatgtggt gaggtttgat
gatgacaaca gccccagctt tatccagatt aggtctgtggccaagaagca ccccaagacc
tgggtgcatt acattgctgc tgaggaagag gattgggactatgcccccct ggtgctggcc
cctgatgaca ggagctacaa gtctcagtac ctgaacaatggccctcagag gattggcagg
aagtacaaga aggtgaggtt catggcttac actgatgagaccttcaagac cagggaggcc
attcagcatg aatctgggat cctgggcccc ctgctgtatggggaggtggg ggacaccctg
ctgattattt tcaagaacca ggccagcagg ccctacaacatttatcctca tggcattact
gatgtgagac ccctgtacag caggaggctg cctaagggggtgaagcacct gaaggacttc
cccatcctgc ctggggagat cttcaagtac aagtggactgtgactgtgga ggatggcccc
actaagtctg accccaggtg cctgactagg tactactccagctttgtgaa catggagagg
gacctggcct ctggcctgat tggccccctg ctgatctgctacaaggagtc tgtggatcag
aggggcaacc agatcatgtc tgacaagaga aatgtgatcctgttctctgt gtttgatgag
aataggtctt ggtacctgac tgagaacatc cagaggtttctgcctaatcc tgctggggtg
cagctggagg atcctgagtt ccaggcctct aacattatgcacagcatcaa tgggtatgtg
tttgacagcc tgcagctgtc tgtgtgcctg catgaggtggcctactggta catcctgagc
attggggccc agactgactt tctgtctgtg ttcttctctggctacacctt taagcataag
atggtgtatg aggacaccct gactctgttc cccttctctggggagactgt gttcatgagc
atggagaacc caggcctgtg gatcctgggc tgccacaactctgatttcag gaataggggc
atgactgccc tgctgaaggt gagcagctgt gataagaacactggggacta ttatgaggat
agctatgagg acatctctgc ctacctgctg agcaagaacaatgccattga gcccaggagc
ttcagccaga atcctcctgt gctgaagagg caccagagggagatcaccag gaccaccctg
cagtctgatc aggaggagat tgactatgat gacactatctctgtggagat gaagaaggag
gactttgaca tctatgatga ggatgagaat cagagccccaggagcttcca gaagaagact
agacactact ttattgctgc tgtggagagg ctgtgggactatggcatgag ctcttctccc
catgtgctga gaaacagggc ccagtctggc tctgtgccccagttcaagaa ggtggtcttc
caggagttca ctgatggctc tttcacccag cctctgtatagaggggagct gaatgagcac
ctgggcctgc tgggccctta catcagggct gaggtggaggacaatatcat ggtgaccttc
aggaaccagg ctagcaggcc ctactctttc tacagcagcctgatcagcta tgaggaggac
cagaggcagg gggctgagcc taggaagaat tttgtgaagcccaatgagac caagacctac
ttctggaagg tgcagcacca catggctccc actaaggatgagtttgactg caaggcctgg
gcctactttt ctgatgtgga cctggagaag gatgtgcattctggcctgat tggccccctg
ctggtctgcc acaccaatac tctgaaccct gctcatgggagacaggtgac tgtgcaggag
tttgccctgt tcttcaccat ctttgatgag accaagtcctggtactttac tgagaacatg
gagaggaatt gcagggcccc ttgcaacatc cagatggaggaccccacctt caaggaaaat
tataggttcc atgccatcaa tggctacatc atggacaccctgcctggcct ggtgatggcc
caggaccaga ggatcaggtg gtatctgctg tctatgggctctaatgagaa catccacagc
atccatttct ctggccatgt gttcactgtg aggaagaaggaggagtataa gatggctctg
tacaacctgt accctggggt ctttgagact gtggagatgctgcccagcaa ggctggcatt
tggagggtgg agtgcctgat tggggaacac ctgcatgctgggatgagcac cctgttcctg
gtgtactcta acaagtgcca gaccccactg ggcatggcttctggccacat cagggatttc
cagattactg cctctggcca gtatggccag tgggctcccaagctggctag gctgcactac
tctgggagca tcaatgcctg gtctactaag gagcctttctcttggatcaa agtggacctg
ctggccccta tgatcatcca tgggatcaag actcagggggccaggcagaa gttcagcagc
ctgtacatct ctcagttcat cattatgtac agcctggatggcaagaagtg gcagacctac
aggggcaaca gcactggcac cctgatggtg ttctttgggaatgtggacag ctctgggatt
aagcacaaca tctttaaccc ccccatcatt gccaggtatatcaggctgca ccctacccac
tacagcatta ggagcaccct gaggatggag ctgatgggctgtgacctgaa cagctgcagc
atgcccctgg ggatggagag caaggccatt tctgatgctcagatcactgc ttctagctac
ttcactaaca tgtttgccac ctggtctccc agcaaggctagactgcacct gcaggggagg
agcaatgcct ggaggcccca ggtgaataat cccaaggagtggctgcaggt ggatttccag
aaaaccatga aggtgactgg ggtgactacc cagggggtgaagtctctgct gaccagcatg
tatgtgaagg agttcctgat cagcagcagc caggatgggcatcagtggac cctgttcttt
cagaatggga aggtgaaggt gtttcagggc aatcaggacagcttcacccc tgtggtgaac
agcctggacc cccccctgct gaccaggtac ctgaggatccacccccagag ctgggtgcat
cagattgccc tgaggatgga ggtgctgggc tgtgaggcccaggacctgta ctga
FVIIIをコードするCpGが低減した核酸変種X05(配列番号5)
atgcagattg agctgtctac ttgcttcttc ctgtgcctgctgaggttctg cttctctgcc
actaggaggt attacctggg ggctgtggag ctgagctgggactatatgca gtctgacctg
ggggagctgc ctgtggatgc caggtttcct cccagggtgcctaagagctt ccccttcaac
acctctgtgg tgtacaagaa gactctgttt gtggagtttactgatcatct gttcaacatt
gccaagccca ggcctccttg gatggggctg ctgggccccaccatccaggc tgaggtgtat
gacactgtgg tgattaccct gaagaatatg gccagccatcctgtgagcct gcatgctgtg
ggggtgagct attggaaggc ctctgagggg gctgagtatgatgatcagac tagccagagg
gagaaggagg atgacaaggt gttccctggg gggagccatacctatgtgtg gcaggtgctg
aaggagaatg gccccatggc ctctgaccct ctgtgcctgacttatagcta cctgagccat
gtggatctgg tgaaggacct gaactctggc ctgattggggccctgctggt gtgcagggag
ggcagcctgg ccaaggagaa gactcagacc ctgcacaagttcatcctgct gtttgctgtg
tttgatgagg ggaagtcctg gcactctgag actaagaacagcctgatgca ggatagggat
gctgcttctg ccagggcctg gcctaagatg cacactgtgaatggctatgt gaataggagc
ctgcctggcc tgattggctg ccataggaag tctgtgtactggcatgtgat tgggatgggc
accacccctg aggtgcactc tattttcctg gagggccatactttcctggt gaggaaccat
aggcaggcca gcctggagat cagccccatc actttcctgactgcccagac tctgctgatg
gacctgggcc agttcctgct gttctgccac atcagcagccatcagcatga tggcatggag
gcttatgtga aggtggacag ctgccctgag gagcctcagctgaggatgaa gaataatgag
gaggctgagg actatgatga tgacctgact gactctgagatggatgtggt gaggtttgat
gatgacaact ctccctcttt catccagatc aggtctgtggccaagaagca ccctaagacc
tgggtgcact acattgctgc tgaggaggag gattgggactatgcccccct ggtgctggcc
ccagatgaca ggagctacaa gtcccagtac ctgaacaatggcccccagag gattggcagg
aagtacaaga aggtgaggtt catggcttat actgatgagactttcaagac cagggaggcc
atccagcatg agtctggcat cctgggccct ctgctgtatggggaggtggg ggacaccctg
ctgattatct tcaagaacca ggcttctagg ccctacaatatctaccctca tggcatcact
gatgtgaggc ccctgtacag caggaggctg cccaagggggtgaagcatct gaaggatttc
cccatcctgc ctggggagat ctttaagtat aagtggactgtgactgtgga ggatggcccc
actaagtctg accccaggtg cctgaccagg tattacagcagctttgtgaa catggagagg
gatctggctt ctgggctgat tggccccctg ctgatctgctacaaggagtc tgtggaccag
aggggcaacc agatcatgtc tgacaagagg aatgtgatcctgttctctgt gtttgatgag
aataggagct ggtacctgac tgagaacatc cagaggtttctgcccaatcc tgctggggtg
cagctggagg atcctgagtt tcaggcctct aatatcatgcacagcatcaa tggctatgtg
tttgactctc tgcagctgtc tgtgtgcctg catgaggtggcctattggta catcctgagc
attggggccc agactgactt tctgtctgtg tttttttctggctacacctt caagcacaag
atggtgtatg aggatactct gactctgttc cctttttctggggagactgt gttcatgtct
atggagaacc ctgggctgtg gattctgggc tgccacaattctgacttcag gaacagaggc
atgactgctc tgctgaaggt gagcagctgt gacaagaacactggggacta ctatgaggac
tcttatgagg acatttctgc ctacctgctg agcaagaacaatgccattga gcccagaagc
ttttctcaga acccccctgt gctgaagagg caccagagggagatcaccag gaccaccctg
cagtctgacc aggaggagat tgactatgat gatactatttctgtggagat gaagaaggag
gactttgaca tctatgatga ggatgagaac cagagccccaggtctttcca gaagaagact
aggcactact ttattgctgc tgtggagagg ctgtgggactatgggatgtc tagctctcct
catgtgctga ggaacagggc ccagtctggc tctgtgccccagtttaaaaa ggtggtgttc
caggaattca ctgatggcag ctttacccag cctctgtacaggggggagct gaatgagcac
ctggggctgc tggggcctta cattagggct gaggtggaggacaacatcat ggtgaccttc
aggaatcagg ccagcaggcc ctactctttc tacagcagcctgatctctta tgaggaggac
cagaggcagg gggctgaacc caggaagaac tttgtgaagcccaatgagac caagacctac
ttctggaagg tgcagcacca catggctccc accaaggatgagtttgattg caaggcctgg
gcttacttct ctgatgtgga tctggagaag gatgtgcactctgggctgat tggccccctg
ctggtgtgcc acaccaacac tctgaaccct gcccatggcagacaggtgac tgtgcaggag
tttgccctgt tcttcactat ctttgatgag actaagagctggtacttcac tgagaacatg
gagaggaatt gcagggcccc ttgcaacatc cagatggaggaccccacctt taaggagaac
tacaggtttc atgccattaa tggctacatc atggacaccctgcctggcct ggtgatggcc
caggaccaga ggatcaggtg gtacctgctg tctatggggagcaatgagaa catccacagc
attcacttct ctggccatgt gttcactgtg aggaagaaggaggagtacaa gatggccctg
tacaacctgt accctggggt gtttgagact gtggagatgctgcccagcaa ggctgggatc
tggagggtgg agtgcctgat tggggagcac ctgcatgctgggatgagcac cctgttcctg
gtgtatagca acaagtgcca gacccccctg ggcatggcctctggccacat cagagacttt
cagattactg cctctggcca gtatgggcag tgggcccccaagctggccag gctgcactat
tctggctcta ttaatgcctg gagcactaag gagcccttcagctggattaa ggtggacctg
ctggctccca tgatcatcca tggcatcaag actcagggggccaggcagaa gttctcttct
ctgtacatca gccagttcat tatcatgtac tccctggatggcaagaagtg gcagacctat
aggggcaaca gcactggcac cctgatggtg ttctttgggaatgtggacag ctctggcatc
aagcataata tcttcaatcc ccccatcatt gctaggtacatcaggctgca ccccacccac
tactctatta ggtctaccct gaggatggag ctgatgggctgtgacctgaa cagctgcagc
atgcctctgg gcatggagag caaagccatc tctgatgcccagatcactgc cagcagctac
tttaccaaca tgtttgctac ttggagcccc agcaaggccaggctgcacct gcaggggagg
tctaatgcct ggaggcccca ggtgaacaac cccaaggagtggctgcaggt ggacttccag
aagactatga aggtgactgg ggtgaccacc cagggggtgaagagcctgct gacctctatg
tatgtgaagg agttcctgat tagcagcagc caggatggccaccagtggac cctgtttttc
cagaatggga aggtgaaggt gtttcagggg aaccaggacagcttcactcc tgtggtgaac
tctctggacc cccccctgct gaccaggtat ctgaggatccaccctcagag ctgggtgcac
cagattgccc tgaggatgga ggtgctgggc tgtgaggcccaggacctgta ctga
FVIIIをコードするCpGが低減した核酸変種X06(配列番号6)
atgcagattg agctgagcac ctgcttcttc ctgtgcctgctgaggttttg cttctctgcc
accaggaggt actacctggg ggctgtggag ctgagctgggattacatgca gtctgacctg
ggggagctgc ctgtggatgc caggttccct cccagggtgcccaagtcttt ccccttcaac
acttctgtgg tgtacaagaa gaccctgttt gtggagtttactgaccacct gttcaacatt
gccaagccca ggcctccctg gatgggcctg ctgggccccaccattcaggc tgaggtgtat
gacactgtgg tcatcaccct gaaaaatatg gctagccaccctgtgtctct gcatgctgtg
ggggtgagct actggaaggc ctctgagggg gctgagtatgatgaccagac tagccagagg
gagaaggagg atgacaaggt gttccctggg ggcagccacacttatgtgtg gcaggtgctg
aaagagaatg gccccatggc ttctgatccc ctgtgtctgacctatagcta cctgagccat
gtggatctgg tgaaggacct gaactctggc ctgattggggccctgctggt gtgcagggag
ggcagcctgg ctaaggagaa gacccagacc ctgcataagttcatcctgct gtttgctgtg
tttgatgagg gcaagagctg gcactctgag actaagaacagcctgatgca ggatagggat
gctgcttctg ccagggcctg gcccaagatg cacactgtgaatgggtatgt gaacaggagc
ctgcctggcc tgattggctg ccataggaag tctgtctattggcatgtgat tggcatgggc
actactcctg aggtgcacag catctttctg gagggccacaccttcctggt gaggaaccac
aggcaggcca gcctggagat ctctcccatc actttcctgactgctcagac cctgctgatg
gacctgggcc agttcctgct gttctgtcac atctctagccaccagcatga tggcatggag
gcctatgtga aggtggatag ctgccctgag gaaccccagctgaggatgaa gaacaatgag
gaggctgagg attatgatga tgatctgact gattctgagatggatgtggt gaggtttgat
gatgacaatt ctcctagctt cattcagatc agatctgtggccaaaaagca tcctaagact
tgggtgcatt atattgctgc tgaggaggag gattgggattatgcccccct ggtgctggct
cctgatgata ggagctacaa gtctcagtac ctgaataatgggccccagag gattggcagg
aagtacaaga aggtgaggtt catggcctac actgatgagaccttcaagac cagggaggcc
attcagcatg agtctgggat tctggggccc ctgctgtatggggaggtggg ggataccctg
ctgatcattt tcaagaacca ggccagcagg ccctacaacatctaccccca tgggattact
gatgtgaggc ccctgtactc taggaggctg cctaagggggtgaagcacct gaaggatttt
cctatcctgc ctggggaaat cttcaagtac aagtggactgtgactgtgga ggatggcccc
actaagtctg atcccaggtg tctgaccagg tattatagctcttttgtgaa catggagagg
gatctggcct ctgggctgat tggccctctg ctgatctgctacaaggagtc tgtggaccag
aggggcaacc agatcatgtc tgacaagagg aatgtgatcctgttctctgt gtttgatgag
aacaggagct ggtatctgac tgagaacatc cagaggtttctgcccaatcc tgctggggtg
cagctggagg atcctgagtt ccaggctagc aacatcatgcacagcatcaa tgggtatgtg
tttgacagcc tgcagctgtc tgtgtgtctg catgaggtggcctactggta tatcctgtct
attggggccc agactgactt cctgtctgtg tttttttctgggtatacttt taagcacaag
atggtgtatg aggacaccct gactctgttc cccttctctggggagactgt gtttatgagc
atggagaacc ctggcctgtg gatcctgggc tgccacaattctgacttcag gaataggggg
atgactgccc tgctgaaggt gagcagctgt gataagaatactggggacta ctatgaggac
tcttatgagg acatttctgc ctatctgctg tctaagaacaatgccattga acccaggagc
ttctctcaga acccccctgt gctgaagagg caccagagggaaatcaccag aactactctg
cagtctgatc aggaggaaat tgactatgat gacactatttctgtggagat gaagaaggag
gactttgaca tctatgatga ggatgagaac cagagcccaaggagcttcca gaagaagact
aggcactact tcattgctgc tgtggagagg ctgtgggactatggcatgag cagcagcccc
catgtgctga gaaacagggc ccagtctggg tctgtgccccagttcaagaa ggtggtgttc
caggagttca ctgatgggag cttcacccag cccctgtataggggggagct gaatgagcac
ctgggcctgc tgggccccta tattagggct gaggtggaggacaacatcat ggtgaccttc
aggaatcagg cctctaggcc ctacagcttc tacagcagcctgattagcta tgaggaggat
cagaggcagg gggctgaacc caggaagaac tttgtgaagcccaatgagac caagacctat
ttctggaagg tgcagcatca catggccccc accaaggatgagtttgactg caaggcctgg
gcctacttct ctgatgtgga tctggagaag gatgtgcactctggcctgat tggccccctg
ctggtgtgcc acaccaacac cctgaaccct gctcatggcaggcaggtgac tgtgcaggag
tttgccctgt tcttcaccat ctttgatgag actaagtcttggtacttcac tgagaatatg
gagaggaatt gcagggcccc ctgcaatatt cagatggaagaccccacctt caaggagaat
tacaggttcc atgccattaa tggctacatc atggataccctgcctggcct ggtgatggcc
caggatcaga ggatcaggtg gtacctgctg agcatgggcagcaatgagaa catccactct
atccacttct ctggccatgt gtttactgtg aggaagaaggaggagtataa gatggccctg
tacaacctgt accctggggt ctttgagact gtggagatgctgccttctaa ggctggcatt
tggagggtgg agtgcctgat tggggaacac ctgcatgctggcatgtctac cctgttcctg
gtgtacagca ataagtgcca gacccccctg ggcatggcctctgggcatat cagggatttc
cagatcactg cctctggcca gtatggccag tgggccccaaagctggctag gctgcactac
tctgggagca tcaatgcctg gagcactaag gagcccttcagctggatcaa ggtggacctg
ctggccccca tgattatcca tgggattaag actcagggggccaggcagaa gttcagcagc
ctgtacatca gccagttcat tatcatgtac agcctggatggcaagaagtg gcagacctat
aggggcaact ctactgggac cctgatggtg ttctttgggaatgtggatag ctctgggatc
aagcacaata tcttcaaccc ccccatcatt gccaggtatatcaggctgca ccccacccac
tacagcatta ggtctaccct gaggatggag ctgatgggctgtgatctgaa cagctgtagc
atgcctctgg gcatggagtc taaggccatt tctgatgcccagattactgc tagcagctac
ttcaccaaca tgtttgccac ctggtctccc agcaaggccaggctgcatct gcagggcagg
tctaatgctt ggaggcccca ggtgaacaac ccaaaggagtggctgcaggt ggatttccag
aagactatga aggtgactgg ggtgaccact cagggggtgaagtctctgct gacctctatg
tatgtgaagg agttcctgat ctctagcagc caggatggccatcagtggac cctgttcttc
cagaatggca aggtgaaagt gttccagggc aatcaggatagcttcactcc agtggtgaac
agcctggatc cccctctgct gactaggtac ctgaggatccacccccagag ctgggtgcac
cagattgccc tgaggatgga ggtgctgggc tgtgaggcccaggacctgta ctga
FVIIIをコードするCpGが低減した核酸変種X07(配列番号7)
atgcagattg agctgagcac ctgcttcttc ctgtgtctgctgaggttctg cttctctgcc
accaggaggt attacctggg ggctgtggag ctgagctgggactatatgca gtctgacctg
ggggagctgc ctgtggatgc taggttcccc cccagggtgcccaagagctt cccctttaac
acttctgtgg tgtacaagaa gaccctgttt gtggagttcactgaccacct gttcaacatt
gccaagccca ggcccccctg gatggggctg ctggggcccaccatccaggc tgaggtgtat
gacactgtgg tgatcaccct gaagaacatg gccagccaccctgtgagcct gcatgctgtg
ggggtgagct actggaaggc ttctgagggg gctgagtatgatgaccagac tagccagagg
gagaaggagg atgacaaggt gtttcctggg ggcagccatacctatgtgtg gcaggtgctg
aaggagaatg gccccatggc ctctgacccc ctgtgcctgacctacagcta cctgtctcat
gtggacctgg tgaaggacct gaactctggc ctgattggggctctgctggt gtgtagggag
ggcagcctgg ctaaggaaaa gacccagacc ctgcataagtttatcctgct gtttgctgtg
tttgatgagg gcaagagctg gcactctgag accaagaacagcctgatgca ggatagggat
gctgcctctg ccagggcttg gcctaagatg cacactgtgaatgggtatgt gaataggagc
ctgcctggcc tgattggctg ccacaggaag tctgtgtactggcatgtgat tgggatgggc
accacccctg aggtccatag catcttcctg gagggccacactttcctggt gaggaaccac
agacaggcct ctctggagat ctctcccatc accttcctgactgctcagac tctgctgatg
gacctgggcc agttcctgct gttttgccat attagcagccaccagcatga tgggatggag
gcctatgtga aggtggatag ctgccctgag gagcctcagctgaggatgaa gaacaatgag
gaggctgaag actatgatga tgacctgact gattctgagatggatgtggt gaggtttgat
gatgacaata gccccagctt cattcagatc aggtctgtggccaagaaaca ccccaagacc
tgggtgcact acattgctgc tgaggaagag gactgggactatgctcccct ggtgctggcc
cctgatgata ggtcttataa gagccagtac ctgaacaatgggccccagag gattggcagg
aagtacaaga aggtgaggtt catggcctac actgatgaaaccttcaaaac cagggaggcc
attcagcatg agtctggcat cctgggccct ctgctgtatggggaggtggg ggacaccctg
ctgatcatct tcaagaacca ggccagcagg ccctacaacatctatcctca tggcatcact
gatgtgaggc ccctgtacag caggaggctg cccaagggggtgaagcacct gaaagacttc
cccatcctgc ctggggagat ctttaagtat aagtggactgtgactgtgga ggatggccct
accaagtctg accccaggtg tctgaccagg tactattctagctttgtgaa catggagagg
gacctggcct ctggcctgat tgggcccctg ctgatctgctacaaggagtc tgtggaccag
aggggcaacc agatcatgtc tgacaagagg aatgtgatcctgttttctgt gtttgatgag
aataggagct ggtacctgac tgagaacatc cagaggtttctgcccaatcc tgctggggtg
cagctggagg atcctgagtt ccaggccagc aatatcatgcatagcatcaa tggctatgtg
tttgacagcc tgcagctgtc tgtgtgcctg catgaggtggcctactggta catcctgagc
attggggccc agactgactt tctgtctgtg ttcttttctggctatacctt caagcacaag
atggtgtatg aggataccct gaccctgttc cccttctctggggagactgt gttcatgagc
atggagaatc ctgggctgtg gatcctgggg tgccacaactctgattttag gaacaggggg
atgactgccc tgctgaaggt gtctagctgt gataagaacactggggacta ctatgaggac
agctatgagg acatttctgc ttatctgctg tctaagaataatgccattga gcccagaagc
ttcagccaga atccccctgt gctgaagaga catcagagggagatcaccag aactaccctg
cagtctgatc aggaggagat tgactatgat gacactatctctgtggagat gaagaaggag
gactttgaca tctatgatga ggatgagaat cagtctcccaggagctttca gaagaagacc
agacattact tcattgctgc tgtggagagg ctgtgggactatggcatgag ctctagccct
catgtgctga ggaacagggc ccagtctggc tctgtgccccagttcaagaa ggtggtgttc
caggaattca ctgatggcag cttcacccag cccctgtacaggggggagct gaatgagcac
ctgggcctgc tggggcctta tatcagggct gaggtggaggataatattat ggtgactttc
aggaaccagg ccagcaggcc ctactctttc tatagcagcctgatctctta tgaggaggat
cagaggcagg gggctgagcc taggaagaac tttgtgaagcccaatgagac taagacctac
ttctggaagg tccagcacca catggcccct accaaggatgagtttgactg caaggcctgg
gcctatttct ctgatgtgga tctggagaag gatgtccattctgggctgat tggccccctg
ctggtgtgcc acactaacac tctgaatcct gcccatggcaggcaggtgac tgtccaggag
tttgccctgt tcttcactat ctttgatgag accaagagctggtactttac tgagaacatg
gagaggaact gcagagctcc ttgcaatatt cagatggaggaccccacctt caaggagaat
tacaggttcc atgccattaa tgggtacatc atggacaccctgcctggcct ggtgatggct
caggaccaga ggatcaggtg gtacctgctg agcatgggctctaatgagaa tatccacagc
atccacttct ctgggcatgt gttcactgtg aggaagaaggaggagtacaa gatggctctg
tataatctgt accctggggt gtttgaaact gtggagatgctgccctctaa ggctggcatc
tggagggtgg agtgcctgat tggggagcac ctgcatgctggcatgagcac cctgttcctg
gtgtacagca acaagtgcca gacccccctg ggcatggcctctggccacat cagggacttc
cagatcactg cctctggcca gtatggccag tgggcccccaagctggccag gctgcactat
tctggcagca tcaatgcctg gagcaccaag gagcccttcagctggatcaa ggtggacctg
ctggccccca tgatcattca tggcatcaag acccagggggccaggcagaa gttcagctct
ctgtacatct ctcagttcat catcatgtac tctctggatgggaagaagtg gcagacctac
aggggcaaca gcactggcac cctgatggtg ttctttgggaatgtggactc ttctggcatc
aagcacaaca tcttcaatcc ccccatcatt gctaggtatattaggctgca tcccacccac
tacagcatca ggtctaccct gaggatggag ctgatgggctgtgacctgaa ctcttgcagc
atgcccctgg gcatggagtc taaggccatc tctgatgcccagattactgc cagcagctac
ttcaccaaca tgtttgccac ctggagcccc tctaaggccaggctgcatct gcaggggagg
agcaatgcct ggaggcctca ggtgaacaac cccaaggagtggctgcaggt ggatttccag
aagaccatga aggtgactgg ggtgaccacc cagggggtcaagagcctgct gaccagcatg
tatgtgaagg agttcctgat cagcagcagc caggatggccaccagtggac tctgttcttt
cagaatggga aggtgaaggt gtttcagggc aatcaggactctttcacccc tgtggtgaac
agcctggacc cccccctgct gaccagatac ctgaggatccacccccagtc ttgggtgcat
cagattgccc tgaggatgga ggtgctgggc tgtgaggctcaggatctgta ctga
FVIIIをコードするCpGが低減した核酸変種X08(配列番号8)
atgcagattg agctgagcac ttgctttttt ctgtgcctgctgaggttttg tttttctgcc
accaggaggt actacctggg ggctgtggag ctgagctgggactatatgca gtctgatctg
ggggagctgc ctgtggatgc caggttcccc cccagggtgcccaagtcttt tcccttcaac
acctctgtgg tgtataagaa gaccctgttt gtggagttcactgaccacct gttcaacatt
gctaagccta ggcccccctg gatgggcctg ctgggccctaccattcaggc tgaggtgtat
gacactgtgg tgatcaccct gaagaacatg gccagccatcctgtgagcct gcatgctgtg
ggggtctctt actggaaggc ctctgagggg gctgagtatgatgaccagac cagccagaga
gagaaggagg atgacaaggt cttccctggg ggctctcacacctatgtgtg gcaggtgctg
aaggaaaatg gccccatggc ctctgacccc ctgtgcctgacctacagcta tctgagccat
gtggatctgg tgaaggacct gaattctggc ctgattggggccctgctggt gtgcagggag
ggcagcctgg ccaaggagaa gacccagacc ctgcacaagtttatcctgct gtttgctgtg
tttgatgagg gcaagtcttg gcactctgag actaagaacagcctgatgca ggacagggat
gctgcctctg ccagggcctg gcccaagatg cacactgtgaatggctatgt gaacaggagc
ctgcctgggc tgattggctg ccacaggaag tctgtgtactggcatgtgat tggcatgggc
accacccctg aggtgcacag catcttcctg gaaggccacactttcctggt gaggaaccat
aggcaggcca gcctggagat cagccctatc accttcctgactgcccagac cctgctgatg
gatctggggc agttcctgct gttctgccac atctctagccaccagcatga tgggatggag
gcctatgtga aggtggacag ctgcccagag gagcctcagctgaggatgaa aaacaatgaa
gaggctgagg attatgatga tgatctgact gactctgagatggatgtggt gagatttgat
gatgacaata gccctagctt tattcagatc aggtctgtggctaagaagca ccccaagacc
tgggtgcatt acattgctgc tgaggaggag gactgggattatgctcctct ggtgctggcc
cctgatgata ggagctacaa gagccagtac ctgaataatggccctcagag gattggcagg
aagtacaaga aggtgaggtt catggcttac actgatgagaccttcaagac tagggaggcc
atccagcatg agtctgggat cctggggccc ctgctgtatggggaggtggg ggacaccctg
ctgatcatct tcaagaacca ggctagcagg ccttacaacatctatcccca tgggatcact
gatgtgagac ctctgtacag caggaggctg cccaagggggtcaagcatct gaaagacttc
cccatcctgc ctggggagat ctttaagtat aagtggactgtgactgtgga ggatgggccc
accaagtctg accccaggtg cctgaccagg tattacagcagctttgtgaa catggagagg
gatctggcct ctgggctgat tggccccctg ctgatctgttacaaggaatc tgtggatcag
aggggcaatc agatcatgtc tgacaagagg aatgtgatcctgttctctgt gtttgatgag
aataggtctt ggtacctgac tgaaaacatc cagaggttcctgcccaaccc tgctggggtc
cagctggagg atcctgagtt ccaggctagc aacatcatgcacagcatcaa tgggtatgtg
tttgatagcc tgcagctgtc tgtgtgcctg catgaggtggcctactggta catcctgtct
attggggccc agactgactt cctgtctgtg ttcttttctggctacacctt caagcacaag
atggtgtatg aggacaccct gaccctgttc cccttctctggggagactgt ctttatgagc
atggagaacc ctgggctgtg gatcctgggc tgccacaactctgatttcag gaataggggc
atgactgctc tgctgaaggt gagctcttgt gacaagaacactggggatta ctatgaggac
agctatgagg acatttctgc ctacctgctg agcaagaacaatgccattga gcctaggagc
tttagccaga atcctcctgt cctgaagagg caccagagggagatcaccag gaccaccctg
cagtctgacc aggaggagat tgactatgat gataccatctctgtggagat gaagaaggag
gactttgaca tctatgatga ggatgagaat cagtctcccaggagcttcca gaagaagacc
aggcactatt tcattgctgc tgtggagagg ctgtgggactatggcatgag cagctctcct
catgtgctga ggaatagggc tcagtctggc tctgtgccccagttcaagaa agtggtgttt
caggagttca ctgatggctc tttcacccag cctctgtataggggggagct gaatgagcac
ctggggctgc tgggccccta tatcagggct gaggtggaggataacatcat ggtgaccttc
aggaaccagg cctctaggcc ctacagcttc tatagcagcctgatcagcta tgaggaggac
cagaggcagg gggctgagcc caggaagaac tttgtgaagcccaatgagac caagacttac
ttctggaagg tgcagcatca catggccccc accaaggatgagtttgactg taaggcctgg
gcctacttct ctgatgtgga tctggagaag gatgtgcactctggcctgat tggccccctg
ctggtgtgcc ataccaatac tctgaaccct gctcatggcaggcaggtgac tgtgcaggag
tttgctctgt tcttcactat ctttgatgag accaagtcttggtatttcac tgagaatatg
gagaggaact gcagggcccc ctgcaacatc cagatggaggaccccacctt taaggagaac
tataggtttc atgccatcaa tggctacatc atggacaccctgcctggcct ggtgatggcc
caggatcaga ggatcaggtg gtacctgctg agcatggggtctaatgagaa catccacagc
atccacttct ctggccatgt gtttactgtg agaaagaaggaggagtacaa gatggctctg
tacaatctgt accctggggt ctttgagact gtggagatgctgcctagcaa ggctgggatc
tggagggtgg agtgcctgat tggggaacat ctgcatgctgggatgtctac tctgttcctg
gtgtacagca acaagtgcca gacccccctg ggcatggcttctggccatat cagggacttt
cagattactg cctctgggca gtatggccag tgggcccccaagctggctag gctgcattat
tctggcagca tcaatgcctg gtctactaag gagcccttcagctggatcaa ggtggatctg
ctggccccca tgatcatcca tggcatcaag acccagggggccaggcagaa gtttagctct
ctgtacatta gccagttcat catcatgtac agcctggatgggaagaagtg gcagacctac
aggggcaatt ctactggcac cctgatggtg ttctttggcaatgtggacag ctctggcatc
aagcacaaca tctttaaccc ccctatcatt gctaggtacatcaggctgca tcccacccat
tacagcatca ggagcaccct gaggatggag ctgatgggctgtgacctgaa ctcttgcagc
atgcccctgg gcatggagag caaggccatt tctgatgcccagattactgc cagcagctac
ttcactaaca tgtttgccac ctggtctccc agcaaggccaggctgcacct gcagggcagg
agcaatgcct ggaggcccca ggtgaacaac cccaaggagtggctgcaggt ggatttccag
aagaccatga aggtgactgg ggtgaccacc cagggggtgaagagcctgct gactagcatg
tatgtgaagg agttcctgat cagctctagc caggatggccaccagtggac tctgtttttc
cagaatggca aggtgaaggt gttccagggc aaccaggactctttcactcc tgtggtgaac
agcctggacc cccccctgct gaccaggtat ctgaggattcacccccagtc ttgggtgcat
cagattgccc tgaggatgga ggtgctgggc tgtgaggcccaggatctgta ctga
FVIIIをコードするCpGが低減した核酸変種X09(配列番号9)
atgcagattg agctgagcac ctgcttcttc ctgtgtctgctgagattttg cttttctgcc
actaggaggt attacctggg ggctgtggag ctgtcttgggactacatgca gtctgatctg
ggggagctgc ctgtggatgc caggttccca cctagggtgcctaagagctt tcccttcaat
acctctgtgg tgtacaagaa gaccctgttt gtggagttcactgaccacct gttcaacatt
gccaagccta ggcccccctg gatgggcctg ctgggccctaccatccaggc tgaagtgtat
gacactgtgg tgatcaccct gaagaacatg gccagccaccctgtgagcct gcatgctgtg
ggggtgtctt actggaaggc ctctgagggg gctgagtatgatgatcagac cagccagagg
gagaaggaag atgacaaggt gttccctggg ggcagccacacctatgtctg gcaggtgctg
aaggagaatg gccccatggc ctctgatccc ctgtgcctgacctactctta cctgagccat
gtggacctgg tgaaggatct gaattctggc ctgattggggccctgctggt gtgcagggag
ggcagcctgg ccaaggagaa gacccagacc ctgcataagttcatcctgct gtttgctgtg
tttgatgaag ggaagagctg gcactctgag actaagaacagcctgatgca ggacagggat
gctgcttctg ccagggcctg gcccaagatg cacactgtgaatggctatgt gaatagaagc
ctgcctggcc tgattgggtg ccacaggaag tctgtgtactggcatgtgat tgggatgggc
actacccctg aggtgcatag catcttcctg gaaggccataccttcctggt gaggaatcat
aggcaggctt ctctggaaat ttctcccatc actttcctgactgctcagac cctgctgatg
gacctgggcc agttcctgct gttctgccac atcagctctcaccagcatga tgggatggag
gcctatgtga aggtggacag ctgtcctgag gagccccagctgaggatgaa gaacaatgag
gaggctgagg actatgatga tgacctgact gactctgagatggatgtggt caggtttgat
gatgacaata gcccctcttt catccagatc aggtctgtggccaagaagca ccccaagact
tgggtgcact acattgctgc tgaggaggag gattgggattatgcccctct ggtgctggcc
cctgatgaca ggagctataa gtctcagtac ctgaataatggcccccagag gattgggagg
aagtataaga aggtgaggtt tatggcctac actgatgagaccttcaagac cagggaggcc
atccagcatg agtctggcat cctgggcccc ctgctgtatggggaggtggg ggataccctg
ctgatcatct tcaagaacca ggcctctagg ccctacaatatctaccctca tggcatcact
gatgtgagac ccctgtatag caggaggctg cctaagggggtgaagcacct gaaggacttc
cccatcctgc ctggggagat cttcaagtat aagtggactgtgactgtgga ggatggcccc
accaagtctg accccaggtg cctgaccagg tattacagctcttttgtgaa catggagagg
gatctggcct ctgggctgat tggcccactg ctgatctgctacaaggagtc tgtggatcag
aggggcaatc agatcatgtc tgacaagagg aatgtgatcctgttttctgt gtttgatgaa
aataggtctt ggtatctgac tgagaacatc cagaggtttctgcccaatcc tgctggggtg
cagctggagg atcctgagtt tcaggcctct aatatcatgcattctatcaa tggctatgtg
tttgacagcc tgcagctgtc tgtgtgcctg catgaggtggcctactggta catcctgagc
attggggctc agactgactt cctgtctgtg ttcttttctggctatacttt caagcacaag
atggtgtatg aggacactct gaccctgttc cccttctctggggagactgt gttcatgtct
atggaaaatc ctgggctgtg gattctgggc tgccacaattctgacttcag gaataggggg
atgactgccc tgctgaaggt gtctagctgt gataagaacactggggatta ctatgaggac
tcttatgaag atatctctgc ctatctgctg agcaagaacaatgccattga gcccaggagc
ttcagccaga acccccctgt gctgaagagg caccagagggagatcaccag gaccactctg
cagtctgatc aggaggagat tgactatgat gacactatctctgtggagat gaagaaggag
gattttgaca tttatgatga ggatgagaac cagtctcccaggagcttcca gaagaagacc
aggcattact ttattgctgc tgtggagagg ctgtgggactatgggatgag cagctctcct
catgtgctga ggaacagggc ccagtctggg tctgtgccccagttcaagaa ggtggtgttc
caggagttca ctgatgggag cttcacccag cccctgtataggggggagct gaatgagcac
ctgggcctgc tgggccccta catcagggct gaggtggaggataatatcat ggtgaccttc
aggaaccagg ctagcaggcc ttacagcttt tacagcagcctgatctctta tgaagaagac
cagaggcagg gggctgagcc caggaagaat tttgtgaagcctaatgagac caagacttat
ttttggaagg tgcagcatca catggctcct accaaggatgagtttgactg caaggcctgg
gcctactttt ctgatgtgga tctggagaag gatgtgcactctggcctgat tggccctctg
ctggtgtgcc atactaacac tctgaaccct gcccatgggaggcaggtgac tgtgcaggag
tttgccctgt tcttcactat ttttgatgag accaagtcttggtatttcac tgagaacatg
gagaggaact gcagggctcc ctgcaacatc cagatggaagaccccacctt caaggagaac
tataggttcc atgccatcaa tgggtacatc atggataccctgcctggcct ggtgatggcc
caggatcaga ggattaggtg gtatctgctg agcatgggctctaatgagaa catccacagc
atccatttct ctggccatgt gttcactgtg aggaagaaggaggagtacaa gatggctctg
tacaacctgt atcctggggt gtttgagact gtggagatgctgcccagcaa ggctggcatc
tggagggtgg aatgcctgat tggggagcac ctgcatgctggcatgagcac tctgttcctg
gtgtatagca acaagtgcca gacccccctg ggcatggcctctggccatat cagggatttc
cagatcactg cttctggcca gtatggccag tgggcccccaagctggccag gctgcactat
tctggcagca tcaatgcctg gagcactaag gagcctttttcttggatcaa ggtggacctg
ctggccccta tgattattca tggcatcaag acccagggggccaggcagaa gttctctagc
ctgtacatct ctcagttcat cattatgtat agcctggatggcaagaagtg gcagacctac
aggggcaata gcactggcac cctgatggtg ttttttgggaatgtggactc ttctgggatc
aagcacaaca tctttaaccc ccccatcatt gccaggtatattaggctgca ccccacccac
tacagcatca ggagcaccct gaggatggag ctgatgggctgtgatctgaa ttcttgctct
atgcccctgg gcatggagag caaggccatc tctgatgcccagatcactgc cagctcttac
ttcaccaaca tgtttgccac ctggtctcct agcaaggccaggctgcatct gcagggcagg
agcaatgcct ggaggcccca ggtgaacaac cccaaggagtggctgcaggt ggacttccag
aagaccatga aggtgactgg ggtgaccact cagggggtgaagagcctgct gacctctatg
tatgtgaagg agttcctgat cagcagcagc caggatggccaccagtggac tctgttcttc
cagaatggga aggtgaaggt gttccagggc aaccaggatagctttacccc tgtggtgaac
agcctggacc ctcctctgct gaccagatac ctgaggatccatcctcagag ctgggtgcac
cagattgccc tgaggatgga ggtgctgggc tgtgaggcccaggatctgta ctga
FVIIIをコードするCpGが低減した核酸変種X10(配列番号10)
atgcagattg agctgagcac ttgcttcttc ctgtgcctgctgaggttctg cttttctgct
actaggaggt actacctggg ggctgtggag ctgagctgggattacatgca gtctgacctg
ggggagctgc cagtggatgc caggttcccc cccagggtgcccaagtcttt tcctttcaac
acctctgtgg tgtacaagaa gaccctgttt gtggagttcactgaccacct gttcaacatt
gccaagccca ggcccccctg gatggggctg ctggggcccaccatccaggc tgaggtgtat
gacactgtgg tgattaccct gaagaacatg gctagccaccctgtgagcct gcatgctgtg
ggggtgagct attggaaggc ctctgagggg gctgagtatgatgatcagac cagccagagg
gaaaaggagg atgacaaggt gttccctggg ggcagccatacttatgtgtg gcaggtgctg
aaggagaatg ggcccatggc ctctgacccc ctgtgcctgacttacagcta tctgagccat
gtggacctgg tgaaggatct gaactctggc ctgattggggctctgctggt gtgcagggag
ggcagcctgg ctaaggagaa gactcagact ctgcataagttcatcctgct gtttgctgtg
tttgatgaag gcaagagctg gcactctgag accaagaactctctgatgca ggatagggat
gctgcctctg ccagggcttg gcccaagatg cacactgtgaatggctatgt gaacaggagc
ctgcctggcc tgattgggtg ccacaggaag tctgtgtactggcatgtgat tggcatgggc
accacccctg aggtgcacag cattttcctg gagggccacaccttcctggt gaggaatcac
aggcaggcca gcctggagat cagccccatc accttcctgactgcccagac cctgctgatg
gacctggggc agtttctgct gttctgccac atcagcagccatcagcatga tggcatggag
gcctatgtga aggtggactc ttgccctgag gagccccagctgaggatgaa gaacaatgag
gaggctgagg attatgatga tgacctgact gactctgagatggatgtggt gaggtttgat
gatgacaata gccccagctt catccagatt aggtctgtggccaagaagca ccctaagacc
tgggtgcact acattgctgc tgaggaggag gattgggattatgcccccct ggtgctggct
cctgatgaca ggtcttataa gagccagtac ctgaacaatgggccccagag gattggcagg
aagtacaaga aggtgaggtt catggcttac actgatgagaccttcaagac tagggaggcc
atccagcatg agtctggcat cctgggcccc ctgctgtatggggaggtggg ggataccctg
ctgatcatct tcaagaacca ggccagcagg ccctacaacatttaccctca tggcatcact
gatgtgaggc ccctgtacag caggagactg cccaagggggtgaagcacct gaaggatttt
cccattctgc ctggggagat cttcaagtac aagtggactgtgactgtgga ggatggcccc
accaagtctg atcccaggtg cctgactagg tactactcttcttttgtgaa tatggagagg
gatctggcct ctggcctgat tggccccctg ctgatctgctacaaggagtc tgtggaccag
aggggcaacc agatcatgtc tgacaagagg aatgtgatcctgttctctgt gtttgatgag
aataggagct ggtacctgac tgagaatatc cagaggttcctgcctaatcc tgctggggtc
cagctggagg atcctgagtt ccaggctagc aacattatgcacagcatcaa tggctatgtg
tttgattctc tgcagctgtc tgtgtgcctg catgaggtggcttactggta catcctgtct
attggggccc agactgattt cctgtctgtg ttcttctctggctacacttt caagcataag
atggtgtatg aggataccct gaccctgttc cccttctctggggagactgt gttcatgtct
atggagaacc ctggcctgtg gatcctgggc tgtcataactctgacttcag aaacaggggc
atgactgccc tgctgaaggt gagcagctgt gacaagaacactggggacta ctatgaggac
agctatgagg atatctctgc ttatctgctg agcaagaataatgccattga gcccaggagc
ttcagccaga acccccctgt gctgaagagg caccagagggagatcactag gactaccctg
cagtctgatc aggaggagat tgactatgat gacaccatctctgtggagat gaagaaggag
gactttgaca tctatgatga ggatgagaac cagtcccccaggtctttcca gaagaagacc
aggcactact tcattgctgc tgtggagagg ctgtgggactatggcatgag ctctagcccc
catgtgctga ggaacagggc tcagtctggc tctgtgccccagttcaagaa ggtggtcttc
caggagttca ctgatggctc ttttacccag cctctgtacagaggggagct gaatgagcac
ctgggcctgc tgggccccta catcagggct gaggtggaggataatatcat ggtgaccttc
agaaaccagg cctctaggcc ctacagcttc tacagcagcctgatctctta tgaggaggat
cagaggcagg gggctgagcc caggaagaac tttgtgaagcccaatgagac caagacctac
ttctggaagg tgcagcacca tatggcccct actaaggatgagtttgactg caaggcctgg
gcttattttt ctgatgtgga cctggagaag gatgtgcactctgggctgat tggccccctg
ctggtgtgcc acaccaacac cctgaaccct gcccatggcaggcaggtgac tgtgcaggag
tttgccctgt tcttcactat ctttgatgag accaagagctggtacttcac tgagaacatg
gagagaaatt gtagggctcc ctgcaatatc cagatggaggaccccacctt caaagaaaat
tacagattcc atgccatcaa tgggtacatc atggataccctgcctgggct ggtgatggct
caggaccaga ggatcaggtg gtacctgctg agcatggggtctaatgagaa catccactct
atccatttct ctggccatgt gttcactgtg agaaagaaggaggagtataa gatggctctg
tacaacctgt acccaggggt gtttgagact gtggaaatgctgcccagcaa agctgggatc
tggagggtgg agtgcctgat tggggagcac ctgcatgctggcatgtctac cctgttcctg
gtgtacagca acaagtgcca gactcccctg ggcatggcctctgggcacat cagggatttt
cagatcactg cctctggcca gtatggccag tgggcccccaagctggccag gctgcactac
tctggcagca ttaatgcttg gagcactaag gagcccttcagctggatcaa ggtggatctg
ctggccccca tgatcatcca tggcatcaag acccagggggccaggcagaa gttctctagc
ctgtacattt ctcagttcat catcatgtac agcctggatgggaagaagtg gcagacctac
agggggaaca gcactgggac cctgatggtg ttctttggcaatgtggatag ctctggcatc
aagcacaata tcttcaatcc ccccattatt gccaggtacattaggctgca tcctactcac
tactctatta ggagcaccct gaggatggag ctgatggggtgtgacctgaa cagctgttct
atgcccctgg gcatggagtc taaggctatc tctgatgcccagatcactgc cagcagctac
ttcactaata tgtttgccac ctggagccct agcaaggccagactgcacct gcagggcagg
agcaatgcct ggaggcccca ggtgaacaac cccaaggagtggctgcaggt ggacttccag
aagaccatga aggtgactgg ggtgaccact cagggggtgaagagcctgct gaccagcatg
tatgtgaagg agttcctgat cagcagcagc caggatggccaccagtggac cctgttcttc
cagaatggga aggtgaaggt gttccagggc aaccaggactctttcacccc tgtggtgaac
agcctggatc ctcccctgct gaccaggtac ctgaggatccacccccagag ctgggtgcac
cagattgctc tgaggatgga agtgctgggc tgtgaggcccaggatctgta ctga
FVIIIをコードするCpGが低減した核酸変種X11(配列番号11)
atgcagattg agctgagcac ctgcttcttc ctgtgcctgctgaggttttg cttctctgct
accaggaggt actacctggg ggctgtggag ctgagctgggactatatgca gtctgacctg
ggggagctgc ctgtggatgc taggttccct cccagggtgcccaagagctt cccctttaat
acctctgtgg tgtacaagaa aaccctgttt gtggagttcactgaccatct gttcaacatt
gccaagccca ggcccccttg gatgggcctg ctgggccccaccattcaggc tgaggtgtat
gacactgtgg tcattaccct gaagaacatg gcttctcaccctgtgagcct gcatgctgtg
ggggtgagct actggaaggc ctctgagggg gctgagtatgatgaccagac cagccagagg
gagaaggagg atgataaggt gttccctggg ggcagccacacctatgtgtg gcaggtgctg
aaggagaatg gccccatggc ctctgatccc ctgtgcctgacctactctta tctgtctcat
gtggacctgg tgaaggacct gaactctggc ctgattggggctctgctggt gtgcagggag
ggctctctgg ccaaggagaa gacccagacc ctgcacaagtttattctgct gtttgctgtc
tttgatgagg gcaagagctg gcattctgag accaagaacagcctgatgca ggacagggat
gctgcctctg ccagggcctg gcccaaaatg cacactgtgaatggctatgt gaacaggagc
ctgcctggcc tgattggctg ccacaggaag tctgtgtactggcatgtgat tggcatgggc
accacccctg aggtgcacag catcttcctg gagggccacacctttctggt gaggaatcac
aggcaggcca gcctggagat tagccccatc accttcctgactgcccagac cctgctgatg
gacctgggcc agttcctgct gttctgccac atcagcagccaccagcatga tggcatggag
gcctatgtga aggtggatag ctgccctgag gagccccagctgaggatgaa aaacaatgag
gaggctgagg attatgatga tgacctgact gactctgagatggatgtggt gaggtttgat
gatgacaata gccccagctt tattcagatt aggtctgtggctaagaagca ccccaagact
tgggtgcact acattgctgc tgaggaggag gattgggactatgcccctct ggtcctggcc
cctgatgata ggtcttacaa gagccagtat ctgaacaatggcccccagag gattggcagg
aagtacaaga aggtgaggtt catggcctac actgatgagacctttaagac cagggaggcc
attcagcatg agtctgggat cctgggcccc ctgctgtatggggaggtggg ggacactctg
ctgatcatct tcaagaacca ggccagcagg ccttataacatctaccctca tgggatcact
gatgtgaggc ccctgtactc tagaaggctg cccaagggggtcaagcacct gaaggatttt
cccatcctgc ctggggagat tttcaagtac aagtggactgtgactgtgga ggatggcccc
accaagtctg accctaggtg cctgaccagg tactacagctcttttgtgaa catggagagg
gacctggcct ctggcctgat tggccctctg ctgatttgctacaaggagtc tgtggaccag
aggggcaacc agatcatgtc tgacaagagg aatgtgatcctgttttctgt gtttgatgag
aacaggtctt ggtacctgac tgagaacatc cagaggttcctgcctaaccc agctggggtg
cagctggagg atcctgagtt ccaggccagc aatattatgcatagcattaa tggctatgtg
tttgatagcc tgcagctgtc tgtgtgcctg catgaggtggcctactggta catcctgagc
attggggccc agactgactt tctgtctgtg ttcttctctggctacacctt caagcataag
atggtgtatg aggacaccct gactctgttc cctttttctggggagactgt gtttatgagc
atggagaatc ctggcctgtg gatcctgggc tgccataattctgacttcag gaacaggggc
atgactgccc tgctgaaagt gagcagctgt gacaagaatactggggacta ctatgaagac
agctatgagg acatctctgc ctacctgctg agcaagaacaatgccattga gcccaggagc
ttcagccaga accccccagt gctgaagagg caccagagagagatcaccag gactaccctg
cagtctgacc aggaggagat tgactatgat gacaccatttctgtggagat gaagaaggag
gactttgaca tttatgatga ggatgagaat cagagccccaggagcttcca gaagaagact
aggcactatt ttattgctgc tgtggagagg ctgtgggactatggcatgag cagctctccc
catgtgctga ggaatagggc ccagtctggc tctgtgcctcagttcaagaa ggtggtgttc
caggagttca ctgatggcag ctttacccag cccctgtataggggggagct gaatgagcac
ctgggcctgc tgggccccta tatcagggct gaggtggaggacaatattat ggtgaccttt
aggaaccagg ccagcaggcc ctactctttc tatagcagcctgatcagcta tgaggaggac
cagaggcagg gggctgagcc caggaagaat tttgtgaagcctaatgagac caagacctac
ttctggaagg tgcagcatca catggccccc accaaggatgagtttgactg caaggcttgg
gcctatttct ctgatgtgga cctggagaag gatgtgcactctggcctgat tggccccctg
ctggtgtgcc acactaacac tctgaatcct gcccatggcaggcaggtgac tgtgcaggag
tttgccctgt tcttcaccat ctttgatgag accaagagctggtacttcac tgagaacatg
gagaggaact gcagggcccc ctgcaacatc cagatggaggatcccacctt caaggagaac
tacaggtttc atgccatcaa tggctacatc atggacactctgcctggcct ggtgatggcc
caggatcaga ggatcaggtg gtacctgctg agcatgggctctaatgagaa tatccatagc
atccacttct ctggccatgt gttcactgtc aggaagaaggaggagtacaa gatggctctg
tataatctgt accctggggt gtttgagact gtggagatgctgcccagcaa ggctggcatc
tggagggtgg agtgcctgat tggggagcac ctgcatgctgggatgagcac cctgtttctg
gtgtactcta acaagtgcca gacccccctg ggcatggcctctgggcacat cagggatttc
cagatcactg cttctggcca gtatggccag tgggcccccaagctggccag gctgcactac
tctggcagca tcaatgcctg gtctaccaag gagcccttttcttggattaa ggtggacctg
ctggccccca tgatcatcca tggcatcaag acccagggggccaggcagaa gttcagcagc
ctgtacatca gccagttcat catcatgtac agcctggatggcaaaaagtg gcagacctac
aggggcaata gcactgggac tctgatggtg ttctttggcaatgtggacag ctctgggatc
aagcacaata tcttcaaccc tcccatcatt gctaggtacatcaggctgca ccccacccac
tatagcatca ggtctaccct gaggatggag ctgatgggctgtgacctgaa ctcttgcagc
atgcccctgg gcatggagtc caaagctatc tctgatgcccagattactgc cagcagctac
ttcaccaaca tgtttgccac ctggtctccc tctaaggccaggctgcacct gcagggcagg
agcaatgcct ggaggcccca ggtgaacaat cccaaggagtggctgcaggt ggatttccag
aaaactatga aggtgactgg ggtgaccacc cagggggtgaagtctctgct gaccagcatg
tatgtgaagg agttcctgat ctcttctagc caggatggccaccagtggac tctgttcttc
cagaatggca aggtgaaggt gttccagggc aaccaggacagcttcacccc tgtggtgaac
tctctggatc cccccctgct gaccaggtac ctgaggattcatccccagag ctgggtgcac
cagattgctc tgagaatgga ggtgctgggg tgtgaggctcaggacctgta ttga
FVIIIをコードするCpGが低減した核酸変種X12(配列番号12)
atgcagattg agctgtctac ttgttttttt ctgtgcctgctgaggttctg cttctctgcc
accaggaggt attacctggg ggctgtggag ctgagctgggattacatgca gtctgatctg
ggggagctgc ctgtggatgc caggttcccc cccagggtgcccaagagctt ccccttcaac
acctctgtgg tgtataagaa gaccctgttt gtggagttcactgatcatct gtttaacatt
gccaagccca ggcccccctg gatgggcctg ctgggcccaactatccaggc tgaggtgtat
gacactgtgg tcatcaccct gaagaatatg gccagccatcctgtgagcct gcatgctgtg
ggggtgagct actggaaggc ctctgagggg gctgagtatgatgaccagac cagccagagg
gagaaggagg atgacaaggt gttccctggg ggcagccacacctatgtgtg gcaggtgctg
aaggagaatg gccccatggc ctctgacccc ctgtgcctgacttatagcta cctgtctcat
gtggacctgg tgaaggacct gaactctggc ctgattggggccctgctggt ctgtagggaa
ggcagcctgg ccaaggagaa gacccagacc ctgcacaagtttattctgct gtttgctgtg
tttgatgaag gcaagagctg gcactctgag accaagaattctctgatgca ggatagggat
gctgcctctg ccagggcctg gcccaagatg catactgtgaatggctatgt gaacagaagc
ctgcctggcc tgattggctg ccataggaag tctgtgtattggcatgtgat tgggatgggc
actacccctg aagtgcacag cattttcctg gagggccacactttcctggt gaggaaccac
aggcaggcct ctctggagat cagccccatt actttcctgactgcccagac cctgctgatg
gatctgggcc agttcctgct gttctgccac atctctagccaccagcatga tggcatggag
gcctatgtga aggtggacag ctgccctgag gagccccagctgaggatgaa gaataatgag
gaggctgagg attatgatga tgacctgact gactctgagatggatgtggt gaggtttgat
gatgataata gccccagctt catccagatc aggtctgtggccaagaagca tcccaagacc
tgggtgcact atattgctgc tgaagaggag gactgggactatgcccctct ggtgctggct
cctgatgaca ggagctataa gagccagtat ctgaacaatgggccccagag gattgggagg
aagtacaaga aggtgaggtt catggcctac actgatgagacctttaagac cagggaggcc
atccagcatg agtctggcat tctggggccc ctgctgtatggggaggtggg ggacactctg
ctgatcattt tcaagaacca ggccagcagg ccctacaatatttaccccca tggcatcact
gatgtgaggc ccctgtacag caggaggctg cccaagggggtgaagcacct gaaggacttc
cccatcctgc ctggggagat cttcaagtac aagtggactgtgactgtgga ggatggccct
accaagtctg accctaggtg tctgactagg tactacagcagctttgtgaa catggagaga
gacctggctt ctggcctgat tggccccctg ctgatctgctacaaggagtc tgtggatcag
aggggcaacc agattatgtc tgataagagg aatgtcatcctgttctctgt gtttgatgag
aacaggagct ggtatctgac tgagaacatt cagaggttcctgcccaaccc tgctggggtg
cagctggagg accctgagtt ccaggccagc aacatcatgcattctattaa tggctatgtg
tttgacagcc tgcagctgtc tgtgtgcctg catgaggtggcctactggta catcctgagc
attggggccc agactgactt tctgtctgtg tttttctctgggtacacctt caagcacaag
atggtctatg aggacaccct gaccctgttc cccttttctggggaaactgt gtttatgagc
atggagaacc ctgggctgtg gatcctgggc tgccacaactctgactttag gaataggggc
atgactgccc tgctgaaggt gagcagctgt gacaagaatactggggatta ctatgaggac
agctatgagg atatctctgc ctacctgctg agcaagaacaatgccattga gcctaggagc
ttcagccaga acccccctgt gctgaagagg caccagagggagatcaccag gaccaccctg
cagtctgatc aggaggagat tgactatgat gacaccatctctgtggagat gaagaaggag
gactttgata tttatgatga ggatgagaac cagagccccaggagcttcca gaagaagacc
aggcactatt tcattgctgc tgtggagagg ctgtgggactatggcatgag ctctagcccc
catgtgctga ggaacagggc ccagtctggc tctgtgccccagttcaagaa ggtggtgttc
caggaattta ctgatggcag ctttacccag cccctgtacagaggggagct gaatgagcac
ctgggcctgc tgggccccta catcagggct gaggtggaggataatatcat ggtgaccttt
aggaaccagg cctctaggcc ctattctttt tacagcagcctgatcagcta tgaggaggac
cagaggcagg gggctgagcc taggaagaac tttgtgaagcccaatgagac caagacctac
ttttggaaag tgcagcacca catggccccc actaaggatgagtttgattg caaggcctgg
gcctatttct ctgatgtgga cctggagaag gatgtgcactctggcctgat tggccccctg
ctggtgtgcc acaccaacac tctgaaccct gcccatggcaggcaggtgac tgtgcaggag
tttgccctgt tctttaccat ctttgatgag actaagagctggtatttcac tgagaacatg
gagaggaact gcagagcccc ttgcaacatc cagatggaggaccctacctt caaggagaac
tataggttcc atgccatcaa tgggtacatc atggataccctgcctggcct ggtgatggct
caggaccaga ggatcaggtg gtacctgctg agcatggggagcaatgagaa cattcatagc
atccacttct ctgggcatgt gttcactgtg aggaagaaggaggagtataa gatggccctg
tacaacctgt accctggggt gtttgagact gtggagatgctgcccagcaa ggctggcatc
tggagggtgg agtgcctgat tggggagcac ctgcatgctggcatgagcac tctgttcctg
gtgtacagca acaagtgcca gacccccctg ggcatggcctctggccacat cagggacttc
cagattactg cctctgggca gtatgggcag tgggcccccaagctggccag gctgcactac
tctgggtcta tcaatgcttg gagcaccaag gagcctttcagctggatcaa ggtggatctg
ctggccccca tgatcattca tgggatcaag acccagggggccaggcagaa gttcagcagc
ctgtatattt ctcagttcat catcatgtat tctctggatggcaaaaagtg gcagacctat
agagggaaca gcactgggac cctgatggtg ttttttggcaatgtggatag ctctggcatc
aagcacaata tcttcaaccc ccccattatt gccaggtacatcaggctgca ccccacccac
tactctatca ggagcaccct gaggatggag ctgatgggctgtgatctgaa cagctgctct
atgcctctgg ggatggaaag caaggccatc tctgatgcccagatcactgc cagcagctat
ttcaccaata tgtttgccac ttggagccct agcaaggctaggctgcatct gcagggcagg
tctaatgcct ggaggcccca ggtgaacaac cccaaggagtggctgcaggt ggacttccag
aagactatga aagtgactgg ggtgaccacc cagggggtgaaaagcctgct gaccagcatg
tatgtgaagg agttcctgat tagcagcagc caggatggccaccagtggac cctgttcttc
cagaatggga aggtgaaggt gtttcagggc aatcaggatagcttcacccc agtggtgaac
agcctggacc cccccctgct gaccaggtac ctgaggatccacccccagag ctgggtgcac
cagattgccc tgaggatgga ggtgctgggc tgtgaggcccaggatctgta ctga
FVIIIをコードするCpGが低減した核酸変種X13(配列番号13)
atgcagattg agctgagcac ctgctttttc ctgtgcctgctgaggttctg cttctctgct
accaggaggt actacctggg ggctgtggag ctgtcttgggattacatgca gtctgacctg
ggggagctgc ctgtggatgc caggtttccc cccagggtgcccaagtcttt cccctttaac
acctctgtgg tgtataagaa gactctgttt gtggagttcactgatcacct gttcaatatt
gccaagccca ggcccccttg gatgggcctg ctgggccccactatccaggc tgaggtgtat
gacactgtgg tcatcaccct gaagaacatg gccagccaccctgtgagcct gcatgctgtg
ggggtgagct actggaaggc ctctgagggg gctgagtatgatgaccagac cagccagagg
gagaaggagg atgacaaggt gttcccaggg gggtctcacacttatgtgtg gcaggtgctg
aaggagaatg ggcccatggc ctctgaccct ctgtgcctgacttatagcta cctgtctcat
gtggatctgg tgaaggacct gaactctggc ctgattggggccctgctggt gtgcagggag
gggagcctgg ccaaggagaa gacccagacc ctgcacaagttcatcctgct gtttgctgtg
tttgatgagg ggaagagctg gcactctgag accaagaatagcctgatgca ggacagggat
gctgcttctg ctagggcctg gcctaagatg cacactgtgaatggctatgt gaacaggagc
ctgcctggcc tgattgggtg tcacaggaag tctgtgtactggcatgtgat tggcatgggg
actactccag aagtgcacag catcttcctg gaggggcacaccttcctggt gaggaatcac
aggcaggcca gcctggagat ttctcccatc actttcctgactgcccagac cctgctgatg
gatctggggc agttcctgct gttctgccac atcagcagccatcagcatga tgggatggag
gcctatgtga aggtggacag ctgccctgag gagcctcagctgaggatgaa gaacaatgag
gaggctgagg actatgatga tgatctgact gactctgagatggatgtggt gaggtttgat
gatgacaact ctcccagctt catccagatc aggtctgtggccaagaagca ccccaagacc
tgggtgcact acattgctgc tgaggaggag gattgggattatgctcccct ggtgctggct
cctgatgata ggagctacaa gagccagtat ctgaataatgggccccagag gattggcagg
aagtataaga aggtgaggtt catggcctac actgatgagacctttaagac cagggaggct
attcagcatg agtctggcat cctgggcccc ctgctgtatggggaggtggg ggacaccctg
ctgatcattt tcaagaacca ggccagcagg ccctataacatctatcccca tgggatcact
gatgtgaggc ccctgtactc taggaggctg cccaagggggtcaagcacct gaaggacttc
cccatcctgc ctggggagat cttcaagtac aagtggactgtgactgtgga ggatggcccc
actaagtctg accccaggtg cctgactagg tactacagcagctttgtgaa catggagaga
gatctggcct ctggcctgat tggccccctg ctgatctgctacaaagagtc tgtggatcag
aggggcaacc agatcatgtc tgacaagagg aatgtgatcctgttctctgt gtttgatgag
aacagaagct ggtacctgac tgagaacatt cagaggtttctgcccaaccc tgctggggtc
cagctggagg accctgagtt tcaggccagc aacatcatgcacagcatcaa tgggtatgtg
tttgacagcc tgcagctgtc tgtgtgcctg catgaggtggcctactggta tatcctgagc
attggggccc agactgattt cctgtctgtg ttcttctctggctacacttt caagcacaag
atggtgtatg aggataccct gaccctgttc cctttctctggggaaactgt gttcatgagc
atggagaacc ctgggctgtg gatcctgggg tgccacaattctgatttcag gaacagaggc
atgactgctc tgctgaaggt gtctagctgt gacaagaacactggggacta ctatgaggac
agctatgagg acatctctgc ctacctgctg agcaagaacaatgctattga acccaggtct
ttcagccaga acccccctgt gctgaagagg caccagagggagatcactag gaccaccctg
cagtctgatc aggaggagat tgactatgat gacaccatctctgtggagat gaagaaggag
gactttgaca tctatgatga ggatgagaat cagtctcccaggagcttcca gaagaagact
aggcattact tcattgctgc tgtggagagg ctgtgggactatggcatgag ctctagccct
catgtgctga ggaacagggc ccagtctggc tctgtgccccagttcaagaa ggtggtgttt
caggagttca ctgatggcag cttcacccag cccctgtacaggggggagct gaatgagcat
ctgggcctgc tgggccccta catcagggct gaggtggaggacaacatcat ggtgaccttc
agaaatcagg ctagcaggcc ctacagcttc tacagcagcctgatctctta tgaggaggac
cagaggcagg gggctgagcc caggaagaac tttgtgaagcccaatgagac caagacctat
ttctggaagg tgcagcacca catggccccc accaaggatgagtttgattg caaggcctgg
gcctacttct ctgatgtgga cctggagaag gatgtgcattctgggctgat tggccctctg
ctggtgtgcc acaccaacac cctgaatcct gcccatggcaggcaggtgac tgtgcaggag
tttgccctgt tctttactat ctttgatgag accaagtcttggtattttac tgagaacatg
gagaggaact gcagggcccc ctgcaacatc cagatggaggaccccacctt caaggagaac
tacagattcc atgccatcaa tggctacatt atggacactctgcctggcct ggtgatggcc
caggaccaga ggatcaggtg gtacctgctg tctatgggcagcaatgagaa cattcactct
atccacttct ctgggcatgt gttcactgtg aggaagaaggaggagtacaa gatggccctg
tacaacctgt accctggggt gtttgagact gtggagatgctgcctagcaa ggctgggatc
tggagggtgg agtgcctgat tggggagcac ctgcatgctggcatgtctac cctgttcctg
gtgtacagca acaagtgcca gacccccctg ggcatggcctctggccacat cagagatttt
cagatcactg cctctggcca gtatggccag tgggctcctaagctggccag gctgcactac
tctggcagca tcaatgcctg gagcaccaag gagccctttagctggatcaa ggtggacctg
ctggccccca tgatcatcca tggcatcaag actcagggggccaggcagaa gttctctagc
ctgtacatta gccagttcat catcatgtat agcctggatggcaagaagtg gcagacctac
aggggcaaca gcactgggac cctgatggtg ttctttgggaatgtggacag ctctgggatc
aagcacaata tcttcaaccc ccccattatt gccaggtatattaggctgca ccccactcac
tacagcatta ggagcaccct gaggatggag ctgatgggctgtgatctgaa cagctgcagc
atgcccctgg gcatggagtc taaggccatc tctgatgcccagatcactgc cagctcttac
ttcaccaaca tgtttgccac ttggagcccc agcaaggccaggctgcacct gcagggcagg
agcaatgcct ggaggcccca ggtgaacaac cccaaggagtggctgcaggt ggatttccag
aagactatga aggtgactgg ggtgaccact cagggggtgaagagcctgct gactagcatg
tatgtgaagg agttcctgat cagctctagc caggatggccaccagtggac cctgttcttt
cagaatggca aggtgaaggt gttccagggc aaccaggactctttcacccc tgtggtgaat
tctctggacc ctcccctgct gactaggtat ctgaggattcatccccagag ctgggtgcat
cagattgccc tgaggatgga ggtgctgggc tgtgaggcccaggacctgta ttga
FVIIIをコードするCpGが低減した核酸変種X14(配列番号14)
atgcagattg agctgagcac ctgcttcttc ctgtgcctgctgaggttttg cttttctgcc
actaggaggt actacctggg ggctgtggag ctgtcttgggattacatgca gtctgacctg
ggggagctgc cagtggatgc caggttcccc ccaagggtgcccaagtcttt tcccttcaat
acctctgtgg tgtacaagaa gaccctgttt gtggagtttactgatcatct gtttaacatt
gccaagccca ggcccccctg gatggggctg ctgggccccaccatccaggc tgaggtgtat
gatactgtgg tgattaccct gaagaatatg gccagccatcctgtgtctct gcatgctgtg
ggggtgtctt attggaaggc ctctgagggg gctgagtatgatgatcagac cagccagagg
gagaaggagg atgataaggt gttccctggg ggctctcacacctatgtgtg gcaggtgctg
aaggagaatg ggcctatggc ctctgaccca ctgtgcctgacttacagcta tctgagccat
gtggacctgg tgaaggacct gaactctggg ctgattggggccctgctggt gtgcagggag
ggcagcctgg ccaaggagaa gactcagacc ctgcacaagttcatcctgct gtttgctgtg
tttgatgagg gcaagtcttg gcactctgag accaagaacagcctgatgca ggatagggat
gctgcctctg ccagggcctg gcccaagatg cacactgtgaatggctatgt gaacaggtct
ctgcctggcc tgattggctg ccacaggaag tctgtgtactggcatgtgat tggcatgggc
accacccctg aggtgcatag cattttcctg gagggccacaccttcctggt gaggaaccac
aggcaggcta gcctggagat cagccccatc actttcctgactgcccagac cctgctgatg
gacctgggcc agttcctgct gttctgccac atctctagccaccagcatga tggcatggag
gcctatgtga aggtggactc ttgtcctgag gagccccagctgaggatgaa gaacaatgag
gaggctgagg attatgatga tgatctgact gattctgagatggatgtggt gaggtttgat
gatgacaaca gcccctcttt catccagatc aggtctgtggccaagaagca ccccaagacc
tgggtgcact acattgctgc tgaggaggag gattgggattatgcccccct ggtgctggcc
cctgatgaca ggagctataa gtctcagtac ctgaacaatggcccccagag aattggcagg
aagtacaaga aggtgaggtt catggcctat actgatgagaccttcaaaac cagggaggcc
attcagcatg agtctggcat cctggggccc ctgctgtatggggaggtggg ggacaccctg
ctgatcatct tcaagaacca ggctagcagg ccttacaacatctaccccca tgggatcact
gatgtgaggc ccctgtacag caggaggctg cctaagggggtgaagcacct gaaggacttt
cccattctgc ctggggagat cttcaagtat aagtggactgtgactgtgga ggatgggccc
accaagtctg accccaggtg cctgactagg tactactctagctttgtgaa catggagagg
gacctggcct ctgggctgat tggccccctg ctgatctgttacaaggagtc tgtggaccag
aggggcaacc agatcatgtc tgataagagg aatgtgatcctgttctctgt gtttgatgag
aacaggagct ggtacctgac tgagaacatc cagagattcctgcccaaccc tgctggggtg
cagctggagg atcctgagtt ccaggccagc aacatcatgcattctatcaa tgggtatgtg
tttgatagcc tgcagctgtc tgtgtgtctg catgaggtggcctactggta cattctgagc
attggggccc agactgactt cctgtctgtg ttcttctctggctacacttt caaacacaag
atggtgtatg aggacaccct gaccctgttc cccttctctggggagactgt gtttatgagc
atggagaacc ctgggctgtg gattctgggc tgccacaactctgacttcag aaacaggggc
atgactgccc tgctgaaggt gtcttcttgt gataagaacactggggacta ttatgaagac
agctatgagg acatctctgc ctacctgctg agcaagaataatgctattga gcccaggtct
ttctctcaga acccccctgt gctgaagagg caccagagggagatcaccag gaccaccctg
cagtctgatc aggaggagat tgactatgat gacactatttctgtggagat gaagaaggaa
gactttgata tctatgatga ggatgagaac cagagccctaggagcttcca gaagaagact
aggcattact tcattgctgc tgtggagagg ctgtgggactatggcatgag cagcagcccc
catgtgctga ggaatagggc tcagtctggc tctgtgcctcagttcaagaa ggtggtgttc
caggaattca ctgatggcag cttcactcag cccctgtacaggggggagct gaatgagcac
ctggggctgc tgggccctta catcagggct gaggtggaggacaatatcat ggtgaccttt
aggaaccagg cctctaggcc ttacagcttc tactctagcctgatctctta tgaagaggac
cagaggcagg gggctgagcc caggaagaac tttgtgaagcccaatgagac taagacttac
ttctggaagg tgcagcacca catggctccc accaaggatgagtttgactg caaggcttgg
gcctacttct ctgatgtgga cctggagaag gatgtgcactctgggctgat tgggcccctg
ctggtgtgcc acactaacac tctgaatcct gcccatggcagacaggtgac tgtgcaggag
tttgccctgt tttttaccat ctttgatgag actaagtcttggtacttcac tgagaacatg
gagaggaact gcagggcccc ctgcaacatc cagatggaggatcccacctt caaggagaac
tacaggtttc atgccatcaa tggctacatc atggacaccctgcctggcct ggtgatggct
caggaccaga ggattaggtg gtatctgctg agcatgggcagcaatgagaa tatccactct
atccacttct ctgggcatgt gttcactgtg aggaagaaggaggagtacaa gatggccctg
tataacctgt atcctggggt gtttgagact gtggagatgctgcccagcaa ggctggcatc
tggagagtgg agtgcctgat tggggagcac ctgcatgctggcatgagcac tctgtttctg
gtgtatagca acaagtgtca gacccctctg ggcatggcctctgggcacat tagggacttt
cagatcactg cttctggcca gtatgggcag tgggctcccaagctggccag gctgcactat
tctggcagca ttaatgcctg gagcaccaag gagcctttcagctggatcaa ggtggacctg
ctggccccca tgatcatcca tgggatcaag acccagggggctaggcagaa gttcagcagc
ctgtacatca gccagtttat catcatgtat tctctggatggcaagaagtg gcagacctac
aggggcaatt ctactggcac tctgatggtg ttctttgggaatgtggatag ctctgggatc
aagcataata tcttcaatcc ccccattatt gctaggtatatcaggctgca ccccacccac
tatagcatca ggagcaccct gaggatggag ctgatggggtgtgacctgaa cagctgcagc
atgcccctgg gcatggagag caaggctatt tctgatgcccagatcactgc cagcagctac
tttactaata tgtttgccac ctggagcccc agcaaggccagactgcacct gcagggcagg
tctaatgcct ggaggcctca ggtgaataac cccaaggagtggctgcaggt ggacttccag
aaaaccatga aggtgactgg ggtgactacc cagggggtgaagtctctgct gaccagcatg
tatgtgaagg agttcctgat ctcttctagc caggatggccaccagtggac cctgttcttt
cagaatggga aggtgaaggt cttccagggc aaccaggatagcttcacccc tgtggtgaat
agcctggatc ctcctctgct gaccaggtat ctgaggatccacccccagag ctgggtgcat
cagattgccc tgaggatgga ggtgctgggc tgtgaggctcaggacctgta ctga
FVIIIをコードするCpGが低減した核酸変種X15(配列番号15)
atgcagattg agctgagcac ctgtttcttc ctgtgcctgctgaggttctg tttctctgcc
actaggaggt actacctggg ggctgtggag ctgagctgggactatatgca gtctgacctg
ggggagctgc ctgtggatgc caggttcccc cccagggtgcctaagagctt ccccttcaat
acttctgtgg tgtacaagaa gactctgttt gtggagtttactgaccacct gttcaacatt
gctaagccca ggcctccctg gatggggctg ctgggccccaccatccaggc tgaggtgtat
gatactgtgg tgattaccct gaagaacatg gcctctcatccagtgagcct gcatgctgtg
ggggtgagct actggaaggc ctctgaaggg gctgagtatgatgaccagac cagccagagg
gagaaggagg atgacaaggt gttccctggg ggcagccacacctatgtgtg gcaggtgctg
aaggagaatg gcccaatggc ctctgacccc ctgtgcctgacttatagcta cctgagccat
gtggatctgg tgaaggacct gaattctggc ctgattggggccctgctggt gtgcagagag
ggctctctgg ctaaggagaa gacccagact ctgcacaagttcatcctgct gtttgctgtg
tttgatgagg gcaagagctg gcactctgag actaagaatagcctgatgca ggacagggat
gctgcttctg ccagggcctg gcccaagatg catactgtgaatggctatgt gaacaggagc
ctgcctggcc tgattggctg tcacaggaaa tctgtctactggcatgtgat tgggatgggc
actacccctg aggtgcactc tatcttcctg gagggccataccttcctggt gaggaaccac
aggcaggcca gcctggagat ctctcccatt accttcctgactgcccagac cctgctgatg
gatctgggcc agttcctgct gttctgccac atcagcagccaccagcatga tgggatggag
gcttatgtga aggtggatag ctgccctgag gagccccagctgaggatgaa gaacaatgag
gaggctgagg actatgatga tgacctgact gactctgagatggatgtggt gaggtttgat
gatgacaact ctcccagctt tattcagatc aggtctgtggctaagaagca ccccaagact
tgggtgcact acattgctgc tgaggaggag gactgggactatgcccctct ggtgctggct
cctgatgaca ggtcttacaa gtctcagtac ctgaataatggccctcagag gattggcagg
aagtacaaga aggtgaggtt catggcctac actgatgagaccttcaagac cagggaggcc
atccagcatg agtctggcat cctgggcccc ctgctgtatggggaggtggg ggataccctg
ctgatcatct tcaagaatca ggccagcagg ccctacaacatctaccccca tggcatcact
gatgtgaggc cactgtacag caggaggctg cccaagggggtgaagcatct gaaggacttc
cccattctgc ctggggagat cttcaagtac aaatggactgtgactgtgga ggatggccct
accaagtctg accccaggtg tctgaccagg tactacagcagctttgtgaa tatggagagg
gacctggcct ctggcctgat tggccccctg ctgatctgctacaaggagtc tgtggaccag
aggggcaatc agatcatgtc tgataagagg aatgtgattctgttctctgt gtttgatgag
aacaggagct ggtacctgac tgagaacatc cagaggttcctgcccaatcc tgctggggtg
cagctggagg accctgagtt ccaggccagc aatatcatgcacagcatcaa tggctatgtc
tttgacagcc tgcagctgtc tgtgtgcctg catgaggtggcttactggta tattctgagc
attggggccc agactgattt cctgtctgtg ttcttttctggctatacctt taagcacaag
atggtgtatg aggacaccct gaccctgttc cccttctctggggagactgt gttcatgtct
atggagaacc ctgggctgtg gatcctgggc tgccacaactctgacttcag gaacaggggg
atgactgccc tgctgaaggt gtctagctgt gataagaacactggggacta ttatgaggac
agctatgagg acatctctgc ttacctgctg agcaagaacaatgccattga gcccaggtct
ttcagccaga atccccctgt gctgaagagg catcagagggagatcaccag gaccaccctg
cagtctgatc aggaggagat tgattatgat gacactatctctgtggaaat gaagaaggag
gactttgaca tctatgatga ggatgagaac cagagccccaggagcttcca gaagaagacc
aggcactact tcattgctgc tgtggagagg ctgtgggattatggcatgag cagctctccc
catgtgctga ggaacagagc ccagtctggc tctgtgcctcagttcaagaa ggtggtcttc
caggagttca ctgatggctc tttcacccag cccctgtacaggggggagct gaatgagcac
ctgggcctgc tggggcccta cattagggct gaggtggaggataacatcat ggtgactttc
agaaaccagg ccagcaggcc ttacagcttt tactcttctctgattagcta tgaggaggat
cagaggcagg gggctgagcc taggaagaac tttgtgaagcccaatgagac caagacctat
ttctggaagg tgcagcacca catggctccc actaaggatgagtttgactg caaggcttgg
gcctacttct ctgatgtgga cctggagaag gatgtgcactctggcctgat tgggcccctg
ctggtgtgcc acaccaacac cctgaaccct gcccatggcaggcaggtgac tgtgcaggag
tttgccctgt tcttcaccat ctttgatgag actaagagctggtacttcac tgagaacatg
gagaggaact gcagggcccc ctgcaacatc cagatggaggaccccacctt caaggagaat
tacaggttcc atgccatcaa tggctacatt atggacaccctgcctggcct ggtgatggcc
caggatcaga ggatcaggtg gtatctgctg agcatgggctctaatgagaa catccacagc
atccacttct ctggccatgt gtttactgtg aggaagaaggaggaatacaa gatggctctg
tataacctgt accctggggt gtttgagact gtggagatgctgcccagcaa ggctgggatc
tggagggtgg agtgcctgat tggggagcac ctgcatgctgggatgagcac cctgttcctg
gtgtatagca ataagtgcca gacccccctg ggcatggcttctggccacat cagggatttc
cagatcactg cttctggcca gtatggccag tgggctcccaagctggctag gctgcattac
tctgggtcta tcaatgcctg gagcactaag gagcccttcagctggatcaa ggtggacctg
ctggccccca tgatcattca tggcatcaag acccagggggctaggcagaa gttcagcagc
ctgtacatca gccagttcat cattatgtac agcctggatggcaagaagtg gcagacttac
aggggcaata gcactgggac tctgatggtg ttctttggcaatgtggactc ttctggcatc
aagcacaaca tcttcaaccc tcccatcatt gccaggtacattaggctgca ccctacccac
tactctatca ggagcaccct gaggatggag ctgatggggtgtgatctgaa ctcttgcagc
atgcctctgg gcatggaaag caaagccatc tctgatgcccagatcactgc ctctagctat
ttcaccaata tgtttgccac ctggagccct agcaaggccaggctgcacct gcagggcaga
tctaatgcct ggaggcccca ggtgaacaat cccaaggagtggctgcaggt ggacttccag
aagaccatga aggtgactgg ggtgaccact cagggggtgaagagcctgct gactagcatg
tatgtgaagg agttcctgat ctcttctagc caggatggccaccagtggac cctgttcttc
cagaatggca aggtgaaagt gttccagggc aaccaggatagcttcactcc tgtggtgaac
tctctggacc ctcccctgct gactaggtac ctgaggattcatccccagag ctgggtgcac
cagattgccc tgaggatgga ggtgctgggc tgtgaggcccaggatctgta ctga
FVIIIをコードするCpGが低減した核酸変種X16(配列番号16)
atgcagattg agctgagcac ctgcttcttc ctgtgcctgctgaggttctg cttctctgcc
accaggaggt actacctggg ggctgtggag ctgtcttgggactatatgca gtctgacctg
ggggagctgc cagtggatgc caggttcccc cccagggtgcccaagagctt tcctttcaac
acttctgtgg tgtacaagaa gaccctgttt gtggagttcactgaccacct gttcaatatt
gctaagccca ggccaccctg gatgggcctg ctgggccctaccattcaggc tgaggtgtat
gacactgtgg tgattactct gaagaatatg gccagccaccctgtgagcct gcatgctgtg
ggggtgtctt actggaaggc ctctgagggg gctgagtatgatgatcagac ttctcagagg
gagaaggagg atgataaggt gttccctggg ggctctcacacttatgtgtg gcaggtgctg
aaggagaatg gccccatggc ttctgatcca ctgtgcctgacctactctta cctgagccat
gtggacctgg tgaaggacct gaactctggc ctgattggggccctgctggt gtgcagggag
ggcagcctgg ccaaggagaa gacccagacc ctgcataagttcatcctgct gtttgctgtg
tttgatgagg ggaagagctg gcactctgag accaagaattctctgatgca ggacagggat
gctgcctctg ccagggcctg gcctaagatg cacactgtgaatggctatgt gaacaggtct
ctgcctggcc tgattggctg ccacaggaag tctgtgtactggcatgtgat tggcatgggc
actacccctg aggtgcacag cattttcctg gagggccacaccttcctggt caggaaccat
aggcaggcct ctctggagat cagccccatc actttcctgactgcccagac cctgctgatg
gacctgggcc agttcctgct gttctgccac attagcagccaccagcatga tggcatggag
gcctatgtga aggtggactc ttgccctgag gagccccagctgaggatgaa gaacaatgag
gaagctgagg attatgatga tgacctgact gactctgagatggatgtggt gaggtttgat
gatgacaaca gccccagctt catccagatc aggtctgtggccaagaagca ccccaagacc
tgggtgcact acattgctgc tgaggaggag gattgggactatgctcccct ggtgctggct
cctgatgata ggagctacaa gtctcagtac ctgaataatggcccccagag gattggcagg
aagtacaaga aggtgaggtt catggcctac actgatgagaccttcaagac cagagaggct
atccagcatg agtctgggat cctggggccc ctgctgtatggggaggtggg ggacaccctg
ctgatcatct tcaagaacca ggccagcaga ccctacaacatctaccccca tgggatcact
gatgtgaggc ccctgtacag caggaggctg cctaagggggtgaagcacct gaaggacttc
cccatcctgc ctggggagat cttcaagtat aagtggactgtgactgtgga ggatgggccc
accaagtctg accctaggtg cctgactagg tactactctagctttgtgaa catggagagg
gacctggcct ctggcctgat tggccccctg ctgatttgctacaaggagtc tgtggatcag
aggggcaatc agatcatgtc tgacaagagg aatgtgatcctgttctctgt gtttgatgag
aataggtctt ggtacctgac tgagaacatc cagaggttcctgcctaatcc tgctggggtg
cagctggagg accctgagtt tcaggccagc aacatcatgcacagcatcaa tggctatgtg
tttgactctc tgcagctgtc tgtgtgcctg catgaggtggcttactggta tatcctgagc
attggggctc agactgactt cctgtctgtg ttcttttctggctacacttt taagcacaag
atggtgtatg aggacaccct gaccctgttc cccttttctggggagactgt gttcatgtct
atggagaacc ctgggctgtg gattctgggc tgtcacaactctgacttcag aaacaggggc
atgactgccc tgctgaaggt gtctagctgt gacaagaatactggggacta ctatgaggac
agctatgagg acatttctgc ctatctgctg agcaagaacaatgccattga gcccaggagc
ttttctcaga atccccctgt gctgaagagg caccagagagagatcaccag gaccactctg
cagtctgatc aggaggagat tgattatgat gacactatctctgtggagat gaagaaagag
gactttgata tctatgatga ggatgagaat cagtctcccaggagcttcca gaagaagact
agacactact tcattgctgc tgtggagagg ctgtgggactatggcatgag ctctagccct
catgtgctga ggaacagggc ccagtctggg tctgtgccccagttcaagaa ggtggtgttc
caggagttca ctgatggcag ctttacccag cccctgtataggggggagct gaatgagcat
ctgggcctgc tgggccccta tattagggct gaagtggaggacaacatcat ggtgaccttt
aggaaccagg ccagcaggcc ctacagcttt tacagcagcctgattagcta tgaggaggat
cagagacagg gggctgagcc caggaagaac tttgtgaagcccaatgagac caagacctac
ttctggaagg tgcagcacca catggcccct accaaggatgagtttgactg caaggcctgg
gcttacttct ctgatgtgga cctggagaaa gatgtgcactctggcctgat tgggcccctg
ctggtgtgcc acaccaacac cctgaaccct gcccatgggaggcaggtgac tgtgcaggag
tttgccctgt ttttcaccat ctttgatgag accaagagctggtacttcac tgagaacatg
gagaggaact gcagggcccc ctgtaacatc cagatggaggatcctacttt caaggagaac
tacaggttcc atgccattaa tgggtacatc atggacaccctgcctgggct ggtgatggcc
caggatcaga ggattaggtg gtatctgctg tctatgggctctaatgagaa catccactct
atccacttct ctggccatgt gttcactgtg aggaagaaggaggagtacaa gatggccctg
tacaacctgt accctggggt gtttgaaact gtggagatgctgccctctaa agctgggatc
tggagggtgg agtgcctgat tggggagcac ctgcatgctggcatgagcac cctgttcctg
gtgtacagca ataagtgcca gactcccctg ggcatggcttctgggcacat cagggatttc
cagatcactg cctctggcca gtatggccag tgggcccccaagctggctag gctgcactac
tctggcagca tcaatgcctg gagcaccaag gagcccttctcttggattaa ggtggacctg
ctggctccca tgatcattca tggcatcaag acccagggggccaggcagaa gttttctagc
ctgtatatta gccagttcat catcatgtat agcctggatgggaagaagtg gcagacctac
agggggaata gcactggcac cctgatggtg ttttttggcaatgtggattc ttctggcatc
aagcataaca tcttcaatcc ccctatcatt gccaggtacattaggctgca tcccacccat
tactctatca ggagcaccct gaggatggag ctgatggggtgtgatctgaa cagctgtagc
atgcccctgg gcatggagtc caaggctatc tctgatgcccagatcactgc cagcagctac
ttcaccaaca tgtttgccac ctggagcccc agcaaggccaggctgcacct gcagggcagg
tctaatgcct ggaggcccca ggtgaacaat cccaaggagtggctgcaggt ggacttccag
aagactatga aggtgactgg ggtgaccact cagggggtgaagagcctgct gaccagcatg
tatgtgaagg agttcctgat ctcttctagc caggatgggcatcagtggac cctgtttttt
cagaatggca aagtgaaggt gtttcagggg aatcaggacagctttacccc tgtggtgaac
agcctggatc ctcctctgct gactagatac ctgaggatccacccccagag ctgggtccac
cagattgctc tgaggatgga ggtgctgggg tgtgaggctcaggacctgta ctga
FVIIIをコードするCpGが低減した核酸変種X17(配列番号17)
atgcagattg agctgagcac ctgcttcttt ctgtgcctgctgaggttctg cttctctgcc
accaggaggt actacctggg ggctgtggaa ctgagctgggactatatgca gtctgacctg
ggggagctgc ctgtggatgc caggttcccc cccagggtgcccaagtcttt cccctttaac
acttctgtgg tgtacaagaa gaccctgttt gtggagtttactgaccacct gttcaatatt
gccaagccca ggcccccctg gatgggcctg ctgggcccaaccatccaggc tgaggtgtat
gatactgtgg tgatcaccct gaagaacatg gccagccaccctgtgagcct gcatgctgtg
ggggtgagct attggaaggc ttctgagggg gctgagtatgatgaccagac tagccagagg
gagaaggagg atgacaaggt gttccctggg gggtctcatacctatgtgtg gcaggtgctg
aaggagaatg gccccatggc ctctgacccc ctgtgcctgacctattctta cctgagccat
gtggacctgg tcaaggacct gaactctggc ctgattggggctctgctggt gtgcagggag
ggcagcctgg ccaaggagaa gactcagact ctgcataagttcatcctgct gtttgctgtg
tttgatgagg gcaagagctg gcactctgag accaagaactctctgatgca ggatagggat
gctgcctctg ccagggcctg gcccaagatg cacactgtgaatggctatgt gaataggtct
ctgcctggcc tgattggctg ccataggaag tctgtgtactggcatgtgat tggcatgggc
actacccctg aggtgcactc tatcttcctg gaggggcacaccttcctggt gaggaaccac
aggcaggcca gcctggagat ctctcccatc accttcctgactgcccagac tctgctgatg
gacctgggcc agttcctgct gttctgccat atcagcagccaccagcatga tggcatggag
gcctatgtga aggtggacag ctgcccagag gaaccccagctgaggatgaa gaacaatgag
gaggctgagg actatgatga tgacctgact gactctgagatggatgtggt gaggtttgat
gatgacaaca gccccagctt tattcagatc aggtctgtggccaagaagca ccccaagacc
tgggtgcact acattgctgc tgaggaggag gactgggattatgcccccct ggtgctggcc
cctgatgaca ggtcttacaa gtctcagtac ctgaacaatggcccccagag gattgggagg
aagtacaaga aggtgaggtt catggcctac actgatgagaccttcaagac cagggaggcc
atccagcatg agtctggcat cctggggccc ctgctgtatggggaggtggg ggataccctg
ctgattatct tcaagaacca ggctagcagg ccctataacatctaccccca tggcattact
gatgtgaggc ccctgtactc taggagactg cccaagggggtgaagcacct gaaagacttc
cccatcctgc ctggggagat cttcaagtat aagtggactgtgactgtgga ggatggcccc
actaagtctg accccaggtg cctgaccagg tattacagcagctttgtgaa tatggagagg
gatctggctt ctggcctgat tgggcctctg ctgatttgctacaaggagtc tgtggatcag
agggggaacc agattatgtc tgacaagagg aatgtgattctgttctctgt gtttgatgag
aacaggagct ggtacctgac tgagaatatc cagaggttcctgcctaatcc tgctggggtg
cagctggagg accctgagtt ccaggctagc aacattatgcacagcatcaa tggctatgtg
tttgacagcc tgcagctgtc tgtgtgcctg catgaggtggcttactggta cattctgtct
attggggccc agactgactt cctgtctgtg ttcttctctggctacacctt caagcacaag
atggtgtatg aggacactct gaccctgttc cccttctctggggagactgt gttcatgagc
atggagaatc ctgggctgtg gattctgggg tgccacaactctgatttcag gaacaggggc
atgactgccc tgctgaaggt gagcagctgt gacaagaacactggggatta ttatgaggac
agctatgagg acatttctgc ctacctgctg agcaagaacaatgccattga gcctaggagc
ttcagccaga atccccctgt gctgaagaga caccagagggagatcactag gaccactctg
cagtctgatc aggaggagat tgactatgat gacaccatttctgtggagat gaagaaggag
gactttgata tttatgatga ggatgagaac cagagccccagaagcttcca gaagaagacc
aggcactact tcattgctgc tgtggagagg ctgtgggattatggcatgtc ttctagcccc
catgtgctga ggaacagggc tcagtctggc tctgtgcctcagttcaagaa ggtggtgttc
caggagttca ctgatgggag cttcacccag cctctgtacaggggggagct gaatgaacat
ctgggcctgc tggggcccta catcagggct gaggtggaggataatatcat ggtgactttc
aggaatcagg cctctaggcc ctacagcttc tactctagcctgatcagcta tgaggaggac
cagaggcagg gggctgagcc taggaagaat tttgtgaaacccaatgagac caagacctac
ttttggaagg tgcagcacca catggcccct accaaggatgagtttgactg taaggcctgg
gcctacttct ctgatgtgga cctggagaag gatgtgcattctgggctgat tggccccctg
ctggtgtgcc acaccaacac cctgaaccct gcccatggcaggcaggtgac tgtgcaggag
tttgccctgt tcttcaccat ctttgatgag actaagagctggtatttcac tgagaacatg
gagaggaact gtagggctcc ctgcaacatc cagatggaggatccaacttt caaggagaac
tacaggttcc atgccatcaa tggctacatc atggacaccctgcctggcct ggtgatggcc
caggaccaga ggattaggtg gtacctgctg agcatgggctctaatgagaa catccactct
atccacttct ctggccatgt gtttactgtg aggaagaaggaggagtacaa gatggctctg
tacaacctgt accctggggt gtttgagact gtggagatgctgcctagcaa ggctggcatt
tggagagtgg agtgtctgat tggggagcac ctgcatgctgggatgtctac cctgttcctg
gtgtactcta acaagtgcca gacccccctg gggatggcttctgggcacat cagagatttt
cagattactg cttctgggca gtatggccag tgggctcccaagctggccag actgcattac
tctggctcta ttaatgcttg gagcaccaag gagcctttcagctggatcaa ggtggacctg
ctggctccca tgatcatcca tggcattaag actcagggggctaggcagaa gttcagcagc
ctgtatattt ctcagtttat tatcatgtat tctctggatggcaagaagtg gcagacttac
aggggcaaca gcactggcac cctgatggtg ttctttggcaatgtggacag ctctgggatc
aagcataaca tcttcaaccc ccccattatt gccaggtacatcaggctgca ccccacccac
tattctatca ggagcactct gaggatggag ctgatggggtgtgacctgaa cagctgctct
atgcccctgg gcatggagag caaggccatc tctgatgcccagatcactgc cagctcttat
ttcaccaaca tgtttgccac ctggagcccc agcaaggccaggctgcacct gcagggcaga
agcaatgcct ggaggcccca ggtgaacaat cctaaggagtggctgcaggt ggacttccag
aagactatga aggtgactgg ggtgactacc cagggggtgaagagcctgct gaccagcatg
tatgtgaagg agttcctgat tagcagcagc caggatgggcatcagtggac cctgttcttc
cagaatggga aggtgaaggt gttccagggc aatcaggacagcttcacccc tgtggtgaac
agcctggacc cccccctgct gaccaggtac ctgaggatccatccccagag ctgggtgcac
cagattgctc tgagaatgga ggtgctgggc tgtgaggcccaggacctgta ttga
FVIIIをコードするCpGが低減した核酸変種X18(配列番号18)
atgcagattg agctgtctac ctgttttttt ctgtgcctgctgaggttctg cttctctgct
accaggaggt attatctggg ggctgtggag ctgagctgggactacatgca gtctgacctg
ggggagctgc ctgtggatgc caggtttcct cccagggtgcctaagagctt ccccttcaac
acctctgtgg tgtacaagaa gactctgttt gtggagttcactgaccacct gttcaacatt
gccaagccca ggcccccctg gatggggctg ctgggccccactatccaggc tgaggtgtat
gatactgtgg tgattaccct gaagaacatg gcctctcaccctgtgtctct gcatgctgtg
ggggtgagct actggaaggc ttctgagggg gctgaatatgatgatcagac ctctcagagg
gagaaggagg atgacaaggt gtttcctggg ggcagccacacctatgtgtg gcaggtgctg
aaggagaatg ggcccatggc ctctgatccc ctgtgcctgacctacagcta cctgagccat
gtggacctgg tgaaggacct gaactctggc ctgattggggccctgctggt gtgcagggag
ggcagcctgg ccaaggaaaa gacccagacc ctgcataagttcatcctgct gtttgctgtg
tttgatgagg gcaagtcttg gcactctgag accaagaacagcctgatgca ggacagggat
gctgcctctg ctagggcctg gcccaagatg cacactgtgaatgggtatgt gaacagatct
ctgcctggcc tgattggctg ccacaggaag tctgtgtactggcatgtgat tggcatgggg
accacccctg aggtgcatag catcttcctg gaggggcacaccttcctggt gagaaatcat
aggcaggcca gcctggagat tagccccatc accttcctgactgcccagac cctgctgatg
gacctgggcc agttcctgct gttctgccac atttctagccaccagcatga tggcatggag
gcctatgtga aggtggatag ctgccctgaa gagccccagctgaggatgaa gaacaatgag
gaggctgagg attatgatga tgatctgact gactctgagatggatgtggt gaggtttgat
gatgacaaca gccccagctt catccagatc aggtctgtggccaagaagca ccctaagacc
tgggtgcact acattgctgc tgaagaggag gactgggactatgcccccct ggtgctggcc
ccagatgaca ggtcttacaa gagccagtac ctgaataatggcccccagag gattgggagg
aagtataaga aagtgaggtt catggcttac actgatgagacctttaagac tagggaggcc
attcagcatg agtctgggat tctgggccct ctgctgtatggggaggtggg ggacaccctg
ctgatcattt tcaagaacca ggccagcagg ccctataatatttatcccca tgggattact
gatgtcaggc ccctgtacag caggaggctg cctaagggggtgaagcacct gaaggacttc
cccattctgc ctggggagat cttcaagtat aagtggactgtgactgtgga ggatggcccc
accaagtctg atcctaggtg cctgaccagg tactatagcagctttgtgaa catggagagg
gacctggctt ctggcctgat tggccccctg ctgatctgctacaaggaatc tgtggaccag
aggggcaacc agattatgtc tgacaagagg aatgtgatcctgttttctgt gtttgatgag
aataggagct ggtatctgac tgagaacatc cagaggttcctgcccaatcc tgctggggtg
cagctggagg accctgagtt ccaggcttct aacatcatgcatagcatcaa tgggtatgtg
tttgactctc tgcagctgtc tgtgtgcctg catgaggtggcctattggta catcctgagc
attggggccc agactgactt cctgtctgtg ttcttctctggctacacctt caagcacaag
atggtgtatg aggacaccct gaccctgttc cctttctctggggagactgt gttcatgagc
atggagaacc ctggcctgtg gattctgggc tgccataattctgacttcag aaacaggggc
atgactgctc tgctgaaggt gagcagctgt gacaagaatactggggacta ctatgaggac
tcttatgagg atatttctgc ctacctgctg agcaagaacaatgctattga gcccaggagc
ttcagccaga acccccctgt cctgaagagg catcagagggagatcactag gaccaccctg
cagtctgatc aggaggagat tgactatgat gacactatctctgtggaaat gaagaaggag
gactttgata tctatgatga ggatgagaac cagagccccaggtctttcca gaagaagacc
aggcactact tcattgctgc tgtggagagg ctgtgggactatggcatgtc tagcagcccc
catgtgctga ggaacagagc ccagtctggc tctgtgccccagttcaagaa ggtggtgttt
caggagttca ctgatgggag cttcactcag cccctgtataggggggagct gaatgagcat
ctgggcctgc tggggcccta catcagggct gaggtggaggataacatcat ggtgaccttc
aggaaccagg ccagcaggcc ctactctttc tactcttctctgatcagcta tgaggaggat
cagaggcagg gggctgagcc taggaagaac tttgtcaagcctaatgagac taagacctac
ttttggaagg tgcagcacca catggctccc actaaggatgagtttgattg caaggcctgg
gcctacttct ctgatgtgga cctggagaag gatgtgcactctggcctgat tggccccctg
ctggtgtgtc acaccaatac cctgaaccct gcccatggcaggcaggtcac tgtgcaggag
tttgccctgt ttttcactat ctttgatgag actaagtcttggtacttcac tgagaacatg
gaaaggaatt gcagggctcc ctgcaacatc cagatggaggaccccacctt caaggagaac
tacaggtttc atgccatcaa tggctacatc atggacaccctgcctggcct ggtgatggct
caggatcaga ggattaggtg gtatctgctg agcatgggcagcaatgagaa catccacagc
atccactttt ctggccatgt gttcactgtg aggaagaaggaggagtacaa gatggctctg
tacaatctgt accctggggt gtttgagact gtggagatgctgcccagcaa ggctgggatc
tggagggtgg agtgcctgat tggggaacac ctgcatgctggcatgtctac cctgttcctg
gtgtactcta acaagtgcca gactcccctg ggcatggcctctgggcacat cagggacttc
cagatcactg cctctgggca gtatggccag tgggcccctaagctggctag gctgcattac
tctggcagca tcaatgcctg gagcaccaag gagcccttcagctggatcaa ggtggacctg
ctggccccta tgatcatcca tggcatcaag acccagggggccagacagaa gttctcttct
ctgtacatct ctcagttcat catcatgtac tctctggatggcaagaagtg gcagacctac
agggggaatt ctactggcac tctgatggtg ttctttgggaatgtggatag ctctgggatc
aagcataata ttttcaaccc ccccattatt gctaggtacatcaggctgca cccaacccac
tactctatta ggtctaccct gaggatggag ctgatgggctgtgacctgaa ctcttgtagc
atgcccctgg gcatggagag caaggctatc tctgatgcccagatcactgc cagcagctac
tttaccaaca tgtttgctac ttggagcccc agcaaggccaggctgcacct gcagggcagg
agcaatgcct ggaggcccca ggtgaacaac cccaaggagtggctgcaggt ggattttcag
aagaccatga aggtgactgg ggtgaccact cagggggtgaaaagcctgct gactagcatg
tatgtgaagg agtttctgat cagcagctct caggatggccatcagtggac cctgttcttc
cagaatggca aggtgaaggt gttccagggc aaccaggatagcttcacccc tgtggtgaat
agcctggacc cccccctgct gaccaggtac ctgaggatccatccccagag ctgggtgcac
cagattgccc tgaggatgga ggtgctgggc tgtgaagcccaggacctgta ctga
野生型第VIII因子-BDD cDNA(配列番号19)
ATGCAAATAG AGCTCTCCAC CTGCTTCTTT CTGTGCCTTTTGCGATTCTG CTTTAGTGCC
ACCAGAAGAT ACTACCTGGG TGCAGTGGAA CTGTCATGGGACTATATGCA AAGTGATCTC
GGTGAGCTGC CTGTGGACGC AAGATTTCCT CCTAGAGTGCCAAAATCTTT TCCATTCAAC
ACCTCAGTCG TGTACAAAAA GACTCTGTTT GTAGAATTCACGGATCACCT TTTCAACATC
GCTAAGCCAA GGCCACCCTG GATGGGTCTG CTAGGTCCTACCATCCAGGC TGAGGTTTAT
GATACAGTGG TCATTACACT TAAGAACATG GCTTCCCATCCTGTCAGTCT TCATGCTGTT
GGTGTATCCT ACTGGAAAGC TTCTGAGGGA GCTGAATATGATGATCAGAC CAGTCAAAGG
GAGAAAGAAG ATGATAAAGT CTTCCCTGGT GGAAGCCATACATATGTCTG GCAGGTCCTG
AAAGAGAATG GTCCAATGGC CTCTGACCCA CTGTGCCTTACCTACTCATA TCTTTCTCAT
GTGGACCTGG TAAAAGACTT GAATTCAGGC CTCATTGGAGCCCTACTAGT ATGTAGAGAA
GGGAGTCTGG CCAAGGAAAA GACACAGACC TTGCACAAATTTATACTACT TTTTGCTGTA
TTTGATGAAG GGAAAAGTTG GCACTCAGAA ACAAAGAACTCCTTGATGCA GGATAGGGAT
GCTGCATCTG CTCGGGCCTG GCCTAAAATG CACACAGTCAATGGTTATGT AAACAGGTCT
CTGCCAGGTC TGATTGGATG CCACAGGAAA TCAGTCTATTGGCATGTGAT TGGAATGGGC
ACCACTCCTG AAGTGCACTC AATATTCCTC GAAGGTCACACATTTCTTGT GAGGAACCAT
CGCCAGGCGT CCTTGGAAAT CTCGCCAATA ACTTTCCTTACTGCTCAAAC ACTCTTGATG
GACCTTGGAC AGTTTCTACT GTTTTGTCAT ATCTCTTCCCACCAACATGA TGGCATGGAA
GCTTATGTCA AAGTAGACAG CTGTCCAGAG GAACCCCAACTACGAATGAA AAATAATGAA
GAAGCGGAAG ACTATGATGA TGATCTTACT GATTCTGAAATGGATGTGGT CAGGTTTGAT
GATGACAACT CTCCTTCCTT TATCCAAATT CGCTCAGTTGCCAAGAAGCA TCCTAAAACT
TGGGTACATT ACATTGCTGC TGAAGAGGAG GACTGGGACTATGCTCCCTT AGTCCTCGCC
CCCGATGACA GAAGTTATAA AAGTCAATAT TTGAACAATGGCCCTCAGCG GATTGGTAGG
AAGTACAAAA AAGTCCGATT TATGGCATAC ACAGATGAAACCTTTAAGAC TCGTGAAGCT
ATTCAGCATG AATCAGGAAT CTTGGGACCT TTACTTTATGGGGAAGTTGG AGACACACTG
TTGATTATAT TTAAGAATCA AGCAAGCAGA CCATATAACATCTACCCTCA CGGAATCACT
GATGTCCGTC CTTTGTATTC AAGGAGATTA CCAAAAGGTGTAAAACATTT GAAGGATTTT
CCAATTCTGC CAGGAGAAAT ATTCAAATAT AAATGGACAGTGACTGTAGA AGATGGGCCA
ACTAAATCAG ATCCTCGGTG CCTGACCCGC TATTACTCTAGTTTCGTTAA TATGGAGAGA
GATCTAGCTT CAGGACTCAT TGGCCCTCTC CTCATCTGCTACAAAGAATC TGTAGATCAA
AGAGGAAACC AGATAATGTC AGACAAGAGG AATGTCATCCTGTTTTCTGT ATTTGATGAG
AACCGAAGCT GGTACCTCAC AGAGAATATA CAACGCTTTCTCCCCAATCC AGCTGGAGTG
CAGCTTGAGG ATCCAGAGTT CCAAGCCTCC AACATCATGCACAGCATCAA TGGCTATGTT
TTTGATAGTT TGCAGTTGTC AGTTTGTTTG CATGAGGTGGCATACTGGTA CATTCTAAGC
ATTGGAGCAC AGACTGACTT CCTTTCTGTC TTCTTCTCTGGATATACCTT CAAACACAAA
ATGGTCTATG AAGACACACT CACCCTATTC CCATTCTCAGGAGAAACTGT CTTCATGTCG
ATGGAAAACC CAGGTCTATG GATTCTGGGG TGCCACAACTCAGACTTTCG GAACAGAGGC
ATGACCGCCT TACTGAAGGT TTCTAGTTGT GACAAGAACACTGGTGATTA TTACGAGGAC
AGTTATGAAG ATATTTCAGC ATACTTGCTG AGTAAAAACAATGCCATTGA ACCAAGAAGC
TTCTCCCAAA ACCCACCAGT CTTGAAACGC CATCAACGGGAAATAACTCG TACTACTCTT
CAGTCAGATC AAGAGGAAAT TGACTATGAT GATACCATATCAGTTGAAAT GAAGAAGGAA
GATTTTGACA TTTATGATGA GGATGAAAAT CAGAGCCCCCGCAGCTTTCA AAAGAAAACA
CGACACTATT TTATTGCTGC AGTGGAGAGG CTCTGGGATTATGGGATGAG TAGCTCCCCA
CATGTTCTAA GAAACAGGGC TCAGAGTGGC AGTGTCCCTCAGTTCAAGAA AGTTGTTTTC
CAGGAATTTA CTGATGGCTC CTTTACTCAG CCCTTATACCGTGGAGAACT AAATGAACAT
TTGGGACTCC TGGGGCCATA TATAAGAGCA GAAGTTGAAGATAATATCAT GGTAACTTTC
AGAAATCAGG CCTCTCGTCC CTATTCCTTC TATTCTAGCCTTATTTCTTA TGAGGAAGAT
CAGAGGCAAG GAGCAGAACC TAGAAAAAAC TTTGTCAAGCCTAATGAAAC CAAAACTTAC
TTTTGGAAAG TGCAACATCA TATGGCACCC ACTAAAGATGAGTTTGACTG CAAAGCCTGG
GCTTATTTCT CTGATGTTGA CCTGGAAAAA GATGTGCACTCAGGCCTGAT TGGACCCCTT
CTGGTCTGCC ACACTAACAC ACTGAACCCT GCTCATGGGAGACAAGTGAC AGTACAGGAA
TTTGCTCTGT TTTTCACCAT CTTTGATGAG ACCAAAAGCTGGTACTTCAC TGAAAATATG
GAAAGAAACT GCAGGGCTCC CTGCAATATC CAGATGGAAGATCCCACTTT TAAAGAGAAT
TATCGCTTCC ATGCAATCAA TGGCTACATA ATGGATACACTACCTGGCTT AGTAATGGCT
CAGGATCAAA GGATTCGATG GTATCTGCTC AGCATGGGCAGCAATGAAAA CATCCATTCT
ATTCATTTCA GTGGACATGT GTTCACCGTA CGAAAAAAAGAGGAGTATAA AATGGCACTG
TACAATCTCT ATCCAGGTGT TTTTGAGACA GTGGAAATGTTACCATCCAA AGCTGGAATT
TGGCGGGTGG AATGCCTTAT TGGCGAGCAT CTACATGCTGGGATGAGCAC ACTTTTTCTG
GTGTACAGCA ATAAGTGTCA GACTCCCCTG GGAATGGCTTCTGGACACAT TAGAGATTTT
CAGATTACAG CTTCAGGACA ATATGGACAG TGGGCCCCAAAGCTGGCCAG ACTTCATTAT
TCCGGATCAA TCAATGCCTG GAGCACCAAG GAGCCCTTTTCTTGGATCAA GGTGGATCTG
TTGGCACCAA TGATTATTCA CGGCATCAAG ACCCAGGGTGCCCGTCAGAA GTTCTCCAGC
CTCTACATCT CTCAGTTTAT CATCATGTAT AGTCTTGATGGGAAGAAGTG GCAGACTTAT
CGAGGAAATT CCACTGGAAC CTTAATGGTC TTCTTTGGCAATGTGGATTC ATCTGGGATA
AAACACAATA TTTTTAACCC TCCAATTATT GCTCGATACATCCGTTTGCA CCCAACTCAT
TATAGCATTC GCAGCACTCT TCGCATGGAG TTGATGGGCTGTGATTTAAA TAGTTGCAGC
ATGCCATTGG GAATGGAGAG TAAAGCAATA TCAGATGCACAGATTACTGC TTCATCCTAC
TTTACCAATA TGTTTGCCAC CTGGTCTCCT TCAAAAGCTCGACTTCACCT CCAAGGGAGG
AGTAATGCCT GGAGACCTCA GGTGAATAAT CCAAAAGAGTGGCTGCAAGT GGACTTCCAG
AAGACAATGA AAGTCACAGG AGTAACTACT CAGGGAGTAAAATCTCTGCT TACCAGCATG
TATGTGAAGG AGTTCCTCAT CTCCAGCAGT CAAGATGGCCATCAGTGGAC TCTCTTTTTT
CAGAATGGCA AAGTAAAGGT TTTTCAGGGA AATCAAGACTCCTTCACACC TGTGGTGAAC
TCTCTAGACC CACCGTTACT GACTCGCTAC CTTCGAATTCACCCCCAGAG TTGGGTGCAC
CAGATTGCCC TGAGGATGGA GGTTCTGGGC TGCGAGGCACAGGACCTCTA CTGA
V3第VIII因子cDNA(配列番号20)
ATGCAGATTGAGCTGAGCACCTGCTTCTTCCTGTGCCTGCTGAGGTTCTGCTTCTCTGCCACCAGGAGATACTACCTGGGGGCTGTGGAGCTGAGCTGGGACTACATGCAGTCTGACCTGGGGGAGCTGCCTGTGGATGCCAGGTTCCCCCCCAGAGTGCCCAAGAGCTTCCCCTTCAACACCTCTGTGGTGTACAAGAAGACCCTGTTTGTGGAGTTCACTGACCACCTGTTCAACATTGCCAAGCCCAGGCCCCCCTGGATGGGCCTGCTGGGCCCCACCATCCAGGCTGAGGTGTATGACACTGTGGTGATCACCCTGAAGAACATGGCCAGCCACCCTGTGAGCCTGCATGCTGTGGGGGTGAGCTACTGGAAGGCCTCTGAGGGGGCTGAGTATGATGACCAGACCAGCCAGAGGGAGAAGGAGGATGACAAGGTGTTCCCTGGGGGCAGCCACACCTATGTGTGGCAGGTGCTGAAGGAGAATGGCCCCATGGCCTCTGACCCCCTGTGCCTGACCTACAGCTACCTGAGCCATGTGGACCTGGTGAAGGACCTGAACTCTGGCCTGATTGGGGCCCTGCTGGTGTGCAGGGAGGGCAGCCTGGCCAAGGAGAAGACCCAGACCCTGCACAAGTTCATCCTGCTGTTTGCTGTGTTTGATGAGGGCAAGAGCTGGCACTCTGAAACCAAGAACAGCCTGATGCAGGACAGGGATGCTGCCTCTGCCAGGGCCTGGCCCAAGATGCACACTGTGAATGGCTATGTGAACAGGAGCCTGCCTGGCCTGATTGGCTGCCACAGGAAGTCTGTGTACTGGCATGTGATTGGCATGGGCACCACCCCTGAGGTGCACAGCATCTTCCTGGAGGGCCACACCTTCCTGGTCAGGAACCACAGGCAGGCCAGCCTGGAGATCAGCCCCATCACCTTCCTGACTGCCCAGACCCTGCTGATGGACCTGGGCCAGTTCCTGCTGTTCTGCCACATCAGCAGCCACCAGCATGATGGCATGGAGGCCTATGTGAAGGTGGACAGCTGCCCTGAGGAGCCCCAGCTGAGGATGAAGAACAATGAGGAGGCTGAGGACTATGATGATGACCTGACTGACTCTGAGATGGATGTGGTGAGGTTTGATGATGACAACAGCCCCAGCTTCATCCAGATCAGGTCTGTGGCCAAGAAGCACCCCAAGACCTGGGTGCACTACATTGCTGCTGAGGAGGAGGACTGGGACTATGCCCCCCTGGTGCTGGCCCCTGATGACAGGAGCTACAAGAGCCAGTACCTGAACAATGGCCCCCAGAGGATTGGCAGGAAGTACAAGAAGGTCAGGTTCATGGCCTACACTGATGAAACCTTCAAGACCAGGGAGGCCATCCAGCATGAGTCTGGCATCCTGGGCCCCCTGCTGTATGGGGAGGTGGGGGACACCCTGCTGATCATCTTCAAGAACCAGGCCAGCAGGCCCTACAACATCTACCCCCATGGCATCACTGATGTGAGGCCCCTGTACAGCAGGAGGCTGCCCAAGGGGGTGAAGCACCTGAAGGACTTCCCCATCCTGCCTGGGGAGATCTTCAAGTACAAGTGGACTGTGACTGTGGAGGATGGCCCCACCAAGTCTGACCCCAGGTGCCTGACCAGATACTACAGCAGCTTTGTGAACATGGAGAGGGACCTGGCCTCTGGCCTGATTGGCCCCCTGCTGATCTGCTACAAGGAGTCTGTGGACCAGAGGGGCAACCAGATCATGTCTGACAAGAGGAATGTGATCCTGTTCTCTGTGTTTGATGAGAACAGGAGCTGGTACCTGACTGAGAACATCCAGAGGTTCCTGCCCAACCCTGCTGGGGTGCAGCTGGAGGACCCTGAGTTCCAGGCCAGCAACATCATGCACAGCATCAATGGCTATGTGTTTGACAGCCTGCAGCTGTCTGTGTGCCTGCATGAGGTGGCCTACTGGTACATCCTGAGCATTGGGGCCCAGACTGACTTCCTGTCTGTGTTCTTCTCTGGCTACACCTTCAAGCACAAGATGGTGTATGAGGACACCCTGACCCTGTTCCCCTTCTCTGGGGAGACTGTGTTCATGAGCATGGAGAACCCTGGCCTGTGGATTCTGGGCTGCCACAACTCTGACTTCAGGAACAGGGGCATGACTGCCCTGCTGAAAGTCTCCAGCTGTGACAAGAACACTGGGGACTACTATGAGGACAGCTATGAGGACATCTCTGCCTACCTGCTGAGCAAGAACAATGCCATTGAGCCCAGGAGCTTCAGCCAGAACAGCAGGCACCCCAGCACCAGGCAGAAGCAGTTCAATGCCACCACCATCCCTGAGAATGACATAGAGAAGACAGACCCATGGTTTGCCCACCGGACCCCCATGCCCAAGATCCAGAATGTGAGCAGCTCTGACCTGCTGATGCTGCTGAGGCAGAGCCCCACCCCCCATGGCCTGAGCCTGTCTGACCTGCAGGAGGCCAAGTATGAAACCTTCTCTGATGACCCCAGCCCTGGGGCCATTGACAGCAACAACAGCCTGTCTGAGATGACCCACTTCAGGCCCCAGCTGCACCACTCTGGGGACATGGTGTTCACCCCTGAGTCTGGCCTGCAGCTGAGGCTGAATGAGAAGCTGGGCACCACTGCTGCCACTGAGCTGAAGAAGCTGGACTTCAAAGTCTCCAGCACCAGCAACAACCTGATCAGCACCATCCCCTCTGACAACCTGGCTGCTGGCACTGACAACACCAGCAGCCTGGGCCCCCCCAGCATGCCTGTGCACTATGACAGCCAGCTGGACACCACCCTGTTTGGCAAGAAGAGCAGCCCCCTGACTGAGTCTGGGGGCCCCCTGAGCCTGTCTGAGGAGAACAATGACAGCAAGCTGCTGGAGTCTGGCCTGATGAACAGCCAGGAGAGCAGCTGGGGCAAGAATGTGAGCACCAGGAGCTTCCAGAAGAAGACCAGGCACTACTTCATTGCTGCTGTGGAGAGGCTGTGGGACTATGGCATGAGCAGCAGCCCCCATGTGCTGAGGAACAGGGCCCAGTCTGGCTCTGTGCCCCAGTTCAAGAAGGTGGTGTTCCAGGAGTTCACTGATGGCAGCTTCACCCAGCCCCTGTACAGAGGGGAGCTGAATGAGCACCTGGGCCTGCTGGGCCCCTACATCAGGGCTGAGGTGGAGGACAACATCATGGTGACCTTCAGGAACCAGGCCAGCAGGCCCTACAGCTTCTACAGCAGCCTGATCAGCTATGAGGAGGACCAGAGGCAGGGGGCTGAGCCCAGGAAGAACTTTGTGAAGCCCAATGAAACCAAGACCTACTTCTGGAAGGTGCAGCACCACATGGCCCCCACCAAGGATGAGTTTGACTGCAAGGCCTGGGCCTACTTCTCTGATGTGGACCTGGAGAAGGATGTGCACTCTGGCCTGATTGGCCCCCTGCTGGTGTGCCACACCAACACCCTGAACCCTGCCCATGGCAGGCAGGTGACTGTGCAGGAGTTTGCCCTGTTCTTCACCATCTTTGATGAAACCAAGAGCTGGTACTTCACTGAGAACATGGAGAGGAACTGCAGGGCCCCCTGCAACATCCAGATGGAGGACCCCACCTTCAAGGAGAACTACAGGTTCCATGCCATCAATGGCTACATCATGGACACCCTGCCTGGCCTGGTGATGGCCCAGGACCAGAGGATCAGGTGGTACCTGCTGAGCATGGGCAGCAATGAGAACATCCACAGCATCCACTTCTCTGGCCATGTGTTCACTGTGAGGAAGAAGGAGGAGTACAAGATGGCCCTGTACAACCTGTACCCTGGGGTGTTTGAGACTGTGGAGATGCTGCCCAGCAAGGCTGGCATCTGGAGGGTGGAGTGCCTGATTGGGGAGCACCTGCATGCTGGCATGAGCACCCTGTTCCTGGTGTACAGCAACAAGTGCCAGACCCCCCTGGGCATGGCCTCTGGCCACATCAGGGACTTCCAGATCACTGCCTCTGGCCAGTATGGCCAGTGGGCCCCCAAGCTGGCCAGGCTGCACTACTCTGGCAGCATCAATGCCTGGAGCACCAAGGAGCCCTTCAGCTGGATCAAGGTGGACCTGCTGGCCCCCATGATCATCCATGGCATCAAGACCCAGGGGGCCAGGCAGAAGTTCAGCAGCCTGTACATCAGCCAGTTCATCATCATGTACAGCCTGGATGGCAAGAAGTGGCAGACCTACAGGGGCAACAGCACTGGCACCCTGATGGTGTTCTTTGGCAATGTGGACAGCTCTGGCATCAAGCACAACATCTTCAACCCCCCCATCATTGCCAGATACATCAGGCTGCACCCCACCCACTACAGCATCAGGAGCACCCTGAGGATGGAGCTGATGGGCTGTGACCTGAACAGCTGCAGCATGCCCCTGGGCATGGAGAGCAAGGCCATCTCTGATGCCCAGATCACTGCCAGCAGCTACTTCACCAACATGTTTGCCACCTGGAGCCCCAGCAAGGCCAGGCTGCACCTGCAGGGCAGGAGCAATGCCTGGAGGCCCCAGGTCAACAACCCCAAGGAGTGGCTGCAGGTGGACTTCCAGAAGACCATGAAGGTGACTGGGGTGACCACCCAGGGGGTGAAGAGCCTGCTGACCAGCATGTATGTGAAGGAGTTCCTGATCAGCAGCAGCCAGGATGGCCACCAGTGGACCCTGTTCTTCCAGAATGGCAAGGTGAAGGTGTTCCAGGGCAACCAGGACAGCTTCACCCCTGTGGTGAACAGCCTGGACCCCCCCCTGCTGACCAGATACCTGAGGATTCACCCCCAGAGCTGGGTGCACCAGATTGCCCTGAGGATGGAGGTGCTGGGCTGTGAGGCCCAGGACCTGTACTGA
CO3第VIII因子cDNA(配列番号21)
atgcagattg agctgtcaac ttgctttttc ctgtgcctgctgagattttg tttttccgct
actagaagat actacctggg ggctgtggaa ctgtcttgggattacatgca gagtgacctg
ggagagctgc cagtggacgc acgatttcca cctagagtccctaaatcatt ccccttcaac
accagcgtgg tctataagaa aacactgttc gtggagtttactgatcacct gttcaacatc
gctaagcctc ggccaccctg gatgggactg ctgggaccaacaatccaggc agaggtgtac
gacaccgtgg tcattacact gaaaaacatg gcctcacaccccgtgagcct gcatgctgtg
ggcgtcagct actggaaggc ttccgaaggg gcagagtatgacgatcagac ttcccagaga
gaaaaagagg acgataaggt gtttcctggc gggtctcatacctatgtgtg gcaggtcctg
aaagagaatg gccccatggc ttccgaccct ctgtgcctgacctactctta tctgagtcac
gtggacctgg tcaaggatct gaacagcgga ctgatcggagcactgctggt gtgtagggaa
gggagcctgg ctaaggagaa aacccagaca ctgcataagttcattctgct gttcgccgtg
tttgacgaag gaaaatcatg gcacagcgag acaaagaatagtctgatgca ggaccgggat
gccgcttcag ccagagcttg gcccaaaatg cacactgtgaacggctacgt caatcgctca
ctgcctggac tgatcggctg ccaccgaaag agcgtgtattggcatgtcat cggaatgggc
accacacctg aagtgcactc cattttcctg gaggggcatacctttctggt ccgcaaccac
cgacaggcct ccctggagat ctctccaatt accttcctgacagctcagac tctgctgatg
gatctgggac agttcctgct gttttgccac atcagctcccaccagcatga tggcatggag
gcctacgtga aagtggacag ctgtcccgag gaacctcagctgaggatgaa gaacaatgag
gaagctgaag actatgacga tgacctgacc gactccgagatggatgtggt ccgattcgat
gacgataaca gcccctcctt tatccagatt agatctgtggccaagaaaca ccctaagaca
tgggtccatt acatcgcagc cgaggaagag gactgggattatgcaccact ggtgctggca
ccagacgatc gatcctacaa atctcagtat ctgaacaatggaccacagcg gattggcaga
aagtacaaga aagtgaggtt catggcttat accgatgaaaccttcaagac tcgcgaagca
atccagcacg agagcgggat tctgggacca ctgctgtacggagaagtggg ggacaccctg
ctgatcattt ttaagaacca ggccagcagg ccttacaatatctatccaca tggaattaca
gatgtgcgcc ctctgtacag ccggagactg ccaaagggcgtcaaacacct gaaggacttc
ccaatcctgc ccggggaaat ttttaagtat aaatggactgtcaccgtcga ggatggcccc
actaagagcg accctaggtg cctgacccgc tactattctagtttcgtgaa tatggaaagg
gatctggcca gcggactgat cggcccactg ctgatttgttacaaagagag cgtggatcag
agaggcaacc agatcatgtc cgacaagagg aatgtgattctgttcagtgt ctttgacgaa
aaccggtcat ggtatctgac cgagaacatc cagagattcctgcctaatcc agccggagtg
cagctggaag atcctgagtt tcaggcttct aacatcatgcatagtattaa tggctacgtg
ttcgacagtc tgcagctgtc agtgtgtctg cacgaggtcgcttactggta tatcctgagc
attggagcac agacagattt cctgagcgtg ttcttttccggctacacttt taagcataaa
atggtgtatg aggacacact gactctgttc cccttcagcggcgaaaccgt gtttatgtcc
atggagaatc ccgggctgtg gatcctggga tgccacaacagcgatttcag gaatcgcggg
atgactgccc tgctgaaagt gtcaagctgt gacaagaacaccggagacta ctatgaagat
tcatacgagg acatcagcgc atatctgctg tccaaaaacaatgccattga acccaggtct
tttagtcaga atcctccagt gctgaagagg caccagcgcgagatcacccg cactaccctg
cagagtgatc aggaagagat cgactacgac gatacaatttctgtggaaat gaagaaagag
gacttcgata tctatgacga agatgagaac cagagtcctcgatcattcca gaagaaaacc
cggcattact ttattgctgc agtggagcgc ctgtgggattatggcatgtc ctctagtcct
cacgtgctgc gaaatcgggc ccagtcaggg agcgtcccacagttcaagaa agtggtcttc
caggagttta cagacggatc ctttactcag ccactgtaccggggcgaact gaacgagcac
ctggggctgc tgggacccta tatcagagct gaagtggaggataacattat ggtcaccttc
agaaatcagg catctaggcc ttacagtttt tattcaagcctgatctctta cgaagaggac
cagaggcagg gagcagaacc acgaaaaaac ttcgtgaagcctaatgagac caaaacatac
ttttggaagg tgcagcacca tatggcccca acaaaagacgaattcgattg caaggcatgg
gcctattttt ctgacgtgga tctggagaag gacgtccacagtggcctgat cgggccactg
ctggtgtgtc atactaacac cctgaatccc gcacacggcaggcaggtcac tgtccaggaa
ttcgccctgt tctttaccat ctttgatgag acaaaaagctggtacttcac cgaaaacatg
gagcgaaatt gccgggctcc atgtaatatt cagatggaagaccccacatt caaggagaac
taccgctttc atgccatcaa tgggtatatt atggatactctgcccggact ggtcatggct
caggaccaga gaatcaggtg gtacctgctg agcatggggtccaacgagaa tatccactca
attcatttca gcggacacgt gtttactgtc cggaagaaagaagagtataa aatggccctg
tacaacctgt atcccggcgt gttcgaaacc gtcgagatgctgcctagcaa ggcagggatc
tggagagtgg aatgcctgat tggggagcac ctgcatgccggaatgtctac cctgtttctg
gtgtacagta ataagtgtca gacacccctg gggatggcttccggacatat ccgggatttc
cagattaccg catctggaca gtacggccag tgggcccctaagctggctag actgcactat
tccgggtcta tcaacgcttg gtccacaaaa gagcctttctcttggattaa ggtggacctg
ctggcaccaa tgatcattca tggcatcaaa actcagggggccaggcagaa gttctcctct
ctgtacatct cacagtttat catcatgtac agcctggatggcaagaaatg gcagacatac
cgcggcaata gcacagggac tctgatggtg ttctttggcaacgtggacag ttcagggatc
aagcacaaca ttttcaatcc ccctatcatt gctagatacatcaggctgca cccaacccat
tattctattc gaagtacact gcggatggaa ctgatggggtgcgatctgaa cagttgttca
atgcccctgg gaatggagtc caaggcaatc tctgacgcccagattaccgc tagctcctac
ttcactaata tgtttgctac ctggagcccc tccaaagcacgactgcatct gcagggacga
agcaacgcat ggcgaccaca ggtgaacaat cccaaggagtggctgcaggt cgattttcag
aaaactatga aggtgaccgg agtcacaact cagggcgtgaaaagtctgct gacctcaatg
tacgtcaagg agttcctgat ctctagttca caggacggccaccagtggac actgttcttt
cagaacggaa aggtgaaagt cttccagggc aatcaggattcctttacacc tgtggtcaac
tctctggacc cacccctgct gactcgctac ctgcgaatccacccacagtc ctgggtgcat
cagattgcac tgagaatgga agtcctgggc tgcgaggcccaggacctgta ttga
変異型TTRプロモーター(TTRmut)、合成イントロン、CpGが低減した第VIII因子cDNA、ポリA及びITRを含む全長カセット(配列番号23)
cctgcaggca gctgcgcgct cgctcgctca ctgaggccgcccgggcaaag cccgggcgtc
gggcgacctt tggtcgcccg gcctcagtga gcgagcgagcgcgcagagag ggagtggcca
actccatcac taggggttcc tacgcgtgtc tgtctgcacatttcgtagag cgagtgttcc
gatactctaa tctccctagg caaggttcat attgacttaggttacttatt ctccttttgt
tgactaagtc aataatcaga atcagcaggt ttggagtcagcttggcaggg atcagcagcc
tgggttggaa ggagggggta taaaagcccc ttcaccaggagaagccgtca cacagatcca
caagctcctg ctagcaggta agtgccgtgt gtggttcccgcgggcctggc ctctttacgg
gttatggccc ttgcgtgcct tgaattactg acactgacatccactttttc tttttctcca
caggtttaaa cgccaccatg cagattgagc tgagcacctgcttcttcctg tgtctgctga
ggttctgctt ctctgccacc aggaggtatt acctgggggctgtggagctg agctgggact
atatgcagtc tgacctgggg gagctgcctg tggatgctaggttccccccc agggtgccca
agagcttccc ctttaacact tctgtggtgt acaagaagaccctgtttgtg gagttcactg
accacctgtt caacattgcc aagcccaggc ccccctggatggggctgctg gggcccacca
tccaggctga ggtgtatgac actgtggtga tcaccctgaagaacatggcc agccaccctg
tgagcctgca tgctgtgggg gtgagctact ggaaggcttctgagggggct gagtatgatg
accagactag ccagagggag aaggaggatg acaaggtgtttcctgggggc agccatacct
atgtgtggca ggtgctgaag gagaatggcc ccatggcctctgaccccctg tgcctgacct
acagctacct gtctcatgtg gacctggtga aggacctgaactctggcctg attggggctc
tgctggtgtg tagggagggc agcctggcta aggaaaagacccagaccctg cataagttta
tcctgctgtt tgctgtgttt gatgagggca agagctggcactctgagacc aagaacagcc
tgatgcagga tagggatgct gcctctgcca gggcttggcctaagatgcac actgtgaatg
ggtatgtgaa taggagcctg cctggcctga ttggctgccacaggaagtct gtgtactggc
atgtgattgg gatgggcacc acccctgagg tccatagcatcttcctggag ggccacactt
tcctggtgag gaaccacaga caggcctctc tggagatctctcccatcacc ttcctgactg
ctcagactct gctgatggac ctgggccagt tcctgctgttttgccatatt agcagccacc
agcatgatgg gatggaggcc tatgtgaagg tggatagctgccctgaggag cctcagctga
ggatgaagaa caatgaggag gctgaagact atgatgatgacctgactgat tctgagatgg
atgtggtgag gtttgatgat gacaatagcc ccagcttcattcagatcagg tctgtggcca
agaaacaccc caagacctgg gtgcactaca ttgctgctgaggaagaggac tgggactatg
ctcccctggt gctggcccct gatgataggt cttataagagccagtacctg aacaatgggc
cccagaggat tggcaggaag tacaagaagg tgaggttcatggcctacact gatgaaacct
tcaaaaccag ggaggccatt cagcatgagt ctggcatcctgggccctctg ctgtatgggg
aggtggggga caccctgctg atcatcttca agaaccaggccagcaggccc tacaacatct
atcctcatgg catcactgat gtgaggcccc tgtacagcaggaggctgccc aagggggtga
agcacctgaa agacttcccc atcctgcctg gggagatctttaagtataag tggactgtga
ctgtggagga tggccctacc aagtctgacc ccaggtgtctgaccaggtac tattctagct
ttgtgaacat ggagagggac ctggcctctg gcctgattgggcccctgctg atctgctaca
aggagtctgt ggaccagagg ggcaaccaga tcatgtctgacaagaggaat gtgatcctgt
tttctgtgtt tgatgagaat aggagctggt acctgactgagaacatccag aggtttctgc
ccaatcctgc tggggtgcag ctggaggatc ctgagttccaggccagcaat atcatgcata
gcatcaatgg ctatgtgttt gacagcctgc agctgtctgtgtgcctgcat gaggtggcct
actggtacat cctgagcatt ggggcccaga ctgactttctgtctgtgttc ttttctggct
ataccttcaa gcacaagatg gtgtatgagg ataccctgaccctgttcccc ttctctgggg
agactgtgtt catgagcatg gagaatcctg ggctgtggatcctggggtgc cacaactctg
attttaggaa cagggggatg actgccctgc tgaaggtgtctagctgtgat aagaacactg
gggactacta tgaggacagc tatgaggaca tttctgcttatctgctgtct aagaataatg
ccattgagcc cagaagcttc agccagaatc cccctgtgctgaagagacat cagagggaga
tcaccagaac taccctgcag tctgatcagg aggagattgactatgatgac actatctctg
tggagatgaa gaaggaggac tttgacatct atgatgaggatgagaatcag tctcccagga
gctttcagaa gaagaccaga cattacttca ttgctgctgtggagaggctg tgggactatg
gcatgagctc tagccctcat gtgctgagga acagggcccagtctggctct gtgccccagt
tcaagaaggt ggtgttccag gaattcactg atggcagcttcacccagccc ctgtacaggg
gggagctgaa tgagcacctg ggcctgctgg ggccttatatcagggctgag gtggaggata
atattatggt gactttcagg aaccaggcca gcaggccctactctttctat agcagcctga
tctcttatga ggaggatcag aggcaggggg ctgagcctaggaagaacttt gtgaagccca
atgagactaa gacctacttc tggaaggtcc agcaccacatggcccctacc aaggatgagt
ttgactgcaa ggcctgggcc tatttctctg atgtggatctggagaaggat gtccattctg
ggctgattgg ccccctgctg gtgtgccaca ctaacactctgaatcctgcc catggcaggc
aggtgactgt ccaggagttt gccctgttct tcactatctttgatgagacc aagagctggt
actttactga gaacatggag aggaactgca gagctccttgcaatattcag atggaggacc
ccaccttcaa ggagaattac aggttccatg ccattaatgggtacatcatg gacaccctgc
ctggcctggt gatggctcag gaccagagga tcaggtggtacctgctgagc atgggctcta
atgagaatat ccacagcatc cacttctctg ggcatgtgttcactgtgagg aagaaggagg
agtacaagat ggctctgtat aatctgtacc ctggggtgtttgaaactgtg gagatgctgc
cctctaaggc tggcatctgg agggtggagt gcctgattggggagcacctg catgctggca
tgagcaccct gttcctggtg tacagcaaca agtgccagacccccctgggc atggcctctg
gccacatcag ggacttccag atcactgcct ctggccagtatggccagtgg gcccccaagc
tggccaggct gcactattct ggcagcatca atgcctggagcaccaaggag cccttcagct
ggatcaaggt ggacctgctg gcccccatga tcattcatggcatcaagacc cagggggcca
ggcagaagtt cagctctctg tacatctctc agttcatcatcatgtactct ctggatggga
agaagtggca gacctacagg ggcaacagca ctggcaccctgatggtgttc tttgggaatg
tggactcttc tggcatcaag cacaacatct tcaatccccccatcattgct aggtatatta
ggctgcatcc cacccactac agcatcaggt ctaccctgaggatggagctg atgggctgtg
acctgaactc ttgcagcatg cccctgggca tggagtctaaggccatctct gatgcccaga
ttactgccag cagctacttc accaacatgt ttgccacctggagcccctct aaggccaggc
tgcatctgca ggggaggagc aatgcctgga ggcctcaggtgaacaacccc aaggagtggc
tgcaggtgga tttccagaag accatgaagg tgactggggtgaccacccag ggggtcaaga
gcctgctgac cagcatgtat gtgaaggagt tcctgatcagcagcagccag gatggccacc
agtggactct gttctttcag aatgggaagg tgaaggtgtttcagggcaat caggactctt
tcacccctgt ggtgaacagc ctggaccccc ccctgctgaccagatacctg aggatccacc
cccagtcttg ggtgcatcag attgccctga ggatggaggtgctgggctgt gaggctcagg
atctgtactg agcggccgca ataaaagatc agagctctagagatctgtgt gttggttttt
tgtgtaggaa cccctagtga tggagttggc cactccctctctgcgcgctc gctcgctcac
tgaggccggg cgaccaaagg tcgcccgacg cccgggctttgcccgggcgg cctcagtgag
cgagcgagcg cgcagctgcc tgcagg
変異型TTRプロモーター(TTRmut)、合成イントロン、CpGが低減した第VIII因子cDNA、ポリA及びITRを含む全長プラスミド(配列番号24)
cctgcaggca gctgcgcgct cgctcgctca ctgaggccgcccgggcaaag cccgggcgtc
gggcgacctt tggtcgcccg gcctcagtga gcgagcgagcgcgcagagag ggagtggcca
actccatcac taggggttcc tacgcgtgtc tgtctgcacatttcgtagag cgagtgttcc
gatactctaa tctccctagg caaggttcat attgacttaggttacttatt ctccttttgt
tgactaagtc aataatcaga atcagcaggt ttggagtcagcttggcaggg atcagcagcc
tgggttggaa ggagggggta taaaagcccc ttcaccaggagaagccgtca cacagatcca
caagctcctg ctagcaggta agtgccgtgt gtggttcccgcgggcctggc ctctttacgg
gttatggccc ttgcgtgcct tgaattactg acactgacatccactttttc tttttctcca
caggtttaaa cgccaccatg cagattgagc tgagcacctgcttcttcctg tgtctgctga
ggttctgctt ctctgccacc aggaggtatt acctgggggctgtggagctg agctgggact
atatgcagtc tgacctgggg gagctgcctg tggatgctaggttccccccc agggtgccca
agagcttccc ctttaacact tctgtggtgt acaagaagaccctgtttgtg gagttcactg
accacctgtt caacattgcc aagcccaggc ccccctggatggggctgctg gggcccacca
tccaggctga ggtgtatgac actgtggtga tcaccctgaagaacatggcc agccaccctg
tgagcctgca tgctgtgggg gtgagctact ggaaggcttctgagggggct gagtatgatg
accagactag ccagagggag aaggaggatg acaaggtgtttcctgggggc agccatacct
atgtgtggca ggtgctgaag gagaatggcc ccatggcctctgaccccctg tgcctgacct
acagctacct gtctcatgtg gacctggtga aggacctgaactctggcctg attggggctc
tgctggtgtg tagggagggc agcctggcta aggaaaagacccagaccctg cataagttta
tcctgctgtt tgctgtgttt gatgagggca agagctggcactctgagacc aagaacagcc
tgatgcagga tagggatgct gcctctgcca gggcttggcctaagatgcac actgtgaatg
ggtatgtgaa taggagcctg cctggcctga ttggctgccacaggaagtct gtgtactggc
atgtgattgg gatgggcacc acccctgagg tccatagcatcttcctggag ggccacactt
tcctggtgag gaaccacaga caggcctctc tggagatctctcccatcacc ttcctgactg
ctcagactct gctgatggac ctgggccagt tcctgctgttttgccatatt agcagccacc
agcatgatgg gatggaggcc tatgtgaagg tggatagctgccctgaggag cctcagctga
ggatgaagaa caatgaggag gctgaagact atgatgatgacctgactgat tctgagatgg
atgtggtgag gtttgatgat gacaatagcc ccagcttcattcagatcagg tctgtggcca
agaaacaccc caagacctgg gtgcactaca ttgctgctgaggaagaggac tgggactatg
ctcccctggt gctggcccct gatgataggt cttataagagccagtacctg aacaatgggc
cccagaggat tggcaggaag tacaagaagg tgaggttcatggcctacact gatgaaacct
tcaaaaccag ggaggccatt cagcatgagt ctggcatcctgggccctctg ctgtatgggg
aggtggggga caccctgctg atcatcttca agaaccaggccagcaggccc tacaacatct
atcctcatgg catcactgat gtgaggcccc tgtacagcaggaggctgccc aagggggtga
agcacctgaa agacttcccc atcctgcctg gggagatctttaagtataag tggactgtga
ctgtggagga tggccctacc aagtctgacc ccaggtgtctgaccaggtac tattctagct
ttgtgaacat ggagagggac ctggcctctg gcctgattgggcccctgctg atctgctaca
aggagtctgt ggaccagagg ggcaaccaga tcatgtctgacaagaggaat gtgatcctgt
tttctgtgtt tgatgagaat aggagctggt acctgactgagaacatccag aggtttctgc
ccaatcctgc tggggtgcag ctggaggatc ctgagttccaggccagcaat atcatgcata
gcatcaatgg ctatgtgttt gacagcctgc agctgtctgtgtgcctgcat gaggtggcct
actggtacat cctgagcatt ggggcccaga ctgactttctgtctgtgttc ttttctggct
ataccttcaa gcacaagatg gtgtatgagg ataccctgaccctgttcccc ttctctgggg
agactgtgtt catgagcatg gagaatcctg ggctgtggatcctggggtgc cacaactctg
attttaggaa cagggggatg actgccctgc tgaaggtgtctagctgtgat aagaacactg
gggactacta tgaggacagc tatgaggaca tttctgcttatctgctgtct aagaataatg
ccattgagcc cagaagcttc agccagaatc cccctgtgctgaagagacat cagagggaga
tcaccagaac taccctgcag tctgatcagg aggagattgactatgatgac actatctctg
tggagatgaa gaaggaggac tttgacatct atgatgaggatgagaatcag tctcccagga
gctttcagaa gaagaccaga cattacttca ttgctgctgtggagaggctg tgggactatg
gcatgagctc tagccctcat gtgctgagga acagggcccagtctggctct gtgccccagt
tcaagaaggt ggtgttccag gaattcactg atggcagcttcacccagccc ctgtacaggg
gggagctgaa tgagcacctg ggcctgctgg ggccttatatcagggctgag gtggaggata
atattatggt gactttcagg aaccaggcca gcaggccctactctttctat agcagcctga
tctcttatga ggaggatcag aggcaggggg ctgagcctaggaagaacttt gtgaagccca
atgagactaa gacctacttc tggaaggtcc agcaccacatggcccctacc aaggatgagt
ttgactgcaa ggcctgggcc tatttctctg atgtggatctggagaaggat gtccattctg
ggctgattgg ccccctgctg gtgtgccaca ctaacactctgaatcctgcc catggcaggc
aggtgactgt ccaggagttt gccctgttct tcactatctttgatgagacc aagagctggt
actttactga gaacatggag aggaactgca gagctccttgcaatattcag atggaggacc
ccaccttcaa ggagaattac aggttccatg ccattaatgggtacatcatg gacaccctgc
ctggcctggt gatggctcag gaccagagga tcaggtggtacctgctgagc atgggctcta
atgagaatat ccacagcatc cacttctctg ggcatgtgttcactgtgagg aagaaggagg
agtacaagat ggctctgtat aatctgtacc ctggggtgtttgaaactgtg gagatgctgc
cctctaaggc tggcatctgg agggtggagt gcctgattggggagcacctg catgctggca
tgagcaccct gttcctggtg tacagcaaca agtgccagacccccctgggc atggcctctg
gccacatcag ggacttccag atcactgcct ctggccagtatggccagtgg gcccccaagc
tggccaggct gcactattct ggcagcatca atgcctggagcaccaaggag cccttcagct
ggatcaaggt ggacctgctg gcccccatga tcattcatggcatcaagacc cagggggcca
ggcagaagtt cagctctctg tacatctctc agttcatcatcatgtactct ctggatggga
agaagtggca gacctacagg ggcaacagca ctggcaccctgatggtgttc tttgggaatg
tggactcttc tggcatcaag cacaacatct tcaatccccccatcattgct aggtatatta
ggctgcatcc cacccactac agcatcaggt ctaccctgaggatggagctg atgggctgtg
acctgaactc ttgcagcatg cccctgggca tggagtctaaggccatctct gatgcccaga
ttactgccag cagctacttc accaacatgt ttgccacctggagcccctct aaggccaggc
tgcatctgca ggggaggagc aatgcctgga ggcctcaggtgaacaacccc aaggagtggc
tgcaggtgga tttccagaag accatgaagg tgactggggtgaccacccag ggggtcaaga
gcctgctgac cagcatgtat gtgaaggagt tcctgatcagcagcagccag gatggccacc
agtggactct gttctttcag aatgggaagg tgaaggtgtttcagggcaat caggactctt
tcacccctgt ggtgaacagc ctggaccccc ccctgctgaccagatacctg aggatccacc
cccagtcttg ggtgcatcag attgccctga ggatggaggtgctgggctgt gaggctcagg
atctgtactg agcggccgca ataaaagatc agagctctagagatctgtgt gttggttttt
tgtgtaggaa cccctagtga tggagttggc cactccctctctgcgcgctc gctcgctcac
tgaggccggg cgaccaaagg tcgcccgacg cccgggctttgcccgggcgg cctcagtgag
cgagcgagcg cgcagctgcc tgcaggggca gcttgaaggaaatactaagg caaaggtact
gcaagtgctc gcaacattcg cttatgcgga ttattgccgtagtgccgcga cgccgggggc
aagatgcaga gattgccatg gtacaggccg tgcggttgatattgccaaaa cagagctgtg
ggggagagtt gtcgagaaag agtgcggaag atgcaaaggcgtcggctatt caaggatgcc
agcaagcgca gcatatcgcg ctgtgacgat gctaatcccaaaccttaccc aacccacctg
gtcacgcact gttaagccgc tgtatgacgc tctggtggtgcaatgccaca aagaagagtc
aatcgcagac aacattttga atgcggtcac acgttagcagcatgattgcc acggatggca
acatattaac ggcatgatat tgacttattg aataaaattgggtaaatttg actcaacgat
gggttaattc gctcgttgtg gtagtgagat gaaaagaggcggcgcttact accgattccg
cctagttggt cacttcgacg tatcgtctgg aactccaaccatcgcaggca gagaggtctg
caaaatgcaa tcccgaaaca gttcgcaggt aatagttagagcctgcataa cggtttcggg
attttttata tctgcacaac aggtaagagc attgagtcgataatcgtgaa gagtcggcga
gcctggttag ccagtgctct ttccgttgtg ctgaattaagcgaataccgg aagcagaacc
ggatcaccaa atgcgtacag gcgtcatcgc cgcccagcaacagcacaacc caaactgagc
cgtagccact gtctgtcctg aattcattag taatagttacgctgcggcct tttacacatg
accttcgtga aagcgggtgg caggaggtcg cgctaacaacctcctgccgt tttgcccgtg
catatcggtc acgaacaaat ctgattacta aacacagtagcctggatttg ttctatcagt
aatcgacctt attcctaatt aaatagagca aatccccttattgggggtaa gacatgaaga
tgccagaaaa acatgacctg ttggccgcca ttctcgcggcaaaggaacaa ggcatcgggg
caatccttgc gtttgcaatg gcgtaccttc gcggcagatataatggcggt gcgtttacaa
aaacagtaat cgacgcaacg atgtgcgcca ttatcgcctagttcattcgt gaccttctcg
acttcgccgg actaagtagc aatctcgctt atataacgagcgtgtttatc ggctacatcg
gtactgactc gattggttcg cttatcaaac gcttcgctgctaaaaaagcc ggagtagaag
atggtagaaa tcaataatca acgtaaggcg ttcctcgatatgctggcgtg gtcggaggga
actgataacg gacgtcagaa aaccagaaat catggttatgacgtcattgt aggcggagag
ctatttactg attactccga tcaccctcgc aaacttgtcacgctaaaccc aaaactcaaa
tcaacaggcg ccggacgcta ccagcttctt tcccgttggtgggatgccta ccgcaagcag
cttggcctga aagacttctc tccgaaaagt caggacgctgtggcattgca gcagattaag
gagcgtggcg ctttacctat gattgatcgt ggtgatatccgtcaggcaat cgaccgttgc
agcaatatct gggcttcact gccgggcgct ggttatggtcagttcgagca taaggctgac
agcctgattg caaaattcaa agaagcgggc ggaacggtcagagagattga tgtatgagca
gagtcaccgc gattatctcc gctctggtta tctgcatcatcgtctgcctg tcatgggctg
ttaatcatta ccgtgataac gccattacct acaaagcccagcgcgacaaa aatgccagag
aactgaagct ggcgaacgcg gcaattactg acatgcagatgcgtcagcgt gatgttgctg
cgctcgatgc aaaatacacg aaggagttag ctgatgctaaagctgaaaat gatgctctgc
gtgatgatgt tgccgctggt cgtcgtcggt tgcacatcaaagcagtctgt cagtcagtgc
gtgaagccac caccgcctcc ggcgtggata atgcagcctccccccgactg gcagacaccg
ctgaacggga ttatttcacc ctcagagaga ggctgatcactatgcaaaaa caactggaag
gaacccagaa gtatattaat gagcagtgca gatagagttgcccatatcga tgggcaactc
atgcaattat tgtgagcaat acacacgcgc ttccagcggagtataaatgc ctaaagtaat
aaaaccgagc aatccattta cgaatgtttg ctgggtttctgttttaacaa cattttctgc
gccgccacaa attttggctg catcgacagt tttcttctgcccaattccag aaacgaagaa
atgatgggtg atggtttcct ttggtgctac tgctgccggtttgttttgaa cagtaaacgt
ctgttgagca catcctgtaa taagcagggc cagcgcagtagcgagtagca tttttttcat
ggtgttattc ccgatgcttt ttgaagttcg cagaatcgtatgtgtagaaa attaaacaaa
ccctaaacaa tgagttgaaa tttcatattg ttaatatttattaatgtatg tcaggtgcga
tgaatcgtca ttgtattccc ggattaacta tgtccacagccctgacgggg aacttctctg
cgggagtgtc cgggaataat taaaacgatg cacacagggtttagcgcgta cacgtattgc
attatgccaa cgccccggtg ctgacacgga agaaaccggacgttatgatt tagcgtggaa
agatttgtgt agtgttctga atgctctcag taaatagtaatgaattatca aaggtatagt
aatatctttt atgttcatgg atatttgtaa cccatcggaaaactcctgct ttagcaagat
tttccctgta ttgctgaaat gtgatttctc ttgatttcaacctatcatag gacgtttcta
taagatgcgt gtttcttgag aatttaacat ttacaacctttttaagtcct tttattaaca
cggtgttatc gttttctaac acgatgtgaa tattatctgtggctagatag taaatataat
gtgagacgtt gtgacgtttt agttcagaat aaaacaattcacagtctaaa tcttttcgca
cttgatcgaa tatttcttta aaaatggcaa cctgagccattggtaaaacc ttccatgtga
tacgagggcg cgtagtttgc attatcgttt ttatcgtttcaatctggtct gacctccttg
tgttttgttg atgatttatg tcaaatatta ggaatgttttcacttaatag tattggttgc
gtaacaaagt gcggtcctgc tggcattctg gagggaaatacaaccgacag atgtatgtaa
ggccaacgtg ctcaaatctt catacagaaa gatttgaagtaatattttaa ccgctagatg
aagagcaagc gcatggagcg acaaaatgaa taaagaacaatctgctgatg atccctccgt
ggatctgatt cgtgtaaaaa atatgcttaa tagcaccatttctatgagtt accctgatgt
tgtaattgca tgtatagaac ataaggtgtc tctggaagcattcagagcaa ttgaggcagc
gttggtgaag cacgataata atatgaagga ttattccctggtggttgact gatcaccata
actgctaatc attcaaacta tttagtctgt gacagagccaacacgcagtc tgtcactgtc
aggaaagtgg taaaactgca actcaattac tgcaatgccctcgtaattaa gtgaatttac
aatatcgtcc tgttcggagg gaagaacgcg ggatgttcattcttcatcac ttttaattga
tgtatatgct ctcttttctg acgttagtct ccgacggcaggcttcaatga cccaggctga
gaaattcccg gacccttttt gctcaagagc gatgttaatttgttcaatca tttggttagg
aaagcggatg ttgcgggttg ttgttctgcg ggttctgttcttcgttgaca tgaggttgcc
ccgtattcag tgtcgctgat ttgtattgtc tgaagttgtttttacgttaa gttgatgcag
atcaattaat acgatacctg cgtcataatt gattatttgacgtggtttga tggcctccac
gcacgttgtg atatgtagat gataatcatt atcactttacgggtcctttc cggtgatccg
acaggttacg gggcggcgac ctgcctgatg cggtattttctccttacgca tctgtgcggt
atttcacacc gcatacgtca aagcaaccat agtacgcgccctgtagcggc gcattaagcg
cggcgggtgt ggtggttacg cgcagcgtga ccgctacacttgccagcgcc ttagcgcccg
ctcctttcgc tttcttccct tcctttctcg ccacgttcgccggctttccc cgtcaagctc
taaatcgggg gctcccttta gggttccgat ttagtgctttacggcacctc gaccccaaaa
aacttgattt gggtgatggt tcacgtagtg ggccatcgccctgatagacg gtttttcgcc
ctttgacgtt ggagtccacg ttctttaata gtggactcttgttccaaact ggaacaacac
tcaactctat ctcgggctat tcttttgatt tagacctgcaggcatgcaag cttggcactg
gccgtcgttt tacaacgtcg tgactgggaa aaccctggcgttacccaact taatcgcctt
gcagcacatc cccctttcgc cagctggcgt aatagcgaagaggcccgcac cgatcgccct
tcccaacagt tgcgcagcct gaatggcgaa tgcgatttattcaacaaagc cgccgtcccg
tcaagtcagc gtaatgctct gccagtgtta caaccaattaaccaattctg attagaaaaa
ctcatcgagc atcaaatgaa actgcaattt attcatatcaggattatcaa taccatattt
ttgaaaaagc cgtttctgta atgaaggaga aaactcaccgaggcagttcc ataggatggc
aagatcctgg tatcggtctg cgattccgac tcgtccaacatcaatacaac ctattaattt
cccctcgtca aaaataaggt tatcaagtga gaaatcaccatgagtgacga ctgaatccgg
tgagaatggc aaaagcttat gcatttcttt ccagacttgttcaacaggcc agccattacg
ctcgtcatca aaatcactcg catcaaccaa accgttattcattcgtgatt gcgcctgagc
gagacgaaat acgcgatcgc tgttaaaagg acaattacaaacaggaatcg aatgcaaccg
gcgcaggaac actgccagcg catcaacaat attttcacctgaatcaggat attcttctaa
tacctggaat gctgttttcc cggggatcgc agtggtgagtaaccatgcat catcaggagt
acggataaaa tgcttgatgg tcggaagagg cataaattccgtcagccagt ttagtctgac
catctcatct gtaacatcat tggcaacgct acctttgccatgtttcagaa acaactctgg
cgcatcgggc ttcccataca atcgatagat tgtcgcacctgattgcccga cattatcgcg
agcccattta tacccatata aatcagcatc catgttggaatttaatcgcg gcttcgagca
agacgtttcc cgttgaatat ggctcataac accccttgtattactgttta tgtaagcaga
cagttttatt gttcatgatg atatattttt atcttgtgcaatgtaacatc agagattttg
agacacaacg tggctttgtt gaataaatcg aacttttgctgagttgaagg atcagatcac
gcatcttccc gacaacgcag accgttccgt ggcaaagcaaaagttcaaaa tcaccaactg
gtccacctac aacaaagctc tcatcaaccg tggctccctcactttctggc tggatgatgg
ggcgattcag gcctggtatg agtcagcaac accttcttcacgaggcagac ctctcgacgg
agttccactg agcgtcagac cccgtagaaa agatcaaaggatcttcttga gatccttttt
ttctgcgcgt aatctgctgc ttgcaaacaa aaaaaccaccgctaccagcg gtggtttgtt
tgccggatca agagctacca actctttttc cgaaggtaactggcttcagc agagcgcaga
taccaaatac tgttcttcta gtgtagccgt agttaggccaccacttcaag aactctgtag
caccgcctac atacctcgct ctgctaatcc tgttaccagtggctgctgcc agtggcgata
agtcgtgtct taccgggttg gactcaagac gatagttaccggataaggcg cagcggtcgg
gctgaacggg gggttcgtgc acacagccca gcttggagcgaacgacctac accgaactga
gatacctaca gcgtgagcta tgagaaagcg ccacgcttcccgaagggaga aaggcggaca
ggtatccggt aagcggcagg gtcggaacag gagagcgcacgagggagctt ccagggggaa
acgcctggta tctttatagt cctgtcgggt ttcgccacctctgacttgag cgtcgatttt
tgtgatgctc gtcagggggg cggagcctat ggaaaaacgccagcaacgcg gcctttttac
ggttcctggc cttttgctgg ccttttgctc acatgt
X01~X18核酸配列によりコードされるFVIII-BDD。SQ配列を太字/下線とした(配列番号25)
MQIELSTCFFLCLLRFCFSATRRYYLGAVELSWDYMQSDLGELPVDARFPPRVPKSFPFNTSVVYKKTLFVEFTDHLFNIAKPRPPWMGLLGPTIQAEVYDTVVITLKNMASHPVSLHAVGVSYWKASEGAEYDDQTSQREKEDDKVFPGGSHTYVWQVLKENGPMASDPLCLTYSYLSHVDLVKDLNSGLIGALLVCREGSLAKEKTQTLHKFILLFAVFDEGKSWHSETKNSLMQDRDAASARAWPKMHTVNGYVNRSLPGLIGCHRKSVYWHVIGMGTTPEVHSIFLEGHTFLVRNHRQASLEISPITFLTAQTLLMDLGQFLLFCHISSHQHDGMEAYVKVDSCPEEPQLRMKNNEEAEDYDDDLTDSEMDVVRFDDDNSPSFIQIRSVAKKHPKTWVHYIAAEEEDWDYAPLVLAPDDRSYKSQYLNNGPQRIGRKYKKVRFMAYTDETFKTREAIQHESGILGPLLYGEVGDTLLIIFKNQASRPYNIYPHGITDVRPLYSRRLPKGVKHLKDFPILPGEIFKYKWTVTVEDGPTKSDPRCLTRYYSSFVNMERDLASGLIGPLLICYKESVDQRGNQIMSDKRNVILFSVFDENRSWYLTENIQRFLPNPAGVQLEDPEFQASNIMHSINGYVFDSLQLSVCLHEVAYWYILSIGAQTDFLSVFFSGYTFKHKMVYEDTLTLFPFSGETVFMSMENPGLWILGCHNSDFRNRGMTALLKVSSCDKNTGDYYEDSYEDISAYLLSKNNAIEPRSFSQNPPVLKRHQREITRTTLQSDQEEIDYDDTISVEMKKEDFDIYDEDENQSPRSFQKKTRHYFIAAVERLWDYGMSSSPHVLRNRAQSGSVPQFKKVVFQEFTDGSFTQPLYRGELNEHLGLLGPYIRAEVEDNIMVTFRNQASRPYSFYSSLISYEEDQRQGAEPRKNFVKPNETKTYFWKVQHHMAPTKDEFDCKAWAYFSDVDLEKDVHSGLIGPLLVCHTNTLNPAHGRQVTVQEFALFFTIFDETKSWYFTENMERNCRAPCNIQMEDPTFKENYRFHAINGYIMDTLPGLVMAQDQRIRWYLLSMGSNENIHSIHFSGHVFTVRKKEEYKMALYNLYPGVFETVEMLPSKAGIWRVECLIGEHLHAGMSTLFLVYSNKCQTPLGMASGHIRDFQITASGQYGQWAPKLARLHYSGSINAWSTKEPFSWIKVDLLAPMIIHGIKTQGARQKFSSLYISQFIIMYSLDGKKWQTYRGNSTGTLMVFFGNVDSSGIKHNIFNPPIIARYIRLHPTHYSIRSTLRMELMGCDLNSCSMPLGMESKAISDAQITASSYFTNMFATWSPSKARLHLQGRSNAWRPQVNNPKEWLQVDFQKTMKVTGVTTQGVKSLLTSMYVKEFLISSSQDGHQWTLFFQNGKVKVFQGNQDSFTPVVNSLDPPLLTRYLRIHPQSWVHQIALRMEVLGCEAQDLY
BDDを有する野生型FVIII(配列番号26)
MQIELSTCFFLCLLRFCFSATRRYYLGAVELSWDYMQSDLGELPVDARFPPRVPKSFPFNTSVVYKKTLFVEFTDHLFNIAKPRPPWMGLLGPTIQAEVYDTVVITLKNMASHPVSLHAVGVSYWKASEGAEYDDQTSQREKEDDKVFPGGSHTYVWQVLKENGPMASDPLCLTYSYLSHVDLVKDLNSGLIGALLVCREGSLAKEKTQTLHKFILLFAVFDEGKSWHSETKNSLMQDRDAASARAWPKMHTVNGYVNRSLPGLIGCHRKSVYWHVIGMGTTPEVHSIFLEGHTFLVRNHRQASLEISPITFLTAQTLLMDLGQFLLFCHISSHQHDGMEAYVKVDSCPEEPQLRMKNNEEAEDYDDDLTDSEMDVVRFDDDNSPSFIQIRSVAKKHPKTWVHYIAAEEEDWDYAPLVLAPDDRSYKSQYLNNGPQRIGRKYKKVRFMAYTDETFKTREAIQHESGILGPLLYGEVGDTLLIIFKNQASRPYNIYPHGITDVRPLYSRRLPKGVKHLKDFPILPGEIFKYKWTVTVEDGPTKSDPRCLTRYYSSFVNMERDLASGLIGPLLICYKESVDQRGNQIMSDKRNVILFSVFDENRSWYLTENIQRFLPNPAGVQLEDPEFQASNIMHSINGYVFDSLQLSVCLHEVAYWYILSIGAQTDFLSVFFSGYTFKHKMVYEDTLTLFPFSGETVFMSMENPGLWILGCHNSDFRNRGMTALLKVSSCDKNTGDYYEDSYEDISAYLLSKNNAIEPRSFSQNSRHPSTRQKQFNATTIPENDIEKTDPWFAHRTPMPKIQNVSSSDLLMLLRQSPTPHGLSLSDLQEAKYETFSDDPSPGAIDSNNSLSEMTHFRPQLHHSGDMVFTPESGLQLRLNEKLGTTAATELKKLDFKVSSTSNNLISTIPSDNLAAGTDNTSSLGPPSMPVHYDSQLDTTLFGKKSSPLTESGGPLSLSEENNDSKLLESGLMNSQESSWGKNVSSTESGRLFKGKRAHGPALLTKDNALFKVSISLLKTNKTSNNSATNRKTHIDGPSLLIENSPSVWQNILESDTEFKKVTPLIHDRMLMDKNATALRLNHMSNKTTSSKNMEMVQQKKEGPIPPDAQNPDMSFFKMLFLPESARWIQRTHGKNSLNSGQGPSPKQLVSLGPEKSVEGQNFLSEKNKVVVGKGEFTKDVGLKEMVFPSSRNLFLTNLDNLHENNTHNQEKKIQEEIEKKETLIQENVVLPQIHTVTGTKNFMKNLFLLSTRQNVEGSYDGAYAPVLQDFRSLNDSTNRTKKHTAHFSKKGEEENLEGLGNQTKQIVEKYACTTRISPNTSQQNFVTQRSKRALKQFRLPLEETELEKRIIVDDTSTQWSKNMKHLTPSTLTQIDYNEKEKGAITQSPLSDCLTRSHSIPQANRSPLPIAKVSSFPSIRPIYLTRVLFQDNSSHLPAASYRKKDSGVQESSHFLQGAKKNNLSLAILTLEMTGDQREVGSLGTSATNSVTYKKVENTVLPKPDLPKTSGKVELLPKVHIYQKDLFPTETSNGSPGHLDLVEGSLLQGTEGAIKWNEANRPGKVPFLRVATESSAKTPSKLLDPLAWDNHYGTQIPKEEWKSQEKSPEKTAFKKKDTILSLNACESNHAIAAINEGQNKPEIEVTWAKQGRTERLCSQNPPVLKRHQREITRTTLQSDQEEIDYDDTISVEMKKEDFDIYDEDENQSPRSFQKKTRHYFIAAVERLWDYGMSSSPHVLRNRAQSGSVPQFKKVVFQEFTDGSFTQPLYRGELNEHLGLLGPYIRAEVEDNIMVTFRNQASRPYSFYSSLISYEEDQRQGAEPRKNFVKPNETKTYFWKVQHHMAPTKDEFDCKAWAYFSDVDLEKDVHSGLIGPLLVCHTNTLNPAHGRQVTVQEFALFFTIFDETKSWYFTENMERNCRAPCNIQMEDPTFKENYRFHAINGYIMDTLPGLVMAQDQRIRWYLLSMGSNENIHSIHFSGHVFTVRKKEEYKMALYNLYPGVFETVEMLPSKAGIWRVECLIGEHLHAGMSTLFLVYSNKCQTPLGMASGHIRDFQITASGQYGQWAPKLARLHYSGSINAWSTKEPFSWIKVDLLAPMIIHGIKTQGARQKFSSLYISQFIIMYSLDGKKWQTYRGNSTGTLMVFFGNVDSSGIKHNIFNPPIIARYIRLHPTHYSIRSTLRMELMGCDLNSCSMPLGMESKAISDAQITASSYFTNMFATWSPSKARLHLQGRSNAWRPQVNNPKEWLQVDFQKTMKVTGVTTQGVKSLLTSMYVKEFLISSSQDGHQWTLFFQNGKVKVFQGNQDSFTPVVNSLDPPLLTRYLRIHPQSWVHQIALRMEVLGCEAQDLY
AAV-LK03 VP1キャプシド(配列番号27)
MAADGYLPDWLEDNLSEGIREWWALQPGAPKPKANQQHQDNARGLVLPGYKYLGPGNGLDKGEPVNAADAAALEHDKAYDQQLKAGDNPYLKYNHADAEFQERLKEDTSFGGNLGRAVFQAKKRLLEPLGLVEEAAKTAPGKKRPVDQSPQEPDSSSGVGKSGKQPARKRLNFGQTGDSESVPDPQPLGEPPAAPTSLGSNTMASGGGAPMADNNEGADGVGNSSGNWHCDSQWLGDRVITTSTRTWALPTYNNHLYKQISSQSGASNDNHYFGYSTPWGYFDFNRFHCHFSPRDWQRLINNNWGFRPKKLSFKLFNIQVKEVTQNDGTTTIANNLTSTVQVFTDSEYQLPYVLGSAHQGCLPPFPADVFMVPQYGYLTLNNGSQAVGRSSFYCLEYFPSQMLRTGNNFQFSYTFEDVPFHSSYAHSQSLDRLMNPLIDQYLYYLNRTQGTTSGTTNQSRLLFSQAGPQSMSLQARNWLPGPCYRQQRLSKTANDNNNSNFPWTAASKYHLNGRDSLVNPGPAMASHKDDEEKFFPMHGNLIFGKEGTTASNAELDNVMITDEEEIRTTNPVATEQYGTVANNLQSSNTAPTTRTVNDQGALPGMVWQDRDVYLQGPIWAKIPHTDGHFHPSPLMGGFGLKHPPPQIMIKNTPVPANPPTTFSPAKFASFITQYSTGQVSVEIEWELQKENSKRWNPEIQYTSNYNKSVNVDFTVDTNGVYSEPRPIGTRYLTRPL
AAV-SPK-8005及びAAV-SPK-hFIXにおいて使用したAAV-SPK VP1キャプシド(配列番号28)
MAADGYLPDWLEDNLSEGIREWWDLKPGAPKPKANQQKQDNGRGLVLPGYKYLGPFNGLDKGEPVNAADAAALEHDKAYDQQLQAGDNPYLRYNHADAEFQERLQEDTSFGGNLGRAVFQAKKRVLEPLGLVESPVKTAPGKKRPVEPSPQRSPDSSTGIGKKGQQPAKKRLNFGQTGDSESVPDPQPIGEPPAAPSGVGPNTMAAGGGAPMADNNEGADGVGSSSGNWHCDSTWLGDRVITTSTRTWALPTYNNHLYKQISNGTSGGSTNDNTYFGYSTPWGYFDFNRFHCHFSPRDWQRLINNNWGFRPKRLNFKLFNIQVKEVTQNEGTKTIANNLTSTIQVFTDSEYQLPYVLGSAHQGCLPPFPADVFMIPQYGYLTLNNGSQAVGRSSFYCLEYFPSQMLRTGNNFEFSYNFEDVPFHSSYAHSQSLDRLMNPLIDQYLYYLSRTQSTGGTAGTQQLLFSQAGPNNMSAQAKNWLPGPCYRQQRVSTTLSQNNNSNFAWTGATKYHLNGRDSLVNPGVAMATHKDDEERFFPSSGVLMFGKQGAGKDNVDYSSVMLTSEEEIKTTNPVATEQYGVVADNLQQQNAAPIVGAVNSQGALPGMVWQNRDVYLQGPIWAKIPHTDGNFHPSPLMGGFGLKHPPPQILIKNTPVPADPPTTFNQAKLASFITQYSTGQVSVEIEWELQKENSKRWNPEIQYTSNYYKSTNVDFAVNTEGTYSEPRPIGTRYLTRNL
BDD:Bドメイン(BD)の全体又は少なくとも部分の欠失
FVIII-BDD:Bドメイン欠失を有するFVIII
SQ:SFSQNPPVLKRHQR(配列番号29)
FVIII/SQ:SQを有するFVIII
FVIIIX01~X18:CpGが低減したFVIIIをコードする核酸変種、それぞれ配列番号1~18として示す
TTRmut:TAmGTGTAGからTATTGACTTAGへの4つの変異を有するTTRプロモーター
CO3:コドン最適化FVIII核酸変種、配列番号21として示す
NHP:非ヒト霊長動物
ALT:アラニンアミノトランスフェラーゼ
Dダイマー:血餅の分解からのタンパク質断片
SPK-8005:AAVキャプシド(配列番号28)+TTRmut-hFVIII-X07;AAV-SPK-8005とも称する
SPK-8011:AAV LK03キャプシド(配列番号27)+TTRmut-hFVIII-X07;AAV-SPK-8011とも称する
Claims (44)
- 組換えアデノ随伴ウイルス(rAAV)ベクターを含む血友病Aを有するヒトを治療するための組成物であって、前記ベクターのゲノムが、Bドメイン欠失を有する第VIII因子(FVIII)(hFVIII-BDD)をコードする核酸変種を含み、前記核酸変種が、配列番号7で表される核酸配列を含み、前記rAAVベクターが、LK03キャプシド配列(配列番号27)を含み、前記組成物は、前記ヒトが少なくとも1年にわたり突発的出血を呈しないために使用される、組成物。
- 組換えアデノ随伴ウイルス(rAAV)ベクターを含む血友病Aを有するヒトを治療するための組成物であって、前記ベクターのゲノムが、Bドメイン欠失を有する第VIII因子(FVIII)(hFVIII-BDD)をコードする核酸変種を含み、前記核酸変種が、2つより多くのシトシン-グアニンジヌクレオチド(CpG)を有さない配列番号7で表される核酸配列を含み、前記rAAVベクターが、LK03キャプシド配列(配列番号27)を含み、前記組成物は、前記ヒトが少なくとも1年にわたり突発的出血を呈しないために使用される、組成物。
- 組換えアデノ随伴ウイルス(rAAV)ベクターを含む血友病Aを有するヒトを治療するための組成物であって、前記ベクターのゲノムが、Bドメイン欠失を有する第VIII因子(FVIII)(hFVIII-BDD)をコードする核酸変種を含み、前記核酸変種が、配列番号7で表される核酸配列を含み、前記rAAVベクターが、LK03キャプシド配列(配列番号27)を含み、前記ヒトに投与されるrAAVベクターの用量が、1キログラム当たり6x1012ベクターゲノム(vg/kg)未満であり、前記組成物は、前記ヒトが少なくとも1年にわたり突発的出血を呈しないために使用される、組成物。
- 前記ヒトに投与されるrAAVベクターの用量が、下限及び上限を含めて1x109~1x1014vg/kgである、請求項1に記載の組成物。
- 前記ヒトに投与されるrAAVベクターの用量が、下限及び上限を含めて3x1011~7x1012vg/kgである、請求項1に記載の組成物。
- 凝固活性に反映される、前記ヒトにおいて発現されるhFVIII-BDDの量が、前記rAAVベクターが投与される非ヒト霊長動物試験から得られるデータに基づいて予測される量より多い、請求項1に記載の組成物。
- 凝固活性に反映される、前記ヒトにおいて発現されるhFVIII-BDDの量が、前記rAAVベクターが投与される非ヒト霊長動物試験に由来する線形回帰曲線に基づいて予測される発現より1~4倍多い、請求項1に記載の組成物。
- 凝固活性に反映される、前記ヒトにおいて発現されるhFVIII-BDDの量が、rAAVベクター投与後の14日又はそれを超える日において3%又はそれより多い、rAAVベクター投与後の21日又はそれを超える日において4%又はそれより多い、rAAVベクター投与後の21日又はそれを超える日において5%又はそれより多い、rAAVベクター投与後の21日又はそれを超える日において6%又はそれより多い、rAAVベクター投与後の21日又はそれを超える日において7%又はそれより多い、rAAVベクター投与後の28日又はそれを超える日において8%又はそれより多い、rAAVベクター投与後の28日又はそれを超える日において9%又はそれより多い、rAAVベクター投与後の35日又はそれを超える日において10%又はそれより多い、rAAVベクター投与後の35日又はそれを超える日において11%又はそれより多い、rAAVベクター投与後の35日又はそれを超える日において12%又はそれより多い、請求項1に記載の組成物。
- 凝固活性に反映される、前記ヒトにおいて発現されるhFVIII-BDDの量が、連続する14日の期間にわたり、平均して10%又はそれより多い、請求項1に記載の組成物。
- 前記rAAVベクターが、下限及び上限を含めて1x109~1x1014vg/kgの用量で前記ヒトに投与され、前記hFVIII-BDDが、rAAVベクター投与後の少なくとも1、2、3、4、5、6、7、8、9、10、11、12、13又は14の連続する日、週又は月にわたり平均で12%~100%の活性のレベルで前記ヒトにおいて産生される、請求項1に記載の組成物。
- 前記hFVIII-BDDが、活性が4、6、8又は12の週又は月にわたり5~50%より大きく変動しない定常状態で、前記ヒトにおいて産生される、請求項1に記載の組成物。
- 前記hFVIII-BDDが、活性が4、6、8又は12の週又は月にわたり25~100%より大きく変動しない定常状態で、前記ヒトにおいて産生される、請求項1に記載の組成物。
- 前記ヒトにおいてAAV抗体が、rAAVベクター投与の前に検出されないか、又は前記ヒトがAAVについて血清陰性である、請求項1に記載の組成物。
- 前記ヒトにおいてAAV抗体が、rAAVベクター投与の前に1:5であるか、又は1:5未満である、請求項1に記載の組成物。
- 前記ヒトが、rAAVベクター投与後の少なくとも1、2、3、4、5、6、7、8、9、10、11、12、13又は14の連続する週又は月にわたり前記rAAVベクターに対する細胞性免疫応答を生じない、請求項1に記載の組成物。
- 前記ヒトが、前記hFVIII-BDDの治療効果を減少させ又は遮断するために十分な前記rAAVベクターに対する液性免疫応答を発生させない、請求項1に記載の組成物。
- 前記ヒトが、rAAVベクター投与後の少なくとも1、2、3、4、5又は6カ月にわたり前記rAAVベクターに対する検出可能な抗体を産生しない、請求項1に記載の組成物。
- 免疫抑制剤を投与するステップをさらに含む、請求項1に記載の組成物。
- 前記rAAVベクターが投与された後に免疫抑制剤を投与するステップをさらに含む、請求項1に記載の組成物。
- 前記rAAVベクターがAAV血清型又はAAVシュードタイプを含み、前記AAVシュードタイプが、ITR血清型とは異なるAAVキャプシド血清型を含む、請求項1に記載の組成物。
- 前記ベクターのゲノムが、イントロン、発現制御エレメント、1つ若しくは複数のアデノ随伴ウイルス(AAV)逆末端反復配列(ITR)及び/又はフィラーポリヌクレオチド配列をさらに含む、請求項1に記載の組成物。
- 前記イントロンが、前記核酸変種内にあるか、又は前記核酸変種に隣接する、請求項21に記載の組成物。
- 前記発現制御エレメントが、前記核酸変種に作動可能に連結されている、請求項21に記載の組成物。
- 前記AAV ITRが、前記核酸変種の5’又は3’末端に隣接している、請求項21に記載の組成物。
- 前記フィラーポリヌクレオチド配列が、前記核酸変種の5’又は3’末端に隣接している、請求項21に記載の組成物。
- 前記イントロン、発現制御エレメント、1つ若しくは複数のアデノ随伴ウイルス(AAV)逆末端反復配列(ITR)及び/又はフィラーポリヌクレオチド配列が、低減したシトシン-グアニンジヌクレオチド(CpG)を有するように改変されている、請求項21に記載の組成物。
- 前記発現制御エレメントが、構成的若しくは調節可能な制御エレメント、又は組織特異的発現制御エレメント若しくはプロモーターを含む、請求項21に記載の組成物。
- 前記発現制御エレメントが、肝臓における発現を付与するエレメントを含む、請求項21に記載の組成物。
- 前記発現制御エレメントが、TTRプロモーター又は変異体TTRプロモーターを含む、請求項21に記載の組成物。
- 前記変異体TTRプロモーターが配列番号22を含む、請求項29に記載の組成物。
- 前記ITRが、AAV1、AAV2、AAV3、AAV4、AAV5、AAV6、AAV7、AAV8、AAV9、AAV10、AAV11、Rh10、Rh74若しくはAAV-2i8 AAV血清型のうちのいずれかの1つ又は複数のITR、又はこれらの組合せを含む、請求項21に記載の組成物。
- 前記ベクターのゲノムが、配列番号23に記載されるITR、プロモーター、ポリAシグナル及び/又はイントロン配列を含む、請求項1に記載の組成物。
- 前記rAAVベクターが、前記核酸変種並びに配列番号23における変異型TTRプロモーター(TTRmut)、合成イントロン、ポリA及びITRのうちの1つ又は複数を含む、請求項1に記載の組成物。
- 前記rAAVベクターが、前記核酸変種並びに配列番号23における変異型TTRプロモーター(TTRmut)、合成イントロン、ポリA及びITRのうちの1つ又は複数を含む、請求項1に記載の組成物。
- 前記rAAVベクターが医薬組成物を構成する、請求項1に記載の組成物。
- 前記医薬組成物が、生物学的に適合性の担体又は賦形剤を含む、請求項35に記載の組成物。
- LK03キャプシド(配列番号27)を有する空キャプシドを投与するステップをさらに含む、請求項1に記載の組成物。
- 前記空キャプシド対前記rAAVベクターの比が2:1~50:1である、請求項37に記載の組成物。
- 前記核酸変種によりコードされる前記hFVIII-BDDが、哺乳動物の肝臓において発現される、請求項1に記載の組成物。
- 前記rAAVベクターが、静脈内に、又は動脈内により、前記ヒトに送達される、請求項1に記載の組成物。
- 前記hFVIII-BDDが、血栓症のリスクを実質的に増加させないレベルで発現される、請求項1に記載の組成物。
- 前記hFVIII-BDDの活性が、少なくとも1、2、3若しくは4週、又は少なくとも1、2、3、4、5、6、7、8、9、10若しくは11カ月、又は少なくとも1年にわたり検出可能である、請求項1に記載の組成物。
- 前記ヒトが、少なくとも1、2、3若しくは4週、又は少なくとも1、2、3、4、5、6、7、8、9、10若しくは11カ月、又は少なくとも1年にわたりFVIIIタンパク質の予防を必要としない、請求項1に記載の組成物。
- AAV抗体の存在若しくは量、AAVに対する免疫応答、FVIII若しくはhFVIII-BDD抗体、FVIII若しくはhFVIII-BDDに対する免疫応答、FVIII若しくはhFVIII-BDDの量、FVIII若しくはhFVIII-BDDの活性、1つ若しくは複数の肝臓酵素の量若しくはレベル又は出血症状の頻度、及び/若しくは重篤度若しくは継続期間について前記ヒトを分析又はモニターするステップをさらに含む、請求項1に記載の組成物。
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762540053P | 2017-08-01 | 2017-08-01 | |
US62/540,053 | 2017-08-01 | ||
US201762583890P | 2017-11-09 | 2017-11-09 | |
US62/583,890 | 2017-11-09 | ||
US201762596670P | 2017-12-08 | 2017-12-08 | |
US201762596535P | 2017-12-08 | 2017-12-08 | |
US62/596,670 | 2017-12-08 | ||
US62/596,535 | 2017-12-08 | ||
PCT/US2018/044892 WO2019028192A1 (en) | 2017-08-01 | 2018-08-01 | METHODS OF GENE THERAPY TARGETING FACTOR VIII (FVIII) |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2020533276A JP2020533276A (ja) | 2020-11-19 |
JP2020533276A5 JP2020533276A5 (ja) | 2021-11-25 |
JP7499174B2 true JP7499174B2 (ja) | 2024-06-13 |
Family
ID=65234171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020505478A Active JP7499174B2 (ja) | 2017-08-01 | 2018-08-01 | 第viii因子(fviii)遺伝子治療法 |
Country Status (16)
Country | Link |
---|---|
US (1) | US20200237930A1 (ja) |
EP (1) | EP3661541A4 (ja) |
JP (1) | JP7499174B2 (ja) |
KR (1) | KR20200066289A (ja) |
CN (1) | CN111163796A (ja) |
AU (1) | AU2018312565A1 (ja) |
BR (1) | BR112020001979A2 (ja) |
CA (1) | CA3071519A1 (ja) |
CL (1) | CL2020000295A1 (ja) |
CO (1) | CO2020002283A2 (ja) |
IL (1) | IL272373A (ja) |
MX (1) | MX2020001402A (ja) |
PE (1) | PE20200722A1 (ja) |
PH (1) | PH12020500239A1 (ja) |
SG (1) | SG11202000650YA (ja) |
WO (1) | WO2019028192A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201508026D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Capsid |
PE20231949A1 (es) | 2015-10-30 | 2023-12-05 | Spark Therapeutics Inc | VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA |
WO2020168362A1 (en) | 2019-02-15 | 2020-08-20 | Crispr Therapeutics Ag | Gene editing for hemophilia a with improved factor viii expression |
KR20210151785A (ko) * | 2019-03-13 | 2021-12-14 | 제너레이션 바이오 컴퍼니 | 비바이러스성 dna 벡터 및 fviii 치료제 발현을 위한 이의 용도 |
CN110684798A (zh) * | 2019-09-03 | 2020-01-14 | 深圳新诺微环生物科技有限公司 | 肌肉靶向的微环dna基因治疗 |
EP4051703A1 (en) * | 2019-11-01 | 2022-09-07 | Freeline Therapeutics Limited | Factor viii polypeptide |
CN114989307B (zh) * | 2022-05-11 | 2023-08-01 | 华兰生物工程股份有限公司 | 一种重组人凝血因子Ⅷ-Fc融合蛋白及制备方法 |
CN115948408A (zh) * | 2022-09-23 | 2023-04-11 | 上海信致医药科技有限公司 | 改进的人凝血因子viii基因表达盒及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017075619A1 (en) | 2015-10-30 | 2017-05-04 | Spark Therapeutics, Inc. | Cpg reduced factor viii variants, compositions and methods and uses for treatment of hemostasis disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6818439B1 (en) * | 1994-12-30 | 2004-11-16 | Chiron Corporation | Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders |
JP2003511082A (ja) * | 1999-10-12 | 2003-03-25 | ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 第viii因子をコードするアデノ随伴ウィルスベクターとその使用法 |
EP3770169A1 (en) * | 2013-09-12 | 2021-01-27 | BioMarin Pharmaceutical Inc. | Adeno-associated virus factor viii vectors |
SG11201701033QA (en) * | 2014-08-13 | 2017-03-30 | Philadelphia Children Hospital | An improved expression cassette for packaging and expression of variant factor viii for the treatment of hemostasis disorders |
US10058624B2 (en) * | 2015-04-16 | 2018-08-28 | Emory University | Recombinant promoters and vectors for protein expression in liver and use thereof |
MA42934A (fr) * | 2015-09-24 | 2018-08-01 | Biomarin Pharm Inc | Vecteurs de facteur viii à virus adéno-associé, particules virales associées et formulations thérapeutiques comprenant ceux-ci |
AU2016343887B2 (en) * | 2015-10-28 | 2023-04-06 | Sangamo Therapeutics, Inc. | Liver-specific constructs, factor VIII expression cassettes and methods of use thereof |
US20190144524A1 (en) * | 2016-01-14 | 2019-05-16 | The Children's Hospital Of Philadelphia | Factor viii variants, nucleic acid sequences, and methods and uses for treatment of hemostasis disorders |
-
2018
- 2018-08-01 KR KR1020207005859A patent/KR20200066289A/ko not_active IP Right Cessation
- 2018-08-01 PE PE2020000180A patent/PE20200722A1/es unknown
- 2018-08-01 JP JP2020505478A patent/JP7499174B2/ja active Active
- 2018-08-01 CN CN201880064058.9A patent/CN111163796A/zh active Pending
- 2018-08-01 SG SG11202000650YA patent/SG11202000650YA/en unknown
- 2018-08-01 EP EP18840279.6A patent/EP3661541A4/en active Pending
- 2018-08-01 CA CA3071519A patent/CA3071519A1/en active Pending
- 2018-08-01 AU AU2018312565A patent/AU2018312565A1/en active Pending
- 2018-08-01 MX MX2020001402A patent/MX2020001402A/es unknown
- 2018-08-01 US US16/635,957 patent/US20200237930A1/en active Pending
- 2018-08-01 WO PCT/US2018/044892 patent/WO2019028192A1/en active Application Filing
- 2018-08-01 BR BR112020001979-8A patent/BR112020001979A2/pt unknown
-
2020
- 2020-01-30 IL IL272373A patent/IL272373A/en unknown
- 2020-01-31 PH PH12020500239A patent/PH12020500239A1/en unknown
- 2020-01-31 CL CL2020000295A patent/CL2020000295A1/es unknown
- 2020-02-28 CO CONC2020/0002283A patent/CO2020002283A2/es unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017075619A1 (en) | 2015-10-30 | 2017-05-04 | Spark Therapeutics, Inc. | Cpg reduced factor viii variants, compositions and methods and uses for treatment of hemostasis disorders |
Non-Patent Citations (2)
Title |
---|
Faust, S. M. et al.,CpG-depleted adeno-associated virus vectors evade immune detection,The Journal of Clinical Investigation,2013年,Vol.123, No.7,p.2994-3001,doi:10.1172/JCI68205 |
綿野 亮太,水上浩明,血友病と遺伝子治療,小児内科,2017年07月,第49巻,第7号,p.1038-1043 |
Also Published As
Publication number | Publication date |
---|---|
JP2020533276A (ja) | 2020-11-19 |
PE20200722A1 (es) | 2020-07-21 |
CL2020000295A1 (es) | 2020-12-04 |
CN111163796A (zh) | 2020-05-15 |
MX2020001402A (es) | 2021-01-29 |
CO2020002283A2 (es) | 2020-04-24 |
US20200237930A1 (en) | 2020-07-30 |
PH12020500239A1 (en) | 2021-01-11 |
AU2018312565A1 (en) | 2020-02-27 |
IL272373A (en) | 2020-03-31 |
BR112020001979A2 (pt) | 2020-08-18 |
RU2020108209A (ru) | 2021-09-02 |
KR20200066289A (ko) | 2020-06-09 |
CA3071519A1 (en) | 2019-02-07 |
WO2019028192A1 (en) | 2019-02-07 |
EP3661541A4 (en) | 2021-09-01 |
SG11202000650YA (en) | 2020-02-27 |
EP3661541A1 (en) | 2020-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7499174B2 (ja) | 第viii因子(fviii)遺伝子治療法 | |
JP2022137029A (ja) | CpG減少第VIII因子変種、組成物並びに止血障害の処置のための方法及び使用 | |
JP7361737B2 (ja) | 修飾された第ix因子、並びに、細胞、器官及び組織への遺伝子導入のための組成物、方法及び使用 | |
JP7237903B2 (ja) | 止血疾患を治療するための変異因子viiiのゲノム組込及び発現のための改良された発現カセット | |
US20210393801A1 (en) | Adeno-Associated Virus Vector Delivery for Muscular Dystrophies | |
KR20230069157A (ko) | GJB2를 코딩하는 재조합 아데노 연관 바이러스 (rAAV) 및 그의 용도 | |
US20220339297A1 (en) | Human gene therapy methods for hemophilia a | |
RU2808274C2 (ru) | Способы генотерапии с использованием гена фактора viii (fviii) | |
US20190144524A1 (en) | Factor viii variants, nucleic acid sequences, and methods and uses for treatment of hemostasis disorders | |
US20150210994A1 (en) | FVII Polypeptide Variants Exhibiting Altered Interaction with Endothelial Protein C Receptor (EPCR) and Methods of Use Thereof for Modulating Hemostasis | |
CN116997657A (zh) | 编码GJB2的重组腺相关病毒(rAAV)及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210727 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210727 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211018 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220809 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221101 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230221 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230515 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230804 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231114 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240201 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240507 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240603 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7499174 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |